Using Config: bash/experiments/cfg_pubmed_v2_1.cfg
Runnin subconfig: HDPLDApubmed1PU
# topics: 1000
Using dataset: corpora/pubmed.txt
Scheme: ppu_hdplda_all_topics
100000
200000
300000
400000
500000
600000
700000
800000
900000
1000000
1100000
1200000
1300000
1400000
1500000
1600000
1700000
1800000
1900000
2000000
2100000
2200000
2300000
2400000
2500000
2600000
2700000
2800000
2900000
3000000
3100000
3200000
3300000
3400000
3500000
3600000
3700000
3800000
3900000
4000000
4100000
4200000
4300000
4400000
4500000
4600000
4700000
4800000
4900000
5000000
5100000
5200000
5300000
5400000
5500000
5600000
5700000
5800000
5900000
6000000
6100000
6200000
6300000
6400000
6500000
6600000
6700000
6800000
6900000
7000000
7100000
7200000
7300000
7400000
7500000
7600000
7700000
7800000
7900000
8000000
8100000
HDP gamma: 1.0
HDP start topics: 1
PoissonPolyaUrnHDPLDAInfiniteTopics Parallell HDP.
Rare word threshold: 10
Vocabulary size: 89987

Instance list is: 8199999
Loading data instances...
Config seed:4711
Start seed: 4711
Loaded 8199999 documents, with 768434972 words in total.
Starting iterations (25000 total).
_____________________________

Starting:Mon May 20 18:17:44 EEST 2019
Active in data: 15	K = 0	Empty topics (985)
<100> Log Likelihood: -7.77977731639953E9
Active in data: 19	K = 0	Empty topics (981)
<200> Log Likelihood: -7.753029907233258E9
Active in data: 18	K = 2	Empty topics (982)
<300> Log Likelihood: -7.7426629725187645E9
Active in data: 19	K = 3	Empty topics (981)
<400> Log Likelihood: -7.721850216449265E9
Active in data: 20	K = 4	Empty topics (980)
<500> Log Likelihood: -7.678764971956075E9
Active in data: 22	K = 5	Empty topics (978)
<600> Log Likelihood: -7.635011988269835E9
Active in data: 23	K = 5	Empty topics (977)
<700> Log Likelihood: -7.600843338141356E9
Active in data: 20	K = 5	Empty topics (980)
<800> Log Likelihood: -7.58355845397732E9
Active in data: 22	K = 5	Empty topics (978)
<900> Log Likelihood: -7.571500198965545E9
Active in data: 22	K = 6	Empty topics (978)
<1000> Log Likelihood: -7.563098087056429E9
Active in data: 22	K = 6	Empty topics (978)
<1100> Log Likelihood: -7.556215560406236E9
Active in data: 23	K = 6	Empty topics (977)
<1200> Log Likelihood: -7.549251671167663E9
Active in data: 27	K = 6	Empty topics (973)
<1300> Log Likelihood: -7.541820142933396E9
Active in data: 26	K = 6	Empty topics (974)
<1400> Log Likelihood: -7.536164699411903E9
Active in data: 26	K = 6	Empty topics (974)
<1500> Log Likelihood: -7.532524908312382E9
Active in data: 27	K = 7	Empty topics (973)
<1600> Log Likelihood: -7.529282567158368E9
Active in data: 26	K = 7	Empty topics (974)
<1700> Log Likelihood: -7.526729677896064E9
Active in data: 30	K = 7	Empty topics (970)
<1800> Log Likelihood: -7.523659744381281E9
Active in data: 26	K = 7	Empty topics (974)
<1900> Log Likelihood: -7.519370645348005E9
Active in data: 28	K = 7	Empty topics (972)
<2000> Log Likelihood: -7.514934638593201E9
Active in data: 29	K = 8	Empty topics (971)
<2100> Log Likelihood: -7.510225343939036E9
Active in data: 29	K = 8	Empty topics (971)
<2200> Log Likelihood: -7.505447151957058E9
Active in data: 30	K = 8	Empty topics (970)
<2300> Log Likelihood: -7.500413164237329E9
Active in data: 30	K = 8	Empty topics (970)
<2400> Log Likelihood: -7.494632632156765E9
Active in data: 30	K = 8	Empty topics (970)
<2500> Log Likelihood: -7.487362029467059E9
Active in data: 30	K = 9	Empty topics (970)
<2600> Log Likelihood: -7.477811860452524E9
Active in data: 31	K = 9	Empty topics (969)
<2700> Log Likelihood: -7.465259633862898E9
Active in data: 31	K = 9	Empty topics (969)
<2800> Log Likelihood: -7.453516191941872E9
Active in data: 33	K = 10	Empty topics (967)
<2900> Log Likelihood: -7.444647984743792E9
Active in data: 33	K = 10	Empty topics (967)
<3000> Log Likelihood: -7.438126395585983E9
Active in data: 32	K = 11	Empty topics (968)
<3100> Log Likelihood: -7.432893632392317E9
Active in data: 33	K = 11	Empty topics (967)
<3200> Log Likelihood: -7.428649195376317E9
Active in data: 33	K = 11	Empty topics (967)
<3300> Log Likelihood: -7.42434678252294E9
Active in data: 31	K = 12	Empty topics (969)
<3400> Log Likelihood: -7.420098930996903E9
Active in data: 33	K = 12	Empty topics (967)
<3500> Log Likelihood: -7.415873515823363E9
Active in data: 32	K = 12	Empty topics (968)
<3600> Log Likelihood: -7.412093335028215E9
Active in data: 32	K = 12	Empty topics (968)
<3700> Log Likelihood: -7.408566492456781E9
Active in data: 32	K = 13	Empty topics (968)
<3800> Log Likelihood: -7.40545299467493E9
Active in data: 33	K = 13	Empty topics (967)
<3900> Log Likelihood: -7.402706035405066E9
Active in data: 32	K = 13	Empty topics (968)
<4000> Log Likelihood: -7.400207785414335E9
Active in data: 32	K = 13	Empty topics (968)
<4100> Log Likelihood: -7.397475196591998E9
Active in data: 33	K = 13	Empty topics (967)
<4200> Log Likelihood: -7.39401878751618E9
Active in data: 32	K = 14	Empty topics (968)
<4300> Log Likelihood: -7.389697219137737E9
Active in data: 33	K = 14	Empty topics (967)
<4400> Log Likelihood: -7.386894822832344E9
Active in data: 33	K = 14	Empty topics (967)
<4500> Log Likelihood: -7.384956969550311E9
Active in data: 32	K = 14	Empty topics (968)
<4600> Log Likelihood: -7.383394273531286E9
Active in data: 32	K = 14	Empty topics (968)
<4700> Log Likelihood: -7.381841028996557E9
Active in data: 34	K = 15	Empty topics (966)
<4800> Log Likelihood: -7.380234878943658E9
Active in data: 34	K = 15	Empty topics (966)
<4900> Log Likelihood: -7.378610340101715E9
Active in data: 34	K = 15	Empty topics (966)
<5000> Log Likelihood: -7.376857036145682E9
Active in data: 34	K = 15	Empty topics (966)
<5100> Log Likelihood: -7.374994730163928E9
Active in data: 34	K = 15	Empty topics (966)
<5200> Log Likelihood: -7.373194663362896E9
Active in data: 34	K = 15	Empty topics (966)
<5300> Log Likelihood: -7.371373111327068E9
Active in data: 34	K = 16	Empty topics (966)
<5400> Log Likelihood: -7.369050192899138E9
Active in data: 34	K = 16	Empty topics (966)
<5500> Log Likelihood: -7.36693269397581E9
Active in data: 34	K = 16	Empty topics (966)
<5600> Log Likelihood: -7.365226059604759E9
Active in data: 35	K = 16	Empty topics (965)
<5700> Log Likelihood: -7.364010745849756E9
Active in data: 37	K = 16	Empty topics (963)
<5800> Log Likelihood: -7.362824772259187E9
Active in data: 35	K = 17	Empty topics (965)
<5900> Log Likelihood: -7.361650911850329E9
Active in data: 35	K = 17	Empty topics (965)
<6000> Log Likelihood: -7.360215418973684E9
Active in data: 35	K = 17	Empty topics (965)
<6100> Log Likelihood: -7.358743679367801E9
Active in data: 36	K = 17	Empty topics (964)
<6200> Log Likelihood: -7.357182171703463E9
Active in data: 36	K = 17	Empty topics (964)
<6300> Log Likelihood: -7.355604391436273E9
Active in data: 38	K = 17	Empty topics (962)
<6400> Log Likelihood: -7.354038717292662E9
Active in data: 37	K = 18	Empty topics (963)
<6500> Log Likelihood: -7.35238798588039E9
Active in data: 37	K = 18	Empty topics (963)
<6600> Log Likelihood: -7.350711209592941E9
Active in data: 37	K = 18	Empty topics (963)
<6700> Log Likelihood: -7.348998453864441E9
Active in data: 37	K = 18	Empty topics (963)
<6800> Log Likelihood: -7.347538525959206E9
Active in data: 37	K = 18	Empty topics (963)
<6900> Log Likelihood: -7.346561191896431E9
Active in data: 36	K = 18	Empty topics (964)
<7000> Log Likelihood: -7.345705927527299E9
Active in data: 36	K = 18	Empty topics (964)
<7100> Log Likelihood: -7.344908239837109E9
Active in data: 36	K = 18	Empty topics (964)
<7200> Log Likelihood: -7.344129917919495E9
Active in data: 36	K = 19	Empty topics (964)
<7300> Log Likelihood: -7.343339963938608E9
Active in data: 37	K = 19	Empty topics (963)
<7400> Log Likelihood: -7.342609584708804E9
Active in data: 37	K = 19	Empty topics (963)
<7500> Log Likelihood: -7.341840356586388E9
Active in data: 40	K = 19	Empty topics (960)
<7600> Log Likelihood: -7.34127564423385E9
Active in data: 38	K = 19	Empty topics (962)
<7700> Log Likelihood: -7.3407658516051235E9
Active in data: 38	K = 19	Empty topics (962)
<7800> Log Likelihood: -7.34027719706299E9
Active in data: 39	K = 19	Empty topics (961)
<7900> Log Likelihood: -7.339691932060795E9
Active in data: 38	K = 19	Empty topics (962)
<8000> Log Likelihood: -7.339143540445571E9
Active in data: 38	K = 19	Empty topics (962)
<8100> Log Likelihood: -7.338469080184968E9
Active in data: 38	K = 19	Empty topics (962)
<8200> Log Likelihood: -7.337707041231897E9
Active in data: 38	K = 19	Empty topics (962)
<8300> Log Likelihood: -7.336843391296519E9
Active in data: 38	K = 19	Empty topics (962)
<8400> Log Likelihood: -7.335744869023867E9
Active in data: 39	K = 19	Empty topics (961)
<8500> Log Likelihood: -7.334508833271434E9
Active in data: 40	K = 19	Empty topics (960)
<8600> Log Likelihood: -7.333075055994328E9
Active in data: 38	K = 19	Empty topics (962)
<8700> Log Likelihood: -7.331414751130633E9
Active in data: 38	K = 20	Empty topics (962)
<8800> Log Likelihood: -7.329831919415317E9
Active in data: 40	K = 20	Empty topics (960)
<8900> Log Likelihood: -7.328564600337621E9
Active in data: 42	K = 20	Empty topics (958)
<9000> Log Likelihood: -7.327402518510001E9
Active in data: 43	K = 20	Empty topics (957)
<9100> Log Likelihood: -7.326477094058452E9
Active in data: 44	K = 20	Empty topics (956)
<9200> Log Likelihood: -7.325579888198434E9
Active in data: 44	K = 20	Empty topics (956)
<9300> Log Likelihood: -7.324673017526135E9
Active in data: 42	K = 20	Empty topics (958)
<9400> Log Likelihood: -7.323871156877031E9
Active in data: 41	K = 20	Empty topics (959)
<9500> Log Likelihood: -7.323045956310979E9
Active in data: 39	K = 20	Empty topics (961)
<9600> Log Likelihood: -7.32235678293648E9
Active in data: 39	K = 21	Empty topics (961)
<9700> Log Likelihood: -7.321719876767453E9
Active in data: 42	K = 21	Empty topics (958)
<9800> Log Likelihood: -7.321049023356621E9
Active in data: 43	K = 21	Empty topics (957)
<9900> Log Likelihood: -7.320618506685329E9
Active in data: 41	K = 21	Empty topics (959)
<10000> Log Likelihood: -7.319799259717646E9
Active in data: 42	K = 21	Empty topics (958)
<10100> Log Likelihood: -7.318754735934214E9
Active in data: 42	K = 21	Empty topics (958)
<10200> Log Likelihood: -7.317695821277958E9
Active in data: 42	K = 21	Empty topics (958)
<10300> Log Likelihood: -7.316779364728923E9
Active in data: 43	K = 21	Empty topics (957)
<10400> Log Likelihood: -7.316156710017258E9
Active in data: 42	K = 21	Empty topics (958)
<10500> Log Likelihood: -7.315691468641921E9
Active in data: 41	K = 22	Empty topics (959)
<10600> Log Likelihood: -7.315324014120826E9
Active in data: 41	K = 22	Empty topics (959)
<10700> Log Likelihood: -7.314889469174856E9
Active in data: 41	K = 22	Empty topics (959)
<10800> Log Likelihood: -7.314588334194446E9
Active in data: 41	K = 22	Empty topics (959)
<10900> Log Likelihood: -7.314351106877887E9
Active in data: 41	K = 22	Empty topics (959)
<11000> Log Likelihood: -7.314036600197681E9
Active in data: 41	K = 22	Empty topics (959)
<11100> Log Likelihood: -7.313553271527795E9
Active in data: 41	K = 22	Empty topics (959)
<11200> Log Likelihood: -7.313043341081945E9
Active in data: 41	K = 22	Empty topics (959)
<11300> Log Likelihood: -7.312339297853112E9
Active in data: 41	K = 22	Empty topics (959)
<11400> Log Likelihood: -7.311427410265773E9
Active in data: 42	K = 22	Empty topics (958)
<11500> Log Likelihood: -7.310447015974942E9
Active in data: 41	K = 22	Empty topics (959)
<11600> Log Likelihood: -7.309329846114503E9
Active in data: 44	K = 22	Empty topics (956)
<11700> Log Likelihood: -7.308234837595858E9
Active in data: 42	K = 22	Empty topics (958)
<11800> Log Likelihood: -7.307219661494349E9
Active in data: 42	K = 22	Empty topics (958)
<11900> Log Likelihood: -7.306359750016896E9
Active in data: 42	K = 22	Empty topics (958)
<12000> Log Likelihood: -7.305773515077614E9
Active in data: 42	K = 23	Empty topics (958)
<12100> Log Likelihood: -7.305335301447775E9
Active in data: 43	K = 23	Empty topics (957)
<12200> Log Likelihood: -7.305023534642594E9
Active in data: 43	K = 23	Empty topics (957)
<12300> Log Likelihood: -7.304731980160486E9
Active in data: 44	K = 23	Empty topics (956)
<12400> Log Likelihood: -7.3045703843489E9
Active in data: 45	K = 23	Empty topics (955)
<12500> Log Likelihood: -7.304495332941924E9
Active in data: 44	K = 23	Empty topics (956)
<12600> Log Likelihood: -7.304504363677106E9
Active in data: 44	K = 23	Empty topics (956)
<12700> Log Likelihood: -7.304501497031165E9
Active in data: 44	K = 23	Empty topics (956)
<12800> Log Likelihood: -7.304463203773921E9
Active in data: 44	K = 23	Empty topics (956)
<12900> Log Likelihood: -7.304488632884367E9
Active in data: 44	K = 23	Empty topics (956)
<13000> Log Likelihood: -7.304447076442486E9
Active in data: 44	K = 23	Empty topics (956)
<13100> Log Likelihood: -7.304410166125552E9
Active in data: 44	K = 23	Empty topics (956)
<13200> Log Likelihood: -7.304299289105911E9
Active in data: 43	K = 23	Empty topics (957)
<13300> Log Likelihood: -7.304095419150732E9
Active in data: 44	K = 23	Empty topics (956)
<13400> Log Likelihood: -7.303987345971641E9
Active in data: 44	K = 23	Empty topics (956)
<13500> Log Likelihood: -7.303700925077159E9
Active in data: 44	K = 23	Empty topics (956)
<13600> Log Likelihood: -7.30335672052221E9
Active in data: 45	K = 23	Empty topics (955)
<13700> Log Likelihood: -7.303027694958173E9
Active in data: 45	K = 23	Empty topics (955)
<13800> Log Likelihood: -7.30261043426464E9
Active in data: 45	K = 23	Empty topics (955)
<13900> Log Likelihood: -7.302155664771441E9
Active in data: 45	K = 23	Empty topics (955)
<14000> Log Likelihood: -7.301587446837471E9
Active in data: 46	K = 23	Empty topics (954)
<14100> Log Likelihood: -7.301049027152671E9
Active in data: 45	K = 23	Empty topics (955)
<14200> Log Likelihood: -7.300473728329493E9
Active in data: 45	K = 23	Empty topics (955)
<14300> Log Likelihood: -7.299936842561797E9
Active in data: 45	K = 23	Empty topics (955)
<14400> Log Likelihood: -7.299320098338264E9
Active in data: 45	K = 23	Empty topics (955)
<14500> Log Likelihood: -7.2987007193994055E9
Active in data: 45	K = 23	Empty topics (955)
<14600> Log Likelihood: -7.2979883447378E9
Active in data: 44	K = 23	Empty topics (956)
<14700> Log Likelihood: -7.297219060457581E9
Active in data: 44	K = 23	Empty topics (956)
<14800> Log Likelihood: -7.296367800129513E9
Active in data: 44	K = 24	Empty topics (956)
<14900> Log Likelihood: -7.295597238249533E9
Active in data: 46	K = 24	Empty topics (954)
<15000> Log Likelihood: -7.294871137611934E9
Active in data: 44	K = 24	Empty topics (956)
<15100> Log Likelihood: -7.294102054895088E9
Active in data: 44	K = 24	Empty topics (956)
<15200> Log Likelihood: -7.293213840421197E9
Active in data: 44	K = 24	Empty topics (956)
<15300> Log Likelihood: -7.292137481678298E9
Active in data: 44	K = 24	Empty topics (956)
<15400> Log Likelihood: -7.290787166433793E9
Active in data: 44	K = 24	Empty topics (956)
<15500> Log Likelihood: -7.289371891419502E9
Active in data: 44	K = 24	Empty topics (956)
<15600> Log Likelihood: -7.288155287518151E9
Active in data: 44	K = 24	Empty topics (956)
<15700> Log Likelihood: -7.287210349453063E9
Active in data: 44	K = 24	Empty topics (956)
<15800> Log Likelihood: -7.286395188815808E9
Active in data: 45	K = 24	Empty topics (955)
<15900> Log Likelihood: -7.285749647005701E9
Active in data: 44	K = 24	Empty topics (956)
<16000> Log Likelihood: -7.285305916296738E9
Active in data: 45	K = 24	Empty topics (955)
<16100> Log Likelihood: -7.284809110710452E9
Active in data: 44	K = 24	Empty topics (956)
<16200> Log Likelihood: -7.28432829907438E9
Active in data: 44	K = 24	Empty topics (956)
<16300> Log Likelihood: -7.283832627886028E9
Active in data: 44	K = 24	Empty topics (956)
<16400> Log Likelihood: -7.283230910124189E9
Active in data: 45	K = 24	Empty topics (955)
<16500> Log Likelihood: -7.282709018535452E9
Active in data: 45	K = 25	Empty topics (955)
<16600> Log Likelihood: -7.282258268654212E9
Active in data: 45	K = 25	Empty topics (955)
<16700> Log Likelihood: -7.281811479019035E9
Active in data: 46	K = 25	Empty topics (954)
<16800> Log Likelihood: -7.281424255361154E9
Active in data: 45	K = 25	Empty topics (955)
<16900> Log Likelihood: -7.28100998495099E9
Active in data: 45	K = 25	Empty topics (955)
<17000> Log Likelihood: -7.280628074505633E9
Active in data: 45	K = 25	Empty topics (955)
<17100> Log Likelihood: -7.280144471155835E9
Active in data: 44	K = 25	Empty topics (956)
<17200> Log Likelihood: -7.279753840648625E9
Active in data: 44	K = 25	Empty topics (956)
<17300> Log Likelihood: -7.279273610860487E9
Active in data: 44	K = 25	Empty topics (956)
<17400> Log Likelihood: -7.278869201241502E9
Active in data: 44	K = 25	Empty topics (956)
<17500> Log Likelihood: -7.278440502116551E9
Active in data: 45	K = 25	Empty topics (955)
<17600> Log Likelihood: -7.27801469573711E9
Active in data: 44	K = 25	Empty topics (956)
<17700> Log Likelihood: -7.2774433385134E9
Active in data: 44	K = 25	Empty topics (956)
<17800> Log Likelihood: -7.276833127121959E9
Active in data: 44	K = 26	Empty topics (956)
<17900> Log Likelihood: -7.276084812536403E9
Active in data: 44	K = 26	Empty topics (956)
<18000> Log Likelihood: -7.275361783747315E9
Active in data: 45	K = 26	Empty topics (955)
<18100> Log Likelihood: -7.27454351535571E9
Active in data: 45	K = 26	Empty topics (955)
<18200> Log Likelihood: -7.273625401925715E9
Active in data: 46	K = 26	Empty topics (954)
<18300> Log Likelihood: -7.272568841696293E9
Active in data: 45	K = 26	Empty topics (955)
<18400> Log Likelihood: -7.271515507854876E9
Active in data: 44	K = 27	Empty topics (956)
<18500> Log Likelihood: -7.270475676000334E9
Active in data: 44	K = 27	Empty topics (956)
<18600> Log Likelihood: -7.269363038209761E9
Active in data: 44	K = 27	Empty topics (956)
<18700> Log Likelihood: -7.268365235965854E9
Active in data: 44	K = 27	Empty topics (956)
<18800> Log Likelihood: -7.2673628235752125E9
Active in data: 46	K = 27	Empty topics (954)
<18900> Log Likelihood: -7.266564809341916E9
Active in data: 44	K = 28	Empty topics (956)
<19000> Log Likelihood: -7.265900396068752E9
Active in data: 44	K = 28	Empty topics (956)
<19100> Log Likelihood: -7.265299624824289E9
Active in data: 44	K = 28	Empty topics (956)
<19200> Log Likelihood: -7.264758720347013E9
Active in data: 43	K = 28	Empty topics (957)
<19300> Log Likelihood: -7.2642755263400345E9
Active in data: 44	K = 28	Empty topics (956)
<19400> Log Likelihood: -7.263771419198848E9
Active in data: 44	K = 28	Empty topics (956)
<19500> Log Likelihood: -7.263288617755016E9
Active in data: 44	K = 29	Empty topics (956)
<19600> Log Likelihood: -7.262872707175278E9
Active in data: 44	K = 29	Empty topics (956)
<19700> Log Likelihood: -7.262354972327685E9
Active in data: 44	K = 29	Empty topics (956)
<19800> Log Likelihood: -7.261902890441553E9
Active in data: 44	K = 29	Empty topics (956)
<19900> Log Likelihood: -7.261432450595743E9
Active in data: 44	K = 29	Empty topics (956)
<20000> Log Likelihood: -7.260917039208808E9
Active in data: 45	K = 29	Empty topics (955)
<20100> Log Likelihood: -7.260557889506721E9
Active in data: 44	K = 29	Empty topics (956)
<20200> Log Likelihood: -7.260186377414625E9
Active in data: 44	K = 29	Empty topics (956)
<20300> Log Likelihood: -7.259921442296482E9
Active in data: 44	K = 29	Empty topics (956)
<20400> Log Likelihood: -7.259637690719609E9
Active in data: 44	K = 29	Empty topics (956)
<20500> Log Likelihood: -7.2594226676128645E9
Active in data: 44	K = 29	Empty topics (956)
<20600> Log Likelihood: -7.259255957524884E9
Active in data: 44	K = 29	Empty topics (956)
<20700> Log Likelihood: -7.259071405242322E9
Active in data: 44	K = 29	Empty topics (956)
<20800> Log Likelihood: -7.258888111940081E9
Active in data: 44	K = 29	Empty topics (956)
<20900> Log Likelihood: -7.258760906191606E9
Active in data: 44	K = 29	Empty topics (956)
<21000> Log Likelihood: -7.258657591955539E9
Active in data: 45	K = 29	Empty topics (955)
<21100> Log Likelihood: -7.258572083750704E9
Active in data: 45	K = 29	Empty topics (955)
<21200> Log Likelihood: -7.258472313142304E9
Active in data: 45	K = 29	Empty topics (955)
<21300> Log Likelihood: -7.258291527579103E9
Active in data: 45	K = 29	Empty topics (955)
<21400> Log Likelihood: -7.258226557225252E9
Active in data: 46	K = 29	Empty topics (954)
<21500> Log Likelihood: -7.258114601463619E9
Active in data: 47	K = 29	Empty topics (953)
<21600> Log Likelihood: -7.257996597450695E9
Active in data: 45	K = 29	Empty topics (955)
<21700> Log Likelihood: -7.257898104144651E9
Active in data: 47	K = 29	Empty topics (953)
<21800> Log Likelihood: -7.257853506111674E9
Active in data: 46	K = 29	Empty topics (954)
<21900> Log Likelihood: -7.257743751292077E9
Active in data: 46	K = 29	Empty topics (954)
<22000> Log Likelihood: -7.257685355414049E9
Active in data: 46	K = 29	Empty topics (954)
<22100> Log Likelihood: -7.257612109831671E9
Active in data: 46	K = 29	Empty topics (954)
<22200> Log Likelihood: -7.25757240965089E9
Active in data: 46	K = 29	Empty topics (954)
<22300> Log Likelihood: -7.257505963935633E9
Active in data: 46	K = 29	Empty topics (954)
<22400> Log Likelihood: -7.257437526033887E9
Active in data: 46	K = 29	Empty topics (954)
<22500> Log Likelihood: -7.257347522794811E9
Active in data: 47	K = 29	Empty topics (953)
<22600> Log Likelihood: -7.257312851239452E9
Active in data: 48	K = 29	Empty topics (952)
<22700> Log Likelihood: -7.257192734150615E9
Active in data: 48	K = 29	Empty topics (952)
<22800> Log Likelihood: -7.25716879188753E9
Active in data: 48	K = 29	Empty topics (952)
<22900> Log Likelihood: -7.257138737704582E9
Active in data: 47	K = 29	Empty topics (953)
<23000> Log Likelihood: -7.257049087262161E9
Active in data: 47	K = 29	Empty topics (953)
<23100> Log Likelihood: -7.256971514321689E9
Active in data: 47	K = 29	Empty topics (953)
<23200> Log Likelihood: -7.256923818871617E9
Active in data: 47	K = 29	Empty topics (953)
<23300> Log Likelihood: -7.256815858734492E9
Active in data: 47	K = 29	Empty topics (953)
<23400> Log Likelihood: -7.256779998550072E9
Active in data: 47	K = 29	Empty topics (953)
<23500> Log Likelihood: -7.256681961940845E9
Active in data: 48	K = 29	Empty topics (952)
<23600> Log Likelihood: -7.256556939982485E9
Active in data: 47	K = 29	Empty topics (953)
<23700> Log Likelihood: -7.256546210913248E9
Active in data: 49	K = 29	Empty topics (951)
<23800> Log Likelihood: -7.25639422173161E9
Active in data: 48	K = 29	Empty topics (952)
<23900> Log Likelihood: -7.256256142827757E9
Active in data: 47	K = 29	Empty topics (953)
<24000> Log Likelihood: -7.256031014938726E9
Active in data: 49	K = 29	Empty topics (951)
<24100> Log Likelihood: -7.255860961656587E9
Active in data: 47	K = 29	Empty topics (953)
<24200> Log Likelihood: -7.25573146034566E9
Active in data: 47	K = 29	Empty topics (953)
<24300> Log Likelihood: -7.255562294377818E9
Active in data: 48	K = 29	Empty topics (952)
<24400> Log Likelihood: -7.2554662753281355E9
Active in data: 48	K = 29	Empty topics (952)
<24500> Log Likelihood: -7.255314053935326E9
Active in data: 47	K = 29	Empty topics (953)
<24600> Log Likelihood: -7.255163033641652E9
Active in data: 47	K = 29	Empty topics (953)
<24700> Log Likelihood: -7.255000697438859E9
Active in data: 47	K = 29	Empty topics (953)
<24800> Log Likelihood: -7.254828886316718E9
Active in data: 47	K = 29	Empty topics (953)
<24900> Log Likelihood: -7.254647944665816E9
Active in data: 47	K = 29	Empty topics (953)
<25000> Log Likelihood: -7.254543821540675E9
Finished:Fri May 24 10:09:37 EEST 2019
Top words are: 
Topic 1: care health patient medical research system clinical cost hospital program physician practice information data management problem based development quality treatment
Topic 2: gene protein dna expression sequence genes region rna sequences acid mrna promoter mutant amino transcription human analysis binding cell cdna
Topic 3: model data system analysis measurement time based parameter field distribution function values effect set dynamic number experimental technique approach image
Topic 4: risk age year women children factor population mortality prevalence ci data health smoking incidence disease rates death confidence hospital aged
Topic 5: cancer tumor patient cell carcinoma breast tumour survival malignant year stage lesion primary disease prostate diagnosis lymph metastases lung carcinomas
Topic 6: patient treatment therapy trial effect day dose month mg drug treated clinical week placebo efficacy response disease year randomized group
Topic 7: patient surgery surgical complication treatment year postoperative operation procedure abdominal month resection technique management bladder underwent operative catheter laparoscopic treated
Topic 8: binding structure protein acid interaction reaction site residues complex compound chain form beta structural domain ligand complexes crystal state amino
Topic 9: protein binding membrane acid activity cell gel human purified enzyme molecular fraction kda alpha membranes form affinity beta chromatography peptide
Topic 10: patient disease syndrome clinical diagnosis year disorder treatment symptom lesion diseases chronic severe acute children therapy features presented manifestation systemic
Topic 11: patient disorder children symptom depression social behavior factor treatment scores pain life scale health cognitive anxiety psychiatric relationship problem test
Topic 12: concentration water samples liquid solution acid degrees detection chromatography ph system analysis phase determination mass effect surface chemical material compound
Topic 13: protein cell kinase expression receptor activation pathway phosphorylation factor activity signaling gene induced binding apoptosis tyrosine regulation signal function domain
Topic 14: patient heart coronary artery ventricular myocardial cardiac left infarction aortic disease valve atrial year bypass acute pulmonary failure surgery graft
Topic 15: cell cd mice antigen lymphocytes il immune response gamma expression human class blood responses receptor lymphocyte ifn antibody anti peripheral
Topic 16: bone patient joint implant treatment fractures fracture year hip tissue flap knee dental teeth clinical mm anterior femoral surgery month
Topic 17: cell neuron electron brain rat nerve fiber nucleus layer microscopy region axon neuronal distribution number nervous system cortex section staining
Topic 18: receptor effect rat antagonist induced brain agonist dopamine activity binding neuron alpha mg kg release beta ht response stimulation action
Topic 19: ca cell channel effect calcium na concentration membrane current microm dependent induced intracellular potential transport mm release muscle atp activity
Topic 20: blood pressure flow heart effect arterial min hypertension vascular rat ischemia control cardiac artery cerebral hypertensive rate mm reperfusion angiotensin
Topic 21: cell growth expression factor beta human mrna endothelial collagen protein receptor culture fibroblast tissue tgf matrix proliferation epithelial alpha muscle
Topic 22: task effect visual memory response sleep movement activity stimulus stimuli responses experiment frequency hearing test auditory performance stimulation pattern cortex
Topic 23: activity acid enzyme liver rat effect metabolism concentration oxygen cytochrome oxidative enzymes mitochondrial iron dehydrogenase level radical glutathione activities oxidation
Topic 24: insulin glucose diet cholesterol diabetes acid level diabetic fat plasma effect lipid weight lipoprotein concentration body intake dietary fatty protein
Topic 25: rat day mice liver animal effect control mg kg gastric week induced intestinal administration level dose treated treatment ethanol injection
Topic 26: virus infection hiv antibodies antibody antigen hepatitis infected viral human immunodeficiency anti igg type assay positive vaccine sera serum patient
Topic 27: cell dna tumor effect human cancer induced activity drug apoptosis lines growth treatment vitro radiation agent dose irradiation damage line
Topic 28: il alpha platelet factor cell effect tnf induced production activity human inflammatory neutrophil lp inhibitor oxide necrosis activation release interleukin
Topic 29: gene mutation genetic chromosome analysis genes polymorphism dna region population human patient allele marker chain pcr molecular disease locus deletion
Topic 30: patient level serum control disease test concentration normal blood significantly plasma values correlation ml group healthy clinical liver positive age
Topic 31: patient imaging ct resonance lesion brain tomography mri magnetic scan cerebral images diagnosis computed contrast tumor clinical examination mr cyst
Topic 32: hormone level effect rat estrogen thyroid day pituitary concentration receptor gh lh secretion treatment growth plasma serum progesterone steroid testosterone
Topic 33: infection strain antibiotic bacterial isolates bacteria resistance coli pylori resistant tuberculosis patient positive isolated organism clinical culture aureus negative antimicrobial
Topic 34: muscle exercise nerve degrees muscles activity temperature stimulation control effect motor training spinal pain test cord rate min body force
Topic 35: species infection animal population fish host egg malaria parasite infected larvae adult dog bird number level parasites cattle water control
Topic 36: mg drug concentration dose effect kg administration plasma min ml pharmacokinetic doses oral patient day time level injection infusion hour
Topic 37: plant strain acid growth extract activity cell production species isolated effect root compound bacteria sp seed medium mutant level concentration
Topic 38: infant pregnancy fetal women birth maternal age mother pregnant neonatal day gestation weight newborn week delivery milk gestational pregnancies term
Topic 39: cell patient marrow transplantation blood bone transplant donor graft leukemia recipient acute survival stem rejection csf day transfusion liver allograft
Topic 40: cell development sperm embryos actin embryonic oocytes embryo expression stage early formation mouse spermatozoa protein function vitro drosophila filament pattern
Topic 41: lung pulmonary respiratory patient asthma airway ventilation nasal bronchial allergic allergen function test oxygen air chronic alveolar ige pressure exposure
Topic 42: renal kidney patient plasma urinary calcium excretion sodium serum level dialysis failure glomerular urine concentration renin function normal creatinine chronic
Topic 43: skin eyes patient retinal laser eye visual corneal len ocular wound cataract treatment glaucoma intraocular light surgery acuity burn optic
Topic 44: megsin pyrazinamide maspin serpin ipriflavone dias tryptophan advice pyrazinoic uteroglobin pyrazine nurse niacin quinolinic tuberculosis antituberculosis periodically granule potent summary
Topic 45: seq flame dft retardant em retardance examples ebstein jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin
Topic 46: carnitine jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas
Topic 47: hyperkalemia jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas
Topic 48: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 49: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 50: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 51: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 52: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 53: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 54: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 55: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 56: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 57: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 58: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 59: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 60: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 61: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 62: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 63: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 64: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 65: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 66: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 67: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 68: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 69: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 70: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 71: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 72: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 73: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 74: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 75: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 76: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 77: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 78: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 79: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 80: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 81: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 82: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 83: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 84: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 85: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 86: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 87: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 88: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 89: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 90: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 91: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 92: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 93: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 94: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 95: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 96: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 97: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 98: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 99: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 100: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 101: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 102: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 103: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 104: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 105: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 106: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 107: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 108: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 109: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 110: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 111: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 112: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 113: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 114: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 115: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 116: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 117: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 118: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 119: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 120: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 121: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 122: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 123: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 124: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 125: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 126: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 127: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 128: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 129: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 130: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 131: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 132: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 133: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 134: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 135: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 136: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 137: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 138: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 139: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 140: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 141: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 142: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 143: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 144: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 145: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 146: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 147: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 148: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 149: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 150: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 151: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 152: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 153: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 154: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 155: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 156: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 157: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 158: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 159: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 160: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 161: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 162: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 163: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 164: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 165: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 166: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 167: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 168: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 169: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 170: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 171: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 172: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 173: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 174: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 175: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 176: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 177: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 178: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 179: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 180: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 181: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 182: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 183: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 184: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 185: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 186: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 187: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 188: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 189: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 190: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 191: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 192: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 193: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 194: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 195: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 196: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 197: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 198: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 199: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 200: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 201: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 202: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 203: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 204: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 205: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 206: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 207: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 208: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 209: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 210: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 211: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 212: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 213: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 214: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 215: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 216: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 217: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 218: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 219: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 220: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 221: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 222: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 223: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 224: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 225: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 226: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 227: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 228: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 229: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 230: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 231: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 232: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 233: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 234: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 235: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 236: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 237: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 238: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 239: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 240: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 241: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 242: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 243: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 244: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 245: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 246: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 247: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 248: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 249: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 250: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 251: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 252: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 253: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 254: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 255: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 256: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 257: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 258: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 259: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 260: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 261: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 262: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 263: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 264: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 265: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 266: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 267: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 268: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 269: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 270: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 271: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 272: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 273: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 274: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 275: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 276: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 277: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 278: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 279: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 280: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 281: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 282: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 283: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 284: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 285: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 286: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 287: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 288: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 289: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 290: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 291: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 292: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 293: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 294: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 295: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 296: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 297: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 298: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 299: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 300: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 301: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 302: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 303: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 304: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 305: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 306: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 307: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 308: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 309: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 310: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 311: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 312: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 313: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 314: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 315: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 316: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 317: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 318: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 319: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 320: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 321: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 322: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 323: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 324: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 325: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 326: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 327: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 328: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 329: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 330: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 331: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 332: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 333: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 334: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 335: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 336: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 337: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 338: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 339: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 340: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 341: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 342: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 343: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 344: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 345: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 346: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 347: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 348: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 349: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 350: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 351: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 352: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 353: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 354: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 355: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 356: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 357: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 358: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 359: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 360: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 361: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 362: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 363: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 364: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 365: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 366: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 367: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 368: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 369: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 370: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 371: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 372: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 373: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 374: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 375: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 376: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 377: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 378: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 379: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 380: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 381: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 382: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 383: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 384: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 385: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 386: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 387: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 388: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 389: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 390: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 391: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 392: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 393: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 394: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 395: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 396: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 397: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 398: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 399: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 400: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 401: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 402: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 403: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 404: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 405: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 406: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 407: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 408: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 409: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 410: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 411: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 412: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 413: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 414: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 415: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 416: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 417: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 418: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 419: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 420: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 421: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 422: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 423: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 424: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 425: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 426: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 427: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 428: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 429: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 430: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 431: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 432: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 433: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 434: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 435: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 436: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 437: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 438: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 439: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 440: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 441: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 442: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 443: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 444: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 445: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 446: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 447: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 448: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 449: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 450: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 451: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 452: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 453: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 454: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 455: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 456: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 457: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 458: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 459: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 460: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 461: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 462: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 463: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 464: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 465: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 466: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 467: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 468: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 469: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 470: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 471: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 472: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 473: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 474: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 475: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 476: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 477: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 478: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 479: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 480: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 481: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 482: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 483: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 484: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 485: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 486: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 487: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 488: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 489: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 490: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 491: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 492: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 493: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 494: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 495: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 496: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 497: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 498: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 499: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 500: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 501: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 502: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 503: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 504: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 505: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 506: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 507: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 508: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 509: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 510: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 511: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 512: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 513: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 514: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 515: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 516: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 517: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 518: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 519: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 520: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 521: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 522: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 523: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 524: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 525: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 526: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 527: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 528: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 529: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 530: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 531: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 532: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 533: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 534: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 535: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 536: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 537: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 538: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 539: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 540: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 541: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 542: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 543: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 544: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 545: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 546: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 547: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 548: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 549: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 550: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 551: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 552: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 553: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 554: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 555: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 556: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 557: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 558: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 559: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 560: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 561: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 562: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 563: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 564: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 565: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 566: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 567: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 568: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 569: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 570: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 571: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 572: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 573: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 574: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 575: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 576: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 577: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 578: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 579: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 580: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 581: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 582: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 583: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 584: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 585: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 586: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 587: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 588: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 589: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 590: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 591: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 592: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 593: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 594: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 595: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 596: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 597: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 598: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 599: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 600: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 601: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 602: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 603: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 604: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 605: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 606: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 607: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 608: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 609: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 610: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 611: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 612: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 613: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 614: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 615: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 616: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 617: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 618: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 619: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 620: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 621: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 622: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 623: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 624: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 625: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 626: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 627: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 628: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 629: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 630: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 631: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 632: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 633: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 634: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 635: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 636: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 637: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 638: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 639: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 640: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 641: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 642: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 643: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 644: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 645: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 646: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 647: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 648: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 649: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 650: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 651: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 652: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 653: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 654: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 655: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 656: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 657: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 658: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 659: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 660: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 661: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 662: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 663: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 664: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 665: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 666: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 667: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 668: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 669: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 670: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 671: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 672: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 673: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 674: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 675: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 676: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 677: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 678: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 679: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 680: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 681: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 682: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 683: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 684: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 685: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 686: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 687: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 688: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 689: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 690: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 691: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 692: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 693: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 694: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 695: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 696: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 697: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 698: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 699: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 700: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 701: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 702: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 703: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 704: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 705: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 706: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 707: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 708: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 709: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 710: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 711: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 712: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 713: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 714: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 715: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 716: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 717: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 718: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 719: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 720: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 721: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 722: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 723: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 724: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 725: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 726: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 727: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 728: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 729: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 730: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 731: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 732: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 733: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 734: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 735: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 736: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 737: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 738: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 739: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 740: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 741: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 742: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 743: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 744: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 745: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 746: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 747: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 748: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 749: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 750: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 751: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 752: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 753: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 754: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 755: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 756: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 757: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 758: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 759: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 760: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 761: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 762: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 763: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 764: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 765: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 766: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 767: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 768: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 769: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 770: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 771: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 772: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 773: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 774: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 775: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 776: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 777: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 778: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 779: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 780: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 781: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 782: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 783: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 784: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 785: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 786: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 787: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 788: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 789: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 790: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 791: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 792: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 793: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 794: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 795: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 796: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 797: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 798: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 799: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 800: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 801: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 802: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 803: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 804: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 805: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 806: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 807: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 808: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 809: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 810: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 811: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 812: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 813: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 814: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 815: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 816: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 817: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 818: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 819: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 820: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 821: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 822: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 823: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 824: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 825: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 826: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 827: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 828: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 829: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 830: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 831: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 832: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 833: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 834: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 835: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 836: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 837: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 838: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 839: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 840: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 841: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 842: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 843: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 844: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 845: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 846: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 847: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 848: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 849: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 850: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 851: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 852: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 853: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 854: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 855: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 856: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 857: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 858: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 859: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 860: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 861: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 862: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 863: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 864: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 865: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 866: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 867: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 868: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 869: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 870: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 871: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 872: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 873: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 874: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 875: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 876: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 877: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 878: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 879: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 880: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 881: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 882: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 883: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 884: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 885: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 886: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 887: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 888: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 889: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 890: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 891: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 892: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 893: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 894: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 895: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 896: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 897: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 898: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 899: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 900: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 901: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 902: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 903: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 904: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 905: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 906: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 907: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 908: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 909: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 910: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 911: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 912: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 913: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 914: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 915: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 916: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 917: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 918: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 919: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 920: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 921: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 922: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 923: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 924: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 925: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 926: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 927: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 928: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 929: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 930: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 931: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 932: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 933: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 934: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 935: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 936: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 937: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 938: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 939: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 940: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 941: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 942: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 943: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 944: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 945: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 946: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 947: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 948: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 949: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 950: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 951: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 952: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 953: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 954: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 955: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 956: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 957: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 958: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 959: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 960: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 961: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 962: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 963: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 964: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 965: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 966: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 967: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 968: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 969: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 970: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 971: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 972: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 973: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 974: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 975: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 976: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 977: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 978: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 979: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 980: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 981: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 982: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 983: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 984: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 985: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 986: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 987: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 988: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 989: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 990: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 991: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 992: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 993: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 994: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 995: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 996: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 997: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 998: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 999: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 1000: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Relevance words are: 
Topic 1: care health medical cost research physician program practice nursing services hospital information management nurses medicine education quality public problem decision
Topic 2: gene sequence dna rna protein genes sequences expression promoter region cdna transcription plasmid mutant mrna amino transcript encoding coli domain
Topic 3: model measurement data system simulation algorithm parameter field analysis image equation error computer based dynamic prediction set time dimensional distribution
Topic 4: risk age year women children smoking ci prevalence population mortality confidence factor aged incidence older cohort smoker death rates health
Topic 5: cancer tumor carcinoma breast tumour malignant prostate metastases patient carcinomas survival lymph metastatic metastasis node stage squamous colorectal benign grade
Topic 6: treatment patient therapy trial placebo randomized efficacy dose month treated week drug mg controlled regimen day chemotherapy clinical received adverse
Topic 7: patient surgery surgical complication postoperative operation laparoscopic endoscopic abdominal resection operative catheter bladder reflux procedure bleeding obstruction esophageal underwent drainage
Topic 8: structure binding residues crystal conformation bond nmr interaction reaction conformational site complexes ligand structural compound complex protein atom derivatives spectra
Topic 9: protein binding membrane gel purified kda fraction membranes acid molecular electrophoresis enzyme affinity chromatography bound sulfate polyacrylamide glycoprotein dodecyl purification
Topic 10: syndrome disease patient clinical diagnosis disorder lupus manifestation symptom diseases year lesion severe features rare systemic epilepsy sle sign chronic
Topic 11: disorder depression social anxiety psychiatric cognitive scores children symptom psychological scale schizophrenia mental behavior adolescent personality abuse depressive rating sexual
Topic 12: water liquid samples concentration solution chromatography determination metal column detection spectrometry organic soil ph gas polymer chemical extraction degrees separation
Topic 13: kinase protein phosphorylation activation expression signaling pathway cell receptor tyrosine apoptosis nf pkc hsp kinases cyclin transcription kappab regulation signal
Topic 14: coronary ventricular artery myocardial heart cardiac patient left infarction valve aortic atrial bypass mitral echocardiography stenosis angina angioplasty fibrillation aneurysm
Topic 15: cell cd lymphocytes antigen mice immune il lymphocyte gamma ifn class nk mhc tcr dc ctl mononuclear spleen hla responses
Topic 16: bone joint fractures implant fracture hip teeth flap knee dental ligament femoral tooth mineral tendon spine mandibular bmd cartilage fixation
Topic 17: neuron cell electron axon nucleus fiber nerve layer microscopy brain neuronal ganglion ultrastructural nuclei glial immunoreactivity dorsal projection section nervous
Topic 18: receptor dopamine antagonist agonist rat ht effect nmda brain glutamate gaba serotonin opioid da adrenoceptor induced neuron adrenergic dopaminergic cholinergic
Topic 19: ca channel na calcium microm current atpase atp intracellular voltage transport membrane cyclic cai camp cyclase dependent amp release concentration
Topic 20: pressure blood flow arterial hypertension ischemia heart hypertensive reperfusion vascular angiotensin hg min mmhg systolic cerebral hemodynamic hypoxia cardiac perfusion
Topic 21: cell growth expression collagen tgf endothelial fibroblast factor mrna beta matrix mmp igf culture vegf epithelial cultured adhesion proliferation egf
Topic 22: task memory visual hearing sleep auditory stimulus stimuli eeg movement word learning speech cortex spatial temporal circadian evoked processing motor
Topic 23: enzyme activity oxidative cytochrome dehydrogenase glutathione acid mitochondrial metabolism oxidation iron antioxidant oxidase liver radical enzymes reductase oxygen superoxide gsh
Topic 24: insulin glucose cholesterol diet diabetes diabetic fat lipoprotein dietary ldl intake fatty lipid fed hdl food obese islet vitamin acid
Topic 25: rat mice liver animal day gastric ethanol intestinal bile kg hepatic control week mg intestine effect mucosal mucosa injection administration
Topic 26: virus hiv infection antibodies hepatitis antibody viral immunodeficiency infected vaccine antigen igg hcv sera viruses anti simplex influenza vaccination elisa
Topic 27: cell dna tumor apoptosis lines radiation irradiation cancer human repair effect cytotoxicity agent antitumor damage induced vitro drug line uv
Topic 28: il platelet tnf neutrophil alpha lp inflammatory oxide interleukin necrosis prostaglandin pge macrophages nitric thrombin factor production cytokines pmn cytokine
Topic 29: mutation genetic chromosome gene polymorphism allele alleles genes genotype loci locus chromosomes linkage deletion families genotypes pcr analysis dna chromosomal
Topic 30: patient serum level disease control test ra ad correlation healthy values normal ml cirrhosis concentration significantly rheumatoid marker plasma group
Topic 31: imaging ct resonance tomography mri scan magnetic images computed mr lesion pet cerebral brain intracranial cyst patient angiography spect weighted
Topic 32: hormone estrogen pituitary gh lh thyroid progesterone testosterone estradiol cortisol steroid androgen prolactin acth adrenal fsh hormones tsh prl gnrh
Topic 33: strain infection antibiotic isolates pylori bacterial bacteria tuberculosis aureus staphylococcus antimicrobial coli gram pneumoniae resistant organism salmonella pathogen mic resistance
Topic 34: muscle exercise muscles nerve degrees temperature training motor emg force spinal skeletal cord leg walking contraction stimulation athletes reflex vo
Topic 35: species malaria parasite fish larvae egg parasites bird falciparum plasmodium cattle tick host worm insect trout trypanosoma leishmania cruzi animal
Topic 36: mg drug pharmacokinetic kg dose administration concentration plasma doses anesthesia ml min oral anesthetic intravenous infusion effect analgesia propofol administered
Topic 37: plant extract strain seed leaves leaf arabidopsis root rice fermentation growth sp wheat acid bacteria fruit chloroplast maize fungi seedling
Topic 38: infant pregnancy fetal birth maternal pregnant gestation mother women neonatal newborn gestational pregnancies preterm fetuses prenatal milk delivery abortion neonates
Topic 39: transplantation marrow transplant leukemia recipient donor graft rejection bone allograft transfusion myeloid blood stem cell hematopoietic csa aml csf colony
Topic 40: sperm embryos actin oocytes spermatozoa embryo cell embryonic development filament myosin semen drosophila tubulin microtubules fertilization oocyte testis microtubule blastocyst
Topic 41: lung pulmonary asthma airway respiratory ventilation bronchial nasal allergen allergic breathing asthmatic alveolar ige expiratory inhaled cf fev allergy copd
Topic 42: renal kidney excretion dialysis glomerular urinary renin creatinine pth parathyroid hemodialysis natriuretic calcium sodium tubular urine nephropathy anp aldosterone plasma
Topic 43: eyes retinal skin eye corneal len laser ocular visual cataract glaucoma intraocular acuity burn lenses wound macular optic retina iop
Topic 44: megsin dias pyrazinoic pyrazinamide ipriflavone maspin uteroglobin pyrazine serpin niacin advice quinolinic tryptophan nurse antituberculosis periodically tuberculosis granule summary larger
Topic 45: seq retardance retardant flame dft em ebstein examples lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated
Topic 46: carnitine lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei
Topic 47: hyperkalemia lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei
Topic 48: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 49: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 50: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 51: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 52: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 53: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 54: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 55: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 56: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 57: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 58: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 59: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 60: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 61: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 62: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 63: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 64: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 65: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 66: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 67: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 68: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 69: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 70: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 71: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 72: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 73: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 74: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 75: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 76: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 77: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 78: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 79: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 80: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 81: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 82: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 83: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 84: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 85: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 86: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 87: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 88: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 89: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 90: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 91: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 92: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 93: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 94: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 95: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 96: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 97: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 98: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 99: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 100: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 101: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 102: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 103: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 104: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 105: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 106: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 107: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 108: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 109: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 110: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 111: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 112: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 113: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 114: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 115: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 116: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 117: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 118: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 119: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 120: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 121: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 122: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 123: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 124: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 125: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 126: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 127: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 128: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 129: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 130: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 131: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 132: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 133: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 134: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 135: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 136: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 137: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 138: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 139: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 140: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 141: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 142: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 143: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 144: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 145: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 146: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 147: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 148: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 149: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 150: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 151: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 152: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 153: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 154: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 155: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 156: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 157: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 158: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 159: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 160: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 161: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 162: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 163: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 164: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 165: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 166: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 167: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 168: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 169: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 170: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 171: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 172: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 173: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 174: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 175: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 176: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 177: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 178: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 179: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 180: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 181: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 182: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 183: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 184: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 185: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 186: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 187: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 188: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 189: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 190: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 191: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 192: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 193: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 194: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 195: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 196: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 197: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 198: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 199: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 200: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 201: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 202: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 203: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 204: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 205: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 206: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 207: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 208: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 209: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 210: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 211: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 212: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 213: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 214: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 215: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 216: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 217: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 218: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 219: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 220: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 221: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 222: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 223: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 224: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 225: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 226: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 227: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 228: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 229: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 230: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 231: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 232: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 233: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 234: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 235: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 236: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 237: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 238: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 239: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 240: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 241: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 242: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 243: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 244: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 245: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 246: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 247: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 248: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 249: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 250: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 251: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 252: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 253: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 254: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 255: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 256: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 257: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 258: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 259: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 260: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 261: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 262: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 263: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 264: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 265: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 266: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 267: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 268: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 269: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 270: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 271: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 272: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 273: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 274: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 275: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 276: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 277: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 278: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 279: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 280: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 281: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 282: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 283: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 284: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 285: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 286: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 287: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 288: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 289: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 290: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 291: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 292: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 293: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 294: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 295: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 296: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 297: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 298: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 299: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 300: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 301: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 302: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 303: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 304: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 305: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 306: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 307: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 308: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 309: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 310: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 311: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 312: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 313: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 314: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 315: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 316: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 317: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 318: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 319: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 320: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 321: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 322: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 323: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 324: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 325: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 326: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 327: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 328: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 329: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 330: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 331: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 332: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 333: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 334: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 335: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 336: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 337: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 338: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 339: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 340: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 341: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 342: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 343: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 344: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 345: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 346: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 347: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 348: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 349: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 350: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 351: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 352: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 353: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 354: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 355: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 356: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 357: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 358: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 359: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 360: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 361: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 362: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 363: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 364: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 365: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 366: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 367: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 368: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 369: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 370: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 371: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 372: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 373: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 374: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 375: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 376: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 377: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 378: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 379: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 380: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 381: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 382: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 383: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 384: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 385: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 386: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 387: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 388: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 389: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 390: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 391: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 392: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 393: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 394: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 395: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 396: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 397: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 398: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 399: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 400: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 401: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 402: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 403: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 404: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 405: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 406: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 407: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 408: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 409: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 410: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 411: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 412: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 413: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 414: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 415: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 416: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 417: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 418: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 419: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 420: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 421: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 422: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 423: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 424: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 425: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 426: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 427: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 428: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 429: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 430: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 431: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 432: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 433: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 434: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 435: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 436: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 437: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 438: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 439: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 440: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 441: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 442: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 443: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 444: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 445: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 446: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 447: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 448: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 449: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 450: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 451: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 452: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 453: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 454: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 455: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 456: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 457: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 458: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 459: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 460: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 461: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 462: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 463: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 464: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 465: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 466: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 467: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 468: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 469: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 470: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 471: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 472: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 473: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 474: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 475: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 476: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 477: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 478: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 479: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 480: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 481: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 482: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 483: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 484: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 485: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 486: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 487: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 488: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 489: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 490: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 491: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 492: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 493: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 494: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 495: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 496: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 497: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 498: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 499: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 500: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 501: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 502: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 503: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 504: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 505: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 506: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 507: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 508: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 509: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 510: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 511: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 512: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 513: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 514: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 515: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 516: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 517: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 518: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 519: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 520: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 521: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 522: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 523: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 524: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 525: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 526: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 527: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 528: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 529: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 530: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 531: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 532: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 533: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 534: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 535: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 536: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 537: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 538: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 539: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 540: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 541: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 542: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 543: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 544: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 545: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 546: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 547: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 548: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 549: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 550: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 551: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 552: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 553: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 554: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 555: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 556: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 557: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 558: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 559: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 560: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 561: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 562: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 563: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 564: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 565: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 566: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 567: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 568: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 569: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 570: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 571: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 572: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 573: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 574: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 575: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 576: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 577: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 578: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 579: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 580: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 581: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 582: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 583: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 584: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 585: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 586: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 587: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 588: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 589: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 590: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 591: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 592: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 593: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 594: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 595: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 596: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 597: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 598: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 599: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 600: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 601: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 602: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 603: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 604: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 605: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 606: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 607: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 608: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 609: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 610: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 611: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 612: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 613: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 614: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 615: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 616: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 617: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 618: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 619: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 620: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 621: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 622: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 623: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 624: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 625: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 626: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 627: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 628: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 629: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 630: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 631: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 632: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 633: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 634: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 635: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 636: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 637: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 638: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 639: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 640: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 641: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 642: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 643: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 644: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 645: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 646: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 647: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 648: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 649: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 650: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 651: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 652: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 653: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 654: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 655: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 656: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 657: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 658: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 659: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 660: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 661: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 662: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 663: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 664: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 665: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 666: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 667: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 668: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 669: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 670: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 671: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 672: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 673: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 674: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 675: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 676: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 677: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 678: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 679: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 680: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 681: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 682: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 683: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 684: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 685: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 686: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 687: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 688: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 689: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 690: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 691: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 692: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 693: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 694: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 695: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 696: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 697: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 698: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 699: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 700: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 701: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 702: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 703: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 704: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 705: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 706: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 707: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 708: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 709: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 710: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 711: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 712: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 713: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 714: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 715: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 716: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 717: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 718: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 719: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 720: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 721: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 722: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 723: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 724: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 725: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 726: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 727: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 728: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 729: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 730: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 731: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 732: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 733: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 734: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 735: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 736: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 737: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 738: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 739: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 740: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 741: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 742: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 743: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 744: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 745: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 746: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 747: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 748: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 749: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 750: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 751: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 752: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 753: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 754: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 755: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 756: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 757: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 758: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 759: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 760: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 761: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 762: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 763: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 764: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 765: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 766: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 767: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 768: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 769: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 770: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 771: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 772: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 773: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 774: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 775: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 776: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 777: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 778: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 779: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 780: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 781: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 782: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 783: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 784: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 785: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 786: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 787: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 788: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 789: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 790: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 791: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 792: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 793: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 794: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 795: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 796: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 797: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 798: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 799: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 800: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 801: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 802: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 803: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 804: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 805: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 806: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 807: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 808: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 809: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 810: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 811: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 812: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 813: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 814: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 815: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 816: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 817: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 818: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 819: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 820: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 821: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 822: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 823: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 824: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 825: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 826: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 827: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 828: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 829: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 830: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 831: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 832: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 833: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 834: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 835: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 836: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 837: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 838: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 839: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 840: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 841: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 842: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 843: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 844: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 845: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 846: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 847: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 848: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 849: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 850: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 851: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 852: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 853: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 854: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 855: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 856: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 857: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 858: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 859: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 860: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 861: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 862: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 863: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 864: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 865: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 866: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 867: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 868: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 869: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 870: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 871: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 872: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 873: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 874: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 875: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 876: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 877: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 878: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 879: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 880: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 881: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 882: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 883: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 884: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 885: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 886: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 887: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 888: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 889: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 890: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 891: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 892: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 893: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 894: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 895: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 896: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 897: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 898: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 899: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 900: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 901: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 902: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 903: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 904: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 905: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 906: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 907: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 908: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 909: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 910: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 911: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 912: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 913: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 914: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 915: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 916: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 917: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 918: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 919: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 920: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 921: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 922: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 923: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 924: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 925: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 926: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 927: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 928: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 929: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 930: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 931: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 932: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 933: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 934: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 935: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 936: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 937: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 938: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 939: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 940: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 941: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 942: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 943: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 944: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 945: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 946: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 947: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 948: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 949: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 950: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 951: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 952: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 953: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 954: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 955: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 956: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 957: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 958: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 959: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 960: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 961: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 962: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 963: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 964: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 965: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 966: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 967: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 968: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 969: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 970: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 971: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 972: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 973: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 974: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 975: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 976: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 977: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 978: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 979: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 980: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 981: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 982: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 983: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 984: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 985: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 986: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 987: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 988: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 989: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 990: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 991: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 992: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 993: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 994: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 995: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 996: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 997: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 998: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 999: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic 1000: lict caec drotaa cydab tigemonam aidb phaso hhrb gkd hfas ntv detubulated foxmb carminic tnfrsfb hemeselect spamm lobaplatin asei heterokont
Topic Occurence Count:
[0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0]
Active topics:
[0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 4, 4, 4, 4, 4, 4, 4, 4, 4, 4, 4, 4, 4, 4, 4, 4, 4, 4, 4, 4, 4, 4, 4, 4, 4, 4, 4, 4, 4, 4, 4, 4, 4, 4, 4, 4, 4, 4, 4, 4, 4, 4, 4, 4, 4, 4, 4, 4, 4, 4, 4, 4, 4, 4, 4, 4, 4, 4, 4, 4, 4, 4, 4, 4, 4, 4, 4, 4, 4, 4, 4, 4, 4, 4, 4, 4, 4, 4, 4, 4, 4, 4, 4, 4, 4, 4, 4, 4, 4, 4, 4, 4, 4, 4, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 19, 18, 18, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 29, 28, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29]
Active topics in data:
[14, 13, 13, 12, 11, 11, 12, 11, 10, 11, 11, 11, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 13, 13, 12, 12, 13, 12, 12, 12, 12, 12, 12, 12, 13, 13, 12, 13, 13, 13, 13, 14, 13, 13, 12, 13, 13, 13, 13, 13, 14, 14, 14, 14, 14, 14, 14, 14, 14, 15, 14, 14, 14, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 15, 14, 14, 14, 13, 13, 13, 14, 15, 15, 14, 14, 13, 14, 14, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 16, 15, 16, 15, 15, 16, 16, 15, 15, 16, 15, 15, 15, 15, 15, 15, 15, 15, 16, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 17, 16, 16, 16, 16, 16, 16, 16, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 19, 19, 19, 18, 20, 19, 19, 20, 20, 20, 20, 20, 20, 20, 21, 20, 20, 20, 20, 20, 21, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 18, 18, 18, 18, 18, 18, 18, 18, 18, 19, 19, 18, 18, 19, 18, 18, 18, 18, 19, 18, 18, 18, 18, 18, 19, 19, 19, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 19, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 17, 17, 18, 18, 18, 18, 18, 18, 18, 18, 17, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 18, 18, 18, 19, 17, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 19, 18, 18, 18, 18, 19, 17, 18, 18, 18, 18, 18, 19, 19, 19, 19, 18, 18, 18, 18, 18, 18, 18, 18, 18, 19, 18, 18, 18, 18, 18, 17, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 19, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 19, 17, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 19, 19, 19, 19, 19, 19, 19, 18, 20, 19, 19, 19, 20, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 20, 19, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 22, 21, 21, 20, 20, 20, 20, 20, 20, 20, 22, 21, 20, 20, 20, 20, 20, 21, 20, 20, 20, 20, 20, 20, 20, 21, 20, 20, 19, 23, 21, 20, 20, 20, 20, 20, 21, 20, 20, 20, 20, 20, 21, 20, 20, 22, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 21, 20, 20, 20, 20, 21, 20, 20, 20, 21, 20, 20, 20, 21, 21, 21, 20, 21, 20, 20, 20, 20, 20, 20, 20, 20, 20, 21, 20, 22, 20, 20, 20, 21, 20, 20, 20, 20, 21, 21, 21, 20, 21, 21, 20, 20, 20, 20, 21, 22, 23, 23, 23, 23, 22, 22, 23, 21, 21, 22, 21, 21, 21, 23, 22, 23, 22, 22, 22, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 20, 20, 20, 22, 20, 21, 20, 20, 22, 20, 22, 23, 21, 22, 21, 21, 21, 21, 21, 21, 21, 21, 21, 22, 21, 21, 21, 21, 20, 21, 20, 21, 20, 21, 19, 20, 21, 20, 20, 20, 20, 20, 20, 20, 20, 21, 20, 20, 21, 22, 20, 20, 20, 20, 21, 23, 22, 21, 21, 22, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 22, 22, 23, 22, 22, 22, 22, 22, 23, 23, 22, 23, 21, 22, 22, 22, 23, 23, 23, 25, 24, 25, 24, 23, 23, 23, 23, 23, 23, 23, 22, 23, 23, 23, 24, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 22, 22, 22, 22, 22, 22, 22, 21, 21, 21, 22, 21, 21, 21, 21, 22, 21, 21, 21, 21, 21, 21, 21, 22, 21, 21, 22, 21, 20, 20, 20, 20, 20, 20, 21, 20, 21, 20, 20, 20, 20, 20, 20, 20, 20, 20, 21, 20, 20, 21, 20, 21, 20, 20, 20, 21, 20, 22, 20, 20, 20, 19, 21, 20, 20, 20, 20, 20, 21, 21, 21, 20, 20, 20, 20, 20, 20, 20, 21, 20, 20, 21, 20, 20, 21, 21, 20, 20, 21, 21, 21, 21, 21, 20, 20, 20, 20, 20, 20, 20, 20, 21, 20, 20, 20, 21, 20, 21, 21, 21, 22, 21, 20, 20, 20, 21, 21, 21, 20, 21, 21, 22, 21, 22, 21, 21, 21, 21, 22, 22, 22, 22, 22, 22, 22, 22, 23, 22, 22, 22, 22, 22, 22, 23, 22, 21, 22, 22, 22, 22, 22, 22, 22, 22, 22, 23, 23, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 23, 23, 24, 23, 23, 24, 24, 24, 24, 24, 24, 23, 24, 24, 23, 23, 23, 23, 22, 22, 22, 22, 22, 22, 22, 23, 22, 22, 22, 23, 23, 22, 23, 22, 22, 22, 21, 22, 22, 22, 22, 22, 23, 22, 23, 22, 22, 21, 22, 22, 22, 23, 22, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 24, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 22, 23, 22, 22, 22, 23, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 23, 22, 22, 22, 22, 23, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 23, 22, 22, 22, 22, 22, 21, 22, 22, 23, 22, 22, 22, 23, 23, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 23, 23, 22, 22, 22, 22, 22, 22, 21, 22, 22, 22, 22, 22, 22, 22, 22, 23, 22, 22, 22, 22, 23, 22, 22, 22, 22, 22, 23, 22, 22, 21, 22, 23, 22, 22, 22, 23, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 23, 24, 24, 24, 25, 24, 24, 24, 26, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 25, 25, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 23, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 25, 24, 24, 24, 25, 23, 23, 23, 23, 24, 25, 24, 25, 25, 23, 24, 23, 23, 23, 23, 23, 23, 24, 24, 23, 23, 22, 24, 23, 23, 23, 23, 23, 23, 24, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 24, 24, 23, 24, 24, 24, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 24, 25, 26, 25, 25, 25, 25, 26, 25, 25, 25, 25, 25, 25, 25, 25, 24, 25, 25, 25, 26, 25, 25, 25, 25, 25, 26, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 26, 25, 25, 25, 26, 25, 25, 27, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 27, 26, 27, 26, 25, 26, 26, 25, 25, 25, 25, 25, 25, 25, 26, 26, 26, 26, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 26, 26, 27, 26, 26, 26, 26, 26, 26, 27, 26, 26, 27, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 27, 26, 27, 26, 26, 26, 26, 26, 27, 27, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 28, 26, 26, 27, 26, 26, 26, 26, 26, 26, 26, 26, 26, 25, 27, 27, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 27, 26, 26, 26, 27, 26, 26, 27, 27, 27, 26, 26, 26, 26, 25, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 27, 27, 27, 26, 26, 26, 27, 26, 26, 26, 26, 26, 26, 27, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 25, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 27, 26, 26, 28, 27, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 27, 27, 26, 26, 26, 26, 26, 26, 26, 26, 26, 27, 26, 26, 26, 27, 27, 27, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 25, 26, 26, 27, 26, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 28, 28, 27, 27, 27, 27, 27, 27, 27, 27, 26, 27, 27, 28, 27, 27, 27, 27, 26, 27, 27, 27, 27, 27, 28, 27, 27, 28, 27, 28, 27, 28, 27, 27, 27, 27, 28, 27, 27, 27, 27, 27, 27, 27, 28, 29, 30, 28, 28, 28, 29, 27, 27, 27, 27, 27, 27, 27, 27, 28, 28, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 28, 28, 27, 27, 27, 27, 28, 27, 28, 27, 27, 29, 27, 27, 26, 26, 26, 27, 26, 26, 27, 28, 26, 26, 26, 26, 27, 27, 26, 26, 26, 27, 26, 26, 26, 26, 25, 26, 26, 26, 27, 26, 26, 25, 26, 26, 26, 26, 26, 26, 26, 26, 27, 26, 26, 26, 26, 26, 26, 26, 26, 25, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 27, 26, 27, 26, 26, 26, 26, 27, 26, 26, 26, 27, 26, 27, 26, 26, 26, 26, 26, 26, 27, 26, 26, 26, 26, 25, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 27, 26, 26, 28, 26, 26, 26, 27, 26, 26, 26, 26, 26, 26, 27, 27, 27, 27, 27, 27, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 27, 28, 27, 27, 27, 27, 27, 28, 28, 28, 28, 28, 28, 27, 30, 28, 28, 28, 28, 28, 29, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 29, 28, 28, 28, 28, 29, 28, 27, 27, 27, 27, 27, 27, 27, 27, 27, 26, 26, 26, 27, 26, 26, 26, 26, 26, 26, 26, 26, 27, 26, 26, 27, 25, 26, 26, 27, 27, 26, 26, 26, 27, 26, 26, 26, 26, 26, 26, 26, 27, 26, 26, 26, 26, 27, 26, 26, 27, 26, 27, 26, 26, 26, 26, 26, 26, 27, 27, 26, 26, 26, 26, 26, 27, 26, 26, 27, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 27, 28, 27, 26, 27, 26, 27, 26, 29, 27, 26, 26, 26, 26, 26, 28, 26, 26, 26, 26, 26, 26, 27, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 27, 27, 27, 28, 26, 27, 27, 27, 27, 27, 27, 28, 27, 28, 27, 27, 27, 27, 28, 27, 27, 27, 27, 27, 28, 27, 27, 27, 28, 28, 28, 28, 28, 28, 28, 29, 29, 29, 28, 28, 28, 28, 29, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 29, 27, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 28, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 28, 29, 29, 29, 30, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 28, 28, 28, 28, 28, 28, 28, 29, 28, 28, 28, 29, 28, 28, 28, 28, 28, 28, 27, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 29, 29, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 30, 29, 29, 29, 29, 29, 30, 29, 29, 29, 28, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 28, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 30, 30, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 30, 29, 29, 29, 29, 30, 30, 29, 30, 30, 30, 30, 30, 30, 30, 30, 30, 30, 30, 30, 30, 30, 30, 30, 30, 30, 30, 30, 30, 30, 30, 30, 30, 30, 30, 30, 30, 30, 30, 30, 30, 30, 29, 30, 30, 30, 30, 30, 30, 29, 30, 30, 29, 30, 30, 30, 30, 30, 30, 30, 30, 30, 30, 30, 30, 30, 30, 30, 30, 30, 30, 30, 30, 30, 30, 32, 31, 31, 30, 30, 30, 30, 30, 30, 30, 30, 30, 30, 31, 30, 30, 30, 30, 30, 30, 30, 30, 30, 30, 30, 30, 31, 30, 30, 30, 30, 30, 30, 30, 30, 30, 30, 30, 30, 30, 30, 30, 30, 30, 30, 30, 31, 31, 30, 30, 30, 30, 30, 30, 30, 30, 30, 30, 30, 30, 30, 30, 30, 31, 31, 30, 30, 30, 31, 30, 30, 30, 30, 30, 30, 30, 30, 30, 30, 30, 31, 31, 31, 30, 30, 30, 30, 30, 30, 30, 30, 30, 31, 30, 30, 30, 30, 30, 30, 30, 30, 30, 30, 30, 30, 30, 30, 30, 30, 30, 30, 30, 30, 30, 30, 30, 30, 30, 30, 30, 30, 30, 30, 30, 30, 30, 30, 30, 30, 30, 30, 30, 30, 30, 31, 30, 30, 30, 30, 30, 30, 30, 30, 30, 30, 30, 31, 29, 30, 30, 30, 30, 30, 30, 30, 30, 30, 30, 29, 30, 30, 30, 30, 30, 30, 30, 30, 30, 30, 30, 30, 30, 30, 30, 30, 30, 30, 30, 30, 30, 30, 30, 30, 30, 30, 30, 30, 30, 30, 30, 30, 30, 30, 30, 30, 30, 30, 30, 30, 30, 30, 30, 30, 30, 30, 30, 31, 30, 30, 30, 30, 30, 30, 30, 30, 30, 30, 30, 30, 30, 30, 31, 30, 30, 30, 30, 30, 30, 30, 30, 30, 30, 30, 29, 30, 30, 30, 31, 30, 30, 30, 30, 30, 30, 30, 30, 30, 30, 30, 30, 30, 30, 30, 30, 30, 29, 30, 30, 30, 30, 30, 30, 32, 31, 30, 30, 30, 30, 30, 30, 30, 30, 30, 30, 30, 30, 30, 30, 31, 31, 30, 30, 30, 30, 30, 30, 30, 30, 30, 30, 30, 30, 29, 29, 30, 30, 30, 30, 30, 30, 30, 30, 30, 30, 30, 30, 30, 30, 30, 30, 30, 31, 30, 30, 30, 32, 30, 31, 30, 30, 30, 30, 30, 30, 30, 30, 30, 30, 31, 31, 30, 30, 30, 30, 30, 30, 30, 29, 30, 30, 30, 30, 31, 31, 31, 31, 31, 31, 30, 31, 31, 31, 31, 31, 31, 31, 31, 31, 31, 31, 31, 31, 31, 31, 31, 31, 31, 31, 31, 31, 31, 31, 30, 31, 31, 31, 31, 31, 31, 31, 31, 31, 31, 31, 31, 31, 31, 31, 32, 31, 31, 31, 31, 31, 31, 32, 31, 31, 31, 30, 31, 31, 31, 31, 31, 31, 31, 31, 31, 31, 31, 31, 31, 31, 31, 31, 31, 31, 31, 31, 31, 32, 32, 31, 31, 32, 32, 31, 31, 31, 32, 31, 31, 31, 31, 31, 31, 31, 30, 31, 31, 31, 31, 31, 31, 31, 31, 31, 31, 31, 31, 31, 31, 31, 31, 31, 31, 31, 31, 31, 31, 31, 31, 31, 31, 31, 31, 31, 31, 31, 31, 31, 31, 31, 31, 31, 31, 31, 32, 32, 32, 32, 32, 32, 32, 32, 32, 32, 32, 32, 31, 31, 31, 31, 31, 31, 31, 31, 31, 31, 31, 31, 31, 31, 31, 32, 32, 32, 32, 32, 32, 33, 33, 33, 33, 33, 33, 33, 33, 33, 33, 33, 33, 33, 33, 33, 33, 33, 33, 34, 32, 32, 32, 32, 32, 32, 32, 32, 32, 33, 32, 32, 32, 32, 32, 32, 32, 32, 32, 32, 32, 32, 32, 32, 32, 32, 32, 32, 32, 32, 32, 32, 32, 32, 33, 32, 33, 32, 32, 32, 32, 32, 32, 32, 32, 32, 33, 32, 32, 32, 32, 32, 32, 32, 31, 32, 32, 32, 32, 32, 32, 32, 32, 32, 32, 32, 32, 32, 32, 32, 32, 32, 33, 33, 33, 33, 33, 33, 33, 33, 33, 33, 33, 33, 33, 33, 33, 33, 34, 33, 33, 33, 33, 33, 34, 33, 33, 33, 33, 32, 32, 32, 32, 32, 32, 32, 32, 32, 32, 32, 33, 32, 32, 32, 31, 32, 32, 32, 32, 32, 32, 32, 32, 32, 32, 32, 31, 32, 32, 31, 32, 32, 32, 32, 32, 33, 32, 32, 31, 32, 32, 32, 32, 32, 32, 32, 33, 32, 32, 32, 32, 32, 32, 33, 34, 33, 33, 33, 33, 33, 34, 33, 33, 33, 33, 32, 32, 32, 32, 32, 32, 32, 32, 32, 32, 32, 32, 32, 32, 32, 32, 32, 32, 33, 33, 32, 32, 32, 32, 32, 32, 32, 32, 33, 32, 33, 32, 32, 32, 32, 32, 32, 32, 32, 32, 32, 32, 32, 32, 32, 32, 32, 33, 33, 32, 32, 33, 33, 32, 32, 32, 32, 32, 32, 32, 32, 32, 32, 32, 32, 32, 32, 32, 32, 32, 32, 32, 32, 32, 32, 32, 32, 32, 32, 32, 32, 32, 33, 32, 32, 32, 32, 32, 32, 32, 32, 32, 32, 32, 32, 32, 32, 32, 32, 32, 32, 32, 32, 32, 32, 32, 32, 32, 32, 32, 32, 32, 32, 32, 32, 32, 32, 32, 32, 32, 32, 32, 32, 32, 32, 32, 32, 32, 32, 32, 32, 32, 32, 32, 32, 31, 32, 32, 32, 32, 32, 32, 32, 32, 32, 34, 33, 33, 33, 32, 32, 32, 32, 32, 32, 32, 32, 32, 32, 32, 33, 32, 32, 32, 32, 32, 32, 33, 32, 32, 32, 33, 32, 32, 32, 33, 32, 32, 32, 32, 33, 33, 32, 32, 33, 32, 32, 32, 32, 32, 32, 32, 32, 32, 32, 32, 32, 32, 32, 32, 33, 33, 33, 33, 33, 33, 33, 33, 33, 33, 32, 33, 33, 33, 33, 33, 33, 33, 33, 33, 34, 33, 33, 33, 33, 33, 33, 33, 33, 33, 33, 33, 33, 33, 33, 33, 33, 33, 33, 33, 33, 33, 34, 34, 33, 33, 33, 33, 33, 34, 33, 33, 33, 33, 33, 33, 33, 33, 33, 33, 33, 33, 33, 34, 33, 33, 34, 33, 33, 33, 33, 33, 33, 33, 33, 33, 33, 33, 33, 33, 33, 33, 33, 33, 33, 32, 32, 32, 32, 32, 32, 31, 32, 31, 31, 31, 31, 32, 32, 32, 31, 31, 31, 31, 31, 31, 31, 31, 31, 31, 31, 31, 32, 31, 32, 32, 32, 32, 32, 32, 32, 31, 31, 31, 31, 32, 32, 31, 32, 31, 31, 31, 32, 32, 31, 31, 32, 31, 31, 31, 31, 31, 31, 32, 31, 31, 31, 31, 31, 31, 31, 31, 31, 31, 31, 31, 31, 31, 32, 31, 32, 31, 31, 31, 31, 31, 31, 32, 31, 31, 31, 31, 31, 31, 31, 31, 32, 31, 31, 31, 31, 31, 31, 31, 31, 31, 31, 32, 31, 31, 33, 31, 31, 31, 31, 31, 31, 31, 32, 31, 31, 32, 33, 31, 31, 31, 31, 31, 30, 31, 31, 31, 31, 31, 31, 31, 31, 31, 31, 31, 31, 31, 31, 31, 32, 32, 32, 32, 32, 32, 32, 32, 32, 31, 32, 33, 32, 33, 32, 32, 33, 32, 32, 33, 33, 32, 32, 32, 33, 32, 32, 32, 33, 33, 34, 33, 32, 32, 32, 32, 32, 32, 32, 33, 33, 32, 32, 32, 32, 32, 32, 32, 32, 32, 32, 33, 32, 32, 32, 32, 32, 33, 32, 33, 32, 32, 32, 32, 33, 32, 32, 32, 33, 32, 33, 32, 32, 32, 32, 32, 32, 32, 33, 32, 32, 32, 32, 32, 32, 32, 32, 32, 32, 32, 32, 32, 32, 32, 32, 32, 32, 32, 33, 33, 33, 33, 33, 32, 32, 32, 32, 32, 32, 32, 32, 32, 32, 32, 33, 33, 33, 34, 33, 33, 33, 33, 33, 33, 33, 33, 33, 33, 33, 34, 34, 33, 34, 33, 34, 33, 33, 33, 34, 33, 33, 33, 33, 33, 33, 33, 33, 33, 33, 33, 33, 33, 32, 32, 32, 32, 32, 32, 32, 32, 32, 32, 32, 33, 32, 32, 32, 32, 32, 32, 34, 33, 33, 32, 33, 32, 32, 33, 33, 32, 32, 32, 32, 32, 32, 32, 33, 32, 32, 32, 32, 32, 32, 32, 32, 32, 32, 32, 32, 32, 33, 32, 33, 33, 33, 32, 32, 32, 32, 33, 32, 33, 33, 33, 32, 32, 32, 32, 33, 33, 32, 32, 32, 32, 32, 32, 32, 32, 32, 32, 33, 33, 32, 32, 32, 32, 32, 32, 32, 32, 32, 32, 32, 32, 32, 32, 32, 32, 33, 33, 33, 33, 32, 32, 32, 31, 32, 32, 32, 32, 32, 32, 32, 32, 32, 33, 32, 32, 33, 33, 32, 33, 33, 32, 32, 32, 32, 32, 32, 32, 32, 32, 33, 32, 32, 32, 32, 32, 32, 32, 32, 32, 32, 32, 32, 32, 32, 32, 33, 33, 33, 35, 34, 34, 33, 33, 32, 33, 33, 32, 32, 32, 32, 32, 32, 32, 32, 32, 33, 32, 32, 33, 33, 32, 32, 32, 32, 32, 33, 32, 33, 34, 32, 34, 33, 33, 32, 33, 31, 32, 31, 32, 33, 32, 32, 32, 33, 33, 32, 32, 32, 32, 32, 32, 32, 32, 32, 32, 32, 33, 32, 32, 32, 32, 32, 32, 32, 33, 33, 33, 33, 34, 33, 33, 33, 33, 33, 33, 33, 33, 33, 33, 33, 33, 33, 33, 33, 33, 33, 33, 33, 33, 33, 33, 33, 33, 33, 33, 33, 33, 33, 33, 33, 33, 33, 33, 33, 33, 33, 33, 33, 33, 34, 33, 33, 33, 33, 34, 33, 33, 33, 33, 34, 33, 33, 33, 33, 33, 34, 33, 32, 33, 33, 33, 34, 34, 33, 33, 33, 33, 33, 33, 34, 33, 33, 33, 34, 33, 33, 33, 33, 33, 33, 33, 34, 33, 33, 33, 33, 33, 33, 33, 34, 32, 33, 33, 33, 33, 33, 33, 33, 33, 33, 33, 33, 33, 34, 33, 33, 32, 32, 32, 32, 32, 32, 32, 32, 32, 32, 32, 33, 32, 32, 32, 32, 32, 32, 32, 33, 32, 33, 32, 32, 32, 32, 32, 32, 32, 32, 33, 32, 32, 34, 34, 33, 32, 33, 33, 33, 32, 33, 33, 33, 33, 33, 33, 32, 33, 33, 33, 34, 33, 33, 32, 32, 33, 33, 33, 33, 32, 32, 33, 33, 33, 32, 32, 32, 32, 33, 32, 32, 32, 32, 32, 32, 32, 32, 32, 32, 32, 32, 32, 31, 32, 32, 32, 32, 32, 32, 32, 32, 32, 32, 32, 32, 32, 33, 32, 32, 32, 32, 32, 31, 32, 33, 32, 32, 32, 32, 32, 32, 32, 33, 32, 32, 32, 32, 33, 33, 32, 33, 32, 32, 32, 32, 32, 32, 32, 32, 32, 32, 33, 32, 32, 32, 32, 32, 32, 32, 31, 32, 32, 32, 32, 32, 31, 32, 32, 32, 32, 32, 32, 32, 32, 32, 32, 32, 32, 32, 33, 33, 32, 32, 32, 32, 32, 31, 32, 32, 32, 32, 33, 32, 32, 32, 32, 32, 32, 32, 32, 32, 32, 32, 34, 33, 33, 33, 33, 34, 33, 33, 33, 33, 33, 33, 33, 33, 33, 33, 33, 33, 33, 33, 33, 33, 33, 33, 34, 34, 33, 33, 33, 33, 34, 35, 33, 33, 33, 34, 34, 34, 34, 33, 33, 34, 33, 33, 33, 33, 33, 33, 34, 33, 34, 35, 34, 34, 34, 34, 34, 34, 34, 33, 32, 34, 33, 34, 33, 33, 33, 33, 34, 33, 33, 33, 33, 33, 33, 33, 33, 34, 33, 34, 33, 33, 32, 33, 33, 34, 33, 33, 33, 33, 33, 33, 33, 33, 33, 33, 33, 33, 33, 33, 34, 35, 35, 35, 35, 34, 35, 35, 33, 33, 33, 34, 33, 33, 33, 33, 34, 33, 33, 34, 33, 33, 33, 33, 33, 33, 34, 34, 33, 33, 33, 33, 34, 33, 33, 34, 33, 33, 33, 33, 33, 34, 35, 33, 34, 33, 33, 33, 33, 33, 34, 33, 33, 33, 34, 34, 33, 33, 34, 34, 33, 34, 33, 33, 33, 33, 33, 33, 35, 33, 33, 33, 33, 33, 32, 32, 33, 33, 32, 32, 32, 34, 33, 33, 32, 32, 32, 31, 32, 32, 32, 32, 32, 32, 32, 32, 32, 32, 32, 32, 32, 32, 32, 32, 32, 31, 32, 32, 32, 32, 32, 32, 33, 33, 33, 34, 33, 33, 33, 33, 34, 33, 33, 33, 33, 33, 34, 33, 33, 33, 34, 33, 33, 33, 33, 33, 33, 34, 34, 33, 33, 34, 33, 33, 33, 33, 34, 34, 33, 34, 34, 33, 33, 33, 33, 33, 33, 33, 33, 33, 33, 33, 34, 33, 34, 33, 33, 33, 33, 33, 33, 33, 33, 33, 33, 33, 33, 33, 33, 33, 33, 33, 33, 33, 33, 33, 33, 33, 33, 33, 33, 33, 33, 33, 33, 33, 33, 33, 33, 33, 33, 33, 34, 35, 33, 33, 33, 34, 33, 33, 33, 33, 35, 34, 33, 33, 33, 33, 33, 33, 34, 33, 33, 34, 33, 33, 33, 33, 33, 33, 33, 33, 34, 33, 33, 33, 33, 34, 34, 33, 34, 33, 33, 33, 33, 33, 33, 33, 32, 33, 33, 33, 33, 33, 33, 34, 33, 33, 33, 33, 33, 33, 34, 33, 34, 34, 33, 33, 33, 33, 33, 34, 36, 35, 33, 34, 33, 34, 34, 33, 33, 33, 33, 33, 33, 33, 33, 33, 34, 33, 33, 33, 33, 33, 33, 34, 33, 34, 34, 33, 33, 33, 33, 33, 33, 33, 33, 33, 33, 33, 33, 33, 33, 33, 33, 33, 33, 33, 33, 33, 33, 32, 33, 32, 33, 33, 33, 33, 33, 33, 33, 33, 33, 33, 33, 33, 33, 33, 33, 33, 33, 33, 33, 34, 34, 33, 33, 33, 33, 32, 32, 32, 32, 32, 32, 32, 32, 32, 32, 32, 32, 32, 32, 33, 33, 32, 32, 32, 32, 32, 32, 32, 32, 32, 32, 32, 32, 32, 32, 32, 32, 33, 32, 32, 32, 32, 32, 32, 32, 32, 32, 32, 32, 32, 32, 32, 31, 32, 31, 33, 33, 33, 33, 32, 32, 32, 32, 32, 32, 32, 32, 32, 32, 31, 32, 32, 32, 32, 31, 31, 33, 32, 33, 32, 33, 33, 32, 32, 32, 32, 32, 32, 32, 32, 32, 32, 32, 32, 31, 32, 32, 32, 32, 33, 32, 32, 32, 32, 32, 32, 32, 32, 33, 33, 33, 32, 32, 33, 32, 33, 32, 33, 32, 33, 32, 32, 32, 32, 32, 33, 32, 33, 32, 32, 33, 32, 32, 32, 32, 32, 32, 32, 32, 32, 32, 33, 33, 32, 32, 32, 33, 32, 32, 32, 32, 32, 33, 33, 32, 32, 32, 32, 33, 32, 32, 32, 32, 32, 32, 32, 32, 32, 32, 32, 33, 32, 32, 32, 32, 32, 32, 33, 32, 33, 32, 32, 32, 32, 33, 32, 32, 32, 32, 32, 33, 32, 32, 32, 32, 32, 32, 32, 32, 32, 32, 32, 32, 32, 32, 32, 32, 33, 33, 33, 33, 33, 33, 34, 33, 33, 33, 33, 34, 33, 33, 34, 35, 33, 33, 33, 33, 33, 33, 33, 33, 33, 33, 33, 33, 34, 34, 34, 34, 35, 35, 35, 35, 35, 35, 35, 34, 34, 34, 34, 34, 34, 35, 34, 34, 33, 33, 33, 33, 33, 33, 34, 33, 33, 33, 33, 33, 34, 33, 33, 34, 33, 33, 33, 33, 33, 33, 33, 34, 33, 33, 34, 34, 34, 33, 33, 33, 33, 33, 33, 34, 34, 34, 34, 34, 34, 34, 34, 34, 35, 34, 34, 34, 34, 34, 34, 34, 35, 34, 34, 34, 34, 35, 34, 34, 34, 35, 35, 35, 36, 35, 35, 35, 35, 35, 35, 34, 35, 34, 34, 34, 34, 34, 34, 34, 34, 34, 34, 34, 34, 35, 34, 35, 34, 34, 34, 34, 34, 34, 34, 34, 34, 34, 34, 34, 36, 34, 35, 34, 34, 34, 34, 34, 34, 34, 34, 34, 34, 34, 34, 35, 34, 34, 34, 34, 34, 34, 34, 34, 34, 34, 34, 34, 34, 34, 35, 34, 34, 34, 34, 34, 34, 34, 34, 35, 34, 34, 34, 34, 34, 34, 34, 34, 35, 35, 34, 34, 34, 34, 34, 34, 34, 34, 34, 34, 34, 34, 34, 34, 34, 34, 34, 34, 34, 34, 33, 34, 34, 34, 34, 34, 34, 34, 34, 35, 34, 34, 34, 35, 35, 35, 35, 35, 35, 35, 37, 35, 35, 35, 35, 34, 35, 35, 35, 35, 35, 35, 35, 35, 35, 36, 36, 36, 35, 36, 36, 36, 36, 36, 36, 36, 35, 35, 35, 35, 36, 36, 35, 35, 35, 35, 35, 35, 36, 35, 37, 37, 36, 36, 35, 35, 35, 35, 35, 35, 35, 35, 35, 35, 35, 35, 35, 35, 35, 35, 34, 34, 35, 34, 34, 34, 34, 34, 34, 34, 34, 34, 34, 34, 34, 34, 33, 35, 34, 34, 34, 34, 34, 34, 34, 34, 34, 34, 34, 34, 34, 34, 34, 34, 34, 34, 34, 34, 34, 35, 34, 34, 34, 35, 34, 34, 34, 35, 33, 34, 34, 34, 34, 34, 34, 35, 34, 34, 34, 34, 34, 34, 34, 34, 34, 34, 34, 33, 35, 34, 34, 34, 34, 34, 34, 34, 34, 34, 34, 34, 34, 34, 34, 34, 34, 34, 35, 35, 35, 33, 34, 35, 34, 34, 34, 34, 34, 34, 34, 34, 34, 34, 34, 34, 34, 34, 34, 34, 34, 34, 34, 34, 34, 34, 35, 34, 34, 34, 34, 34, 34, 34, 34, 34, 35, 34, 34, 34, 34, 34, 34, 34, 33, 34, 34, 35, 34, 34, 34, 34, 34, 34, 34, 34, 34, 34, 34, 34, 34, 34, 34, 34, 34, 35, 34, 34, 34, 35, 35, 34, 35, 35, 34, 35, 34, 33, 34, 34, 34, 34, 34, 34, 35, 34, 35, 34, 34, 34, 34, 34, 35, 34, 35, 34, 34, 34, 34, 34, 33, 34, 35, 34, 35, 34, 35, 35, 35, 35, 34, 36, 35, 34, 34, 34, 34, 34, 34, 34, 34, 34, 34, 34, 34, 34, 34, 34, 34, 34, 34, 34, 34, 34, 35, 34, 36, 35, 35, 35, 33, 36, 34, 34, 34, 34, 34, 34, 35, 34, 34, 34, 34, 34, 34, 34, 34, 34, 34, 34, 34, 34, 35, 36, 35, 34, 34, 34, 34, 34, 34, 34, 34, 34, 35, 34, 34, 34, 34, 34, 35, 35, 35, 35, 34, 34, 34, 35, 34, 34, 34, 34, 34, 34, 34, 34, 34, 34, 35, 36, 35, 36, 37, 35, 35, 36, 35, 35, 34, 35, 35, 35, 35, 36, 35, 35, 35, 35, 35, 35, 35, 35, 35, 35, 35, 35, 35, 35, 35, 35, 35, 35, 35, 36, 35, 35, 36, 36, 35, 35, 35, 36, 36, 36, 37, 36, 36, 37, 35, 34, 34, 34, 34, 34, 34, 34, 34, 34, 34, 34, 34, 34, 34, 34, 34, 34, 34, 35, 34, 34, 34, 34, 34, 34, 34, 34, 34, 34, 34, 34, 34, 33, 35, 35, 35, 34, 34, 34, 34, 34, 34, 35, 34, 34, 35, 36, 36, 34, 34, 34, 34, 34, 34, 34, 34, 35, 34, 34, 34, 35, 34, 34, 34, 34, 35, 34, 35, 35, 34, 34, 34, 34, 34, 34, 35, 35, 34, 35, 34, 34, 34, 34, 34, 34, 33, 34, 34, 34, 34, 35, 34, 34, 34, 34, 34, 34, 34, 34, 35, 34, 34, 34, 35, 34, 35, 34, 34, 34, 34, 34, 34, 34, 34, 34, 35, 34, 34, 34, 34, 34, 34, 34, 34, 34, 34, 34, 34, 34, 34, 34, 34, 33, 34, 34, 34, 35, 34, 34, 35, 34, 34, 34, 34, 34, 34, 35, 34, 35, 35, 34, 34, 34, 34, 34, 34, 34, 34, 35, 35, 34, 34, 35, 34, 34, 35, 34, 35, 34, 34, 36, 34, 35, 34, 34, 34, 34, 34, 34, 34, 35, 34, 34, 34, 34, 34, 35, 35, 36, 35, 34, 34, 35, 34, 34, 34, 34, 34, 34, 35, 34, 34, 34, 34, 34, 34, 34, 34, 34, 34, 34, 34, 35, 34, 34, 34, 34, 34, 34, 34, 34, 34, 34, 34, 34, 34, 34, 34, 35, 34, 34, 34, 36, 35, 36, 36, 35, 35, 35, 34, 34, 34, 36, 34, 34, 35, 34, 34, 34, 35, 35, 34, 35, 34, 34, 34, 34, 34, 34, 34, 34, 34, 35, 34, 34, 34, 34, 34, 34, 35, 34, 34, 35, 34, 34, 34, 34, 34, 34, 34, 34, 34, 34, 33, 34, 34, 34, 34, 34, 35, 34, 35, 34, 34, 35, 34, 34, 34, 34, 34, 34, 35, 35, 35, 35, 35, 35, 36, 35, 35, 35, 35, 35, 35, 35, 34, 34, 34, 35, 35, 35, 35, 35, 35, 35, 35, 36, 36, 36, 35, 35, 36, 36, 35, 35, 35, 35, 36, 35, 35, 35, 35, 35, 36, 36, 36, 35, 35, 35, 35, 35, 35, 35, 35, 35, 35, 35, 36, 35, 35, 35, 35, 34, 35, 35, 34, 35, 35, 35, 36, 35, 35, 35, 35, 35, 35, 35, 35, 36, 35, 35, 35, 35, 35, 36, 36, 35, 35, 35, 36, 35, 37, 36, 36, 36, 35, 36, 37, 36, 36, 35, 36, 36, 37, 36, 36, 36, 36, 37, 36, 36, 36, 36, 36, 36, 37, 35, 35, 35, 35, 35, 36, 36, 36, 35, 35, 35, 36, 36, 35, 35, 35, 35, 36, 35, 35, 35, 35, 35, 35, 35, 36, 35, 35, 35, 35, 35, 35, 35, 35, 35, 35, 35, 36, 35, 35, 35, 35, 35, 35, 35, 35, 35, 35, 35, 35, 35, 35, 35, 35, 35, 35, 35, 35, 35, 35, 35, 36, 35, 35, 35, 35, 36, 35, 35, 35, 35, 36, 35, 35, 35, 35, 35, 35, 35, 35, 35, 35, 35, 35, 36, 35, 35, 36, 35, 35, 35, 34, 35, 35, 35, 35, 36, 35, 35, 35, 35, 35, 35, 35, 35, 36, 35, 35, 36, 35, 36, 35, 36, 36, 36, 36, 36, 35, 35, 35, 36, 35, 35, 35, 35, 35, 35, 35, 35, 35, 35, 35, 35, 35, 35, 35, 35, 35, 35, 35, 36, 35, 36, 36, 36, 35, 35, 35, 35, 35, 35, 35, 35, 35, 36, 35, 37, 37, 36, 37, 37, 38, 37, 38, 37, 35, 35, 35, 35, 35, 35, 35, 36, 36, 36, 34, 35, 35, 34, 36, 35, 35, 35, 35, 35, 36, 36, 36, 35, 35, 36, 36, 35, 35, 35, 35, 36, 36, 35, 35, 35, 35, 35, 35, 35, 35, 35, 35, 35, 35, 35, 35, 35, 35, 35, 35, 36, 35, 35, 35, 35, 35, 35, 36, 35, 35, 35, 36, 35, 35, 35, 35, 36, 36, 37, 35, 35, 35, 35, 35, 35, 35, 35, 35, 35, 35, 35, 35, 35, 35, 35, 35, 35, 35, 34, 35, 35, 35, 35, 35, 34, 35, 35, 35, 35, 35, 35, 35, 36, 35, 35, 36, 36, 35, 35, 35, 35, 35, 35, 35, 35, 35, 35, 36, 35, 35, 35, 36, 35, 35, 35, 36, 35, 35, 35, 35, 35, 35, 35, 35, 35, 35, 35, 35, 35, 35, 35, 35, 34, 35, 36, 35, 35, 35, 35, 35, 36, 35, 35, 35, 36, 35, 35, 35, 35, 36, 35, 35, 35, 35, 35, 36, 35, 35, 35, 36, 35, 35, 35, 35, 35, 35, 35, 35, 35, 36, 35, 35, 35, 36, 36, 36, 36, 36, 36, 37, 37, 36, 35, 36, 36, 36, 36, 36, 36, 36, 36, 36, 37, 36, 36, 36, 36, 36, 36, 36, 36, 36, 36, 36, 36, 36, 35, 36, 36, 36, 36, 36, 36, 36, 36, 36, 36, 36, 36, 36, 36, 36, 36, 37, 36, 36, 36, 36, 36, 36, 36, 36, 36, 36, 36, 36, 36, 36, 36, 37, 36, 36, 37, 36, 36, 36, 36, 37, 36, 36, 36, 36, 36, 36, 36, 37, 36, 36, 37, 36, 36, 37, 36, 36, 36, 37, 36, 36, 36, 36, 36, 36, 36, 36, 36, 36, 36, 36, 36, 36, 36, 36, 36, 36, 36, 35, 36, 37, 36, 36, 37, 37, 36, 36, 36, 36, 36, 36, 36, 36, 36, 36, 36, 36, 36, 36, 36, 36, 36, 36, 37, 36, 36, 36, 36, 36, 36, 36, 36, 36, 36, 36, 36, 36, 36, 36, 36, 36, 36, 36, 36, 36, 37, 36, 36, 36, 36, 36, 36, 36, 36, 36, 36, 36, 37, 36, 37, 36, 36, 36, 36, 36, 37, 36, 36, 36, 36, 36, 36, 36, 36, 36, 36, 36, 36, 36, 36, 36, 36, 36, 36, 37, 36, 36, 36, 37, 36, 36, 35, 36, 37, 37, 36, 36, 36, 36, 37, 36, 36, 36, 36, 36, 36, 36, 36, 36, 36, 36, 36, 36, 36, 36, 36, 36, 36, 36, 36, 36, 36, 36, 36, 36, 36, 36, 36, 36, 38, 39, 38, 37, 37, 37, 37, 37, 37, 37, 37, 37, 37, 37, 37, 37, 37, 37, 37, 37, 37, 37, 37, 37, 37, 37, 37, 37, 37, 38, 37, 37, 37, 37, 37, 36, 37, 37, 37, 36, 37, 37, 37, 37, 38, 37, 37, 37, 37, 37, 37, 37, 37, 37, 37, 37, 37, 37, 37, 37, 37, 37, 37, 37, 37, 39, 37, 37, 37, 36, 37, 37, 37, 37, 37, 37, 37, 37, 37, 37, 37, 37, 37, 37, 37, 37, 37, 37, 37, 37, 37, 37, 37, 36, 37, 38, 38, 37, 37, 37, 37, 36, 37, 37, 37, 37, 37, 37, 37, 37, 37, 37, 37, 37, 37, 37, 37, 37, 37, 37, 37, 37, 37, 37, 37, 37, 37, 37, 37, 37, 37, 37, 37, 37, 39, 37, 37, 37, 38, 37, 37, 37, 37, 37, 37, 37, 37, 37, 37, 37, 37, 37, 37, 37, 37, 37, 37, 37, 37, 38, 37, 38, 37, 38, 37, 37, 37, 37, 37, 36, 37, 38, 37, 37, 38, 38, 37, 37, 37, 37, 37, 37, 37, 37, 38, 37, 37, 37, 38, 39, 38, 37, 37, 37, 37, 38, 38, 37, 37, 37, 37, 37, 37, 37, 37, 37, 37, 37, 37, 37, 37, 37, 37, 37, 37, 37, 37, 37, 37, 38, 38, 39, 38, 38, 38, 38, 38, 38, 38, 37, 37, 38, 38, 38, 39, 38, 38, 38, 39, 38, 38, 38, 38, 38, 38, 38, 38, 38, 38, 38, 39, 38, 38, 38, 38, 38, 38, 39, 38, 38, 38, 39, 38, 38, 38, 39, 38, 38, 38, 38, 38, 38, 38, 38, 37, 38, 38, 38, 38, 40, 38, 38, 38, 38, 38, 38, 38, 38, 37, 37, 37, 38, 37, 37, 37, 37, 37, 37, 37, 38, 37, 37, 37, 37, 37, 37, 38, 37, 37, 37, 37, 38, 37, 38, 38, 37, 37, 37, 37, 37, 38, 38, 37, 38, 37, 37, 37, 37, 38, 37, 37, 37, 37, 37, 37, 36, 37, 37, 38, 38, 39, 37, 37, 37, 37, 37, 37, 38, 37, 37, 37, 37, 37, 37, 38, 37, 37, 37, 37, 37, 37, 37, 36, 37, 37, 37, 37, 38, 38, 37, 37, 37, 37, 37, 37, 37, 37, 37, 37, 36, 37, 37, 37, 37, 37, 37, 37, 37, 37, 36, 37, 37, 37, 37, 37, 38, 38, 38, 37, 37, 37, 37, 37, 37, 37, 37, 37, 37, 38, 37, 37, 37, 37, 37, 37, 37, 37, 37, 37, 37, 37, 37, 37, 37, 37, 37, 37, 37, 37, 38, 37, 37, 37, 37, 37, 37, 38, 37, 37, 37, 36, 36, 37, 37, 37, 37, 37, 37, 37, 37, 37, 37, 37, 37, 37, 37, 37, 37, 36, 37, 37, 37, 37, 37, 37, 37, 37, 37, 37, 37, 37, 38, 37, 37, 37, 37, 37, 38, 37, 37, 37, 37, 37, 37, 38, 37, 38, 37, 37, 37, 37, 37, 37, 37, 37, 37, 37, 37, 38, 38, 37, 37, 37, 37, 37, 37, 37, 37, 37, 37, 37, 37, 37, 38, 37, 37, 37, 37, 37, 37, 37, 37, 37, 37, 37, 37, 37, 37, 37, 37, 37, 37, 37, 37, 37, 37, 37, 37, 37, 37, 37, 37, 37, 36, 36, 36, 36, 36, 36, 37, 37, 36, 35, 36, 35, 36, 36, 36, 37, 36, 36, 36, 36, 36, 35, 36, 36, 36, 36, 36, 36, 36, 36, 36, 38, 36, 36, 36, 36, 35, 36, 36, 36, 36, 36, 36, 36, 36, 37, 37, 36, 36, 36, 36, 36, 36, 36, 36, 36, 36, 36, 36, 35, 36, 36, 36, 37, 36, 36, 35, 36, 36, 36, 37, 36, 36, 36, 36, 36, 36, 36, 36, 36, 36, 36, 36, 36, 36, 36, 36, 37, 36, 36, 36, 36, 37, 37, 36, 36, 36, 36, 36, 36, 36, 36, 36, 36, 36, 36, 36, 36, 36, 36, 36, 36, 36, 36, 36, 36, 36, 36, 36, 36, 36, 36, 36, 36, 36, 36, 36, 36, 37, 36, 36, 36, 36, 36, 36, 37, 38, 37, 37, 37, 38, 37, 37, 37, 37, 37, 37, 37, 37, 37, 37, 37, 37, 37, 37, 37, 37, 36, 37, 36, 36, 37, 37, 37, 37, 37, 36, 36, 36, 36, 36, 36, 36, 36, 35, 36, 36, 36, 36, 36, 36, 36, 36, 36, 36, 36, 36, 36, 36, 36, 36, 36, 36, 36, 38, 36, 38, 36, 36, 36, 36, 36, 36, 36, 37, 37, 37, 36, 37, 36, 36, 36, 36, 36, 37, 37, 36, 36, 36, 36, 36, 36, 36, 36, 37, 37, 36, 37, 37, 36, 36, 36, 36, 36, 36, 36, 36, 36, 36, 36, 36, 36, 36, 36, 36, 37, 37, 35, 36, 36, 36, 36, 36, 36, 36, 36, 36, 36, 37, 36, 36, 36, 36, 36, 36, 36, 36, 36, 36, 36, 36, 36, 36, 36, 36, 36, 36, 36, 36, 36, 36, 36, 36, 36, 37, 37, 36, 36, 36, 36, 36, 36, 36, 37, 36, 36, 36, 37, 36, 36, 36, 37, 36, 36, 37, 35, 36, 37, 37, 35, 36, 36, 36, 36, 36, 36, 36, 37, 36, 36, 36, 37, 35, 36, 37, 36, 36, 36, 36, 36, 36, 36, 36, 36, 36, 36, 36, 36, 36, 36, 36, 36, 36, 36, 36, 36, 36, 37, 36, 36, 36, 36, 36, 36, 36, 37, 35, 36, 36, 36, 36, 36, 37, 36, 36, 36, 36, 36, 36, 36, 37, 36, 36, 37, 36, 36, 36, 35, 36, 36, 36, 36, 36, 36, 35, 36, 36, 36, 38, 36, 36, 36, 35, 36, 36, 36, 36, 36, 36, 36, 36, 36, 36, 36, 36, 36, 36, 36, 36, 36, 36, 36, 36, 36, 37, 36, 37, 37, 36, 36, 36, 36, 36, 36, 37, 37, 38, 37, 37, 37, 38, 37, 39, 37, 37, 37, 38, 38, 37, 37, 37, 37, 37, 38, 37, 37, 37, 37, 37, 37, 37, 37, 37, 37, 37, 37, 37, 37, 37, 38, 37, 37, 37, 37, 37, 37, 38, 37, 37, 38, 38, 37, 37, 37, 37, 37, 39, 38, 38, 37, 37, 37, 37, 37, 38, 37, 38, 37, 37, 36, 38, 37, 36, 37, 37, 37, 37, 37, 37, 37, 38, 38, 37, 37, 37, 37, 37, 37, 37, 38, 37, 37, 37, 37, 37, 37, 37, 38, 37, 38, 38, 38, 38, 38, 38, 38, 38, 38, 38, 38, 38, 38, 38, 38, 39, 38, 39, 38, 38, 38, 38, 38, 37, 37, 37, 37, 37, 37, 37, 37, 37, 37, 37, 37, 37, 37, 36, 37, 37, 37, 38, 37, 38, 38, 39, 38, 38, 38, 39, 41, 38, 38, 38, 38, 38, 38, 38, 38, 39, 38, 37, 38, 39, 38, 38, 38, 38, 38, 38, 38, 39, 38, 38, 38, 39, 38, 38, 38, 38, 38, 38, 37, 38, 38, 38, 38, 38, 39, 38, 38, 39, 38, 38, 38, 38, 38, 38, 40, 38, 38, 38, 38, 38, 38, 38, 38, 38, 39, 39, 38, 38, 38, 38, 38, 38, 38, 38, 38, 38, 38, 38, 38, 38, 38, 39, 39, 38, 38, 38, 38, 39, 38, 38, 38, 37, 38, 38, 40, 38, 38, 38, 38, 39, 38, 38, 38, 37, 39, 37, 37, 38, 38, 38, 38, 37, 37, 37, 37, 37, 37, 37, 37, 37, 37, 37, 38, 39, 37, 38, 38, 37, 37, 37, 37, 37, 37, 37, 38, 37, 37, 38, 37, 37, 37, 36, 37, 37, 37, 37, 36, 37, 37, 37, 37, 38, 37, 37, 37, 37, 37, 37, 37, 37, 37, 38, 37, 37, 37, 37, 37, 37, 37, 37, 37, 37, 37, 37, 37, 37, 37, 37, 37, 37, 37, 38, 38, 37, 37, 38, 37, 36, 37, 37, 37, 37, 37, 37, 38, 39, 38, 38, 38, 38, 38, 38, 38, 38, 38, 38, 38, 38, 38, 38, 38, 38, 38, 38, 38, 39, 38, 39, 38, 38, 38, 38, 38, 38, 39, 39, 38, 38, 38, 38, 38, 38, 38, 38, 39, 40, 39, 39, 39, 39, 39, 39, 39, 39, 38, 38, 38, 38, 38, 38, 38, 38, 38, 38, 38, 38, 38, 38, 39, 38, 38, 38, 40, 38, 38, 38, 38, 38, 38, 38, 39, 39, 38, 38, 38, 38, 38, 38, 39, 38, 38, 38, 38, 38, 38, 38, 38, 38, 39, 38, 39, 38, 38, 38, 38, 37, 38, 38, 38, 38, 38, 38, 38, 38, 38, 38, 39, 38, 37, 39, 38, 38, 38, 38, 38, 38, 38, 39, 38, 38, 38, 38, 38, 38, 38, 38, 38, 38, 38, 38, 38, 40, 38, 39, 38, 38, 38, 38, 38, 40, 38, 38, 37, 38, 38, 38, 38, 38, 38, 38, 38, 38, 38, 38, 38, 38, 38, 38, 38, 38, 38, 38, 38, 38, 38, 38, 38, 38, 37, 38, 38, 38, 38, 38, 39, 38, 37, 38, 39, 38, 38, 38, 38, 38, 38, 38, 38, 38, 38, 38, 38, 38, 38, 39, 39, 39, 38, 38, 38, 39, 38, 39, 38, 38, 38, 38, 38, 38, 38, 38, 38, 38, 38, 38, 38, 38, 38, 39, 38, 39, 39, 38, 38, 40, 40, 39, 39, 38, 38, 39, 38, 39, 38, 38, 38, 38, 38, 38, 38, 37, 39, 38, 38, 38, 39, 39, 38, 38, 38, 38, 38, 39, 38, 38, 38, 38, 38, 38, 39, 39, 38, 38, 38, 38, 39, 38, 38, 38, 38, 38, 38, 38, 38, 39, 38, 38, 38, 38, 38, 38, 38, 38, 39, 39, 38, 38, 38, 38, 39, 39, 39, 38, 38, 38, 38, 38, 39, 38, 38, 38, 39, 38, 38, 38, 39, 39, 39, 39, 39, 39, 39, 39, 39, 38, 39, 39, 40, 39, 39, 39, 39, 38, 38, 38, 38, 38, 38, 38, 38, 38, 38, 38, 38, 38, 38, 38, 39, 38, 38, 38, 38, 38, 38, 38, 38, 38, 38, 38, 38, 38, 38, 38, 38, 38, 38, 39, 38, 38, 38, 38, 38, 39, 38, 38, 39, 38, 38, 38, 38, 40, 39, 38, 38, 38, 38, 38, 38, 38, 38, 38, 39, 38, 38, 38, 38, 38, 38, 38, 38, 38, 38, 38, 38, 37, 38, 38, 38, 38, 38, 38, 39, 38, 38, 38, 38, 38, 38, 38, 38, 39, 38, 38, 38, 38, 38, 38, 38, 38, 38, 38, 38, 39, 39, 38, 38, 38, 38, 38, 38, 38, 39, 38, 37, 38, 38, 38, 38, 38, 38, 39, 38, 38, 39, 38, 38, 38, 38, 38, 38, 38, 38, 39, 38, 39, 38, 39, 38, 38, 38, 38, 38, 38, 39, 38, 38, 39, 38, 38, 38, 38, 38, 38, 38, 38, 38, 38, 39, 38, 38, 37, 38, 38, 40, 38, 38, 38, 38, 38, 38, 38, 38, 38, 38, 38, 38, 39, 39, 39, 39, 38, 39, 38, 38, 38, 38, 38, 38, 38, 38, 38, 39, 39, 40, 39, 38, 38, 38, 37, 38, 39, 38, 38, 38, 38, 38, 39, 38, 38, 38, 38, 39, 38, 38, 38, 38, 38, 37, 39, 38, 38, 38, 38, 38, 38, 38, 38, 39, 38, 38, 38, 38, 38, 39, 38, 38, 39, 38, 38, 38, 38, 38, 39, 38, 38, 38, 38, 38, 38, 39, 38, 38, 38, 38, 38, 38, 38, 38, 37, 38, 38, 39, 38, 38, 39, 38, 38, 38, 38, 39, 38, 38, 39, 38, 38, 38, 38, 38, 38, 38, 38, 38, 38, 38, 39, 38, 38, 38, 38, 38, 38, 38, 38, 39, 38, 38, 38, 38, 38, 38, 40, 38, 39, 38, 38, 38, 38, 38, 38, 38, 38, 38, 38, 38, 38, 38, 38, 38, 38, 38, 38, 38, 38, 37, 38, 38, 38, 38, 38, 38, 39, 39, 39, 38, 38, 38, 38, 38, 38, 38, 38, 38, 38, 38, 38, 38, 39, 39, 39, 38, 40, 38, 38, 38, 38, 38, 38, 38, 38, 38, 39, 38, 39, 38, 38, 38, 38, 38, 38, 38, 38, 38, 38, 39, 39, 38, 38, 39, 39, 39, 38, 38, 38, 38, 38, 38, 38, 38, 39, 39, 38, 38, 39, 38, 39, 38, 40, 37, 38, 38, 39, 38, 38, 39, 39, 38, 39, 38, 38, 37, 38, 38, 38, 37, 38, 38, 38, 38, 38, 38, 37, 38, 38, 38, 38, 38, 39, 40, 38, 38, 37, 38, 39, 38, 38, 38, 39, 38, 39, 38, 38, 38, 38, 39, 38, 39, 38, 38, 38, 38, 38, 39, 38, 38, 38, 38, 38, 39, 38, 38, 38, 38, 38, 38, 39, 38, 38, 38, 38, 39, 39, 39, 38, 38, 38, 39, 38, 38, 38, 38, 39, 38, 39, 38, 38, 39, 38, 38, 38, 37, 38, 39, 38, 38, 38, 38, 38, 38, 41, 38, 39, 38, 38, 38, 38, 38, 38, 38, 38, 38, 38, 38, 40, 40, 40, 39, 39, 39, 37, 38, 38, 38, 38, 38, 38, 38, 38, 37, 37, 38, 38, 38, 38, 38, 38, 38, 38, 38, 38, 39, 39, 39, 39, 39, 39, 39, 39, 39, 39, 40, 39, 40, 40, 40, 40, 40, 40, 40, 40, 40, 40, 40, 41, 40, 39, 40, 40, 40, 40, 39, 40, 40, 41, 41, 40, 40, 40, 40, 40, 41, 40, 40, 40, 40, 41, 40, 40, 40, 40, 40, 40, 40, 41, 40, 39, 39, 39, 39, 39, 38, 40, 39, 39, 38, 38, 38, 38, 38, 38, 38, 38, 38, 38, 39, 38, 39, 38, 38, 38, 38, 38, 38, 39, 38, 38, 38, 38, 38, 38, 38, 39, 38, 39, 38, 38, 38, 38, 38, 38, 38, 38, 38, 38, 38, 38, 38, 39, 38, 38, 39, 38, 38, 38, 38, 38, 38, 38, 39, 38, 38, 38, 38, 38, 38, 38, 38, 37, 38, 38, 38, 38, 38, 38, 38, 39, 38, 38, 38, 38, 38, 38, 38, 38, 38, 38, 38, 39, 38, 38, 38, 38, 37, 38, 38, 38, 38, 38, 38, 38, 38, 38, 38, 41, 39, 39, 39, 39, 39, 38, 39, 40, 39, 39, 39, 39, 40, 39, 39, 39, 39, 39, 38, 38, 38, 38, 38, 39, 38, 38, 38, 38, 38, 38, 38, 39, 38, 38, 38, 39, 38, 38, 38, 37, 38, 38, 38, 38, 38, 38, 38, 38, 38, 39, 38, 38, 39, 39, 38, 37, 38, 38, 38, 38, 38, 38, 39, 38, 38, 37, 38, 38, 38, 38, 38, 38, 38, 38, 38, 38, 39, 38, 39, 38, 38, 38, 38, 37, 38, 38, 38, 38, 39, 38, 38, 38, 39, 38, 39, 38, 37, 38, 38, 38, 38, 38, 38, 38, 38, 38, 38, 39, 40, 40, 40, 40, 40, 41, 40, 40, 40, 41, 40, 40, 39, 40, 40, 41, 40, 40, 40, 39, 40, 40, 40, 40, 41, 40, 40, 40, 40, 40, 40, 40, 40, 40, 40, 40, 40, 40, 41, 40, 40, 41, 40, 40, 40, 40, 39, 40, 40, 40, 40, 40, 40, 40, 40, 40, 39, 40, 40, 40, 40, 40, 39, 40, 40, 40, 41, 41, 41, 40, 39, 40, 40, 40, 40, 40, 40, 40, 40, 40, 41, 41, 41, 41, 42, 41, 41, 41, 41, 42, 41, 41, 41, 41, 41, 41, 42, 41, 42, 41, 41, 41, 41, 42, 41, 42, 42, 42, 42, 42, 42, 42, 42, 42, 42, 42, 42, 42, 42, 42, 42, 43, 42, 42, 42, 43, 42, 42, 42, 42, 42, 43, 41, 42, 42, 42, 42, 42, 42, 42, 42, 42, 42, 42, 42, 43, 42, 42, 42, 42, 42, 42, 42, 42, 42, 42, 42, 42, 43, 42, 42, 42, 42, 42, 42, 42, 42, 42, 42, 43, 42, 42, 42, 42, 42, 42, 43, 42, 42, 42, 42, 42, 42, 42, 42, 42, 44, 42, 42, 42, 42, 43, 42, 42, 42, 42, 42, 42, 42, 42, 42, 43, 41, 42, 42, 42, 42, 42, 42, 42, 42, 42, 42, 43, 43, 42, 42, 42, 42, 42, 42, 42, 42, 42, 42, 42, 42, 42, 42, 43, 42, 42, 42, 42, 42, 42, 42, 43, 42, 43, 42, 43, 42, 41, 42, 42, 42, 42, 42, 42, 42, 42, 42, 42, 42, 42, 42, 42, 42, 43, 43, 43, 43, 43, 43, 42, 43, 43, 43, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 43, 43, 43, 43, 43, 43, 43, 43, 43, 43, 43, 43, 43, 43, 43, 43, 42, 43, 44, 43, 43, 43, 43, 43, 43, 43, 42, 43, 43, 44, 42, 43, 44, 44, 44, 44, 43, 43, 43, 43, 44, 43, 43, 43, 43, 43, 43, 43, 43, 43, 43, 43, 43, 43, 43, 44, 43, 43, 43, 43, 43, 43, 43, 43, 43, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 45, 45, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 45, 44, 44, 44, 44, 44, 44, 44, 44, 45, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 45, 45, 45, 45, 45, 45, 45, 45, 47, 45, 45, 45, 45, 45, 44, 43, 44, 44, 43, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 43, 44, 43, 43, 44, 43, 43, 43, 42, 43, 43, 43, 42, 43, 43, 43, 44, 43, 43, 43, 43, 43, 42, 43, 43, 43, 43, 43, 43, 43, 43, 43, 43, 43, 43, 42, 42, 42, 42, 43, 42, 42, 42, 42, 42, 42, 42, 42, 42, 42, 42, 43, 42, 42, 42, 42, 42, 42, 42, 42, 42, 42, 42, 42, 43, 43, 42, 42, 42, 42, 41, 42, 42, 42, 42, 42, 42, 43, 42, 42, 42, 42, 42, 43, 41, 42, 42, 42, 42, 42, 42, 42, 43, 43, 43, 43, 42, 42, 43, 42, 42, 42, 42, 42, 41, 41, 41, 41, 41, 40, 40, 40, 40, 40, 42, 40, 40, 40, 40, 41, 40, 40, 40, 40, 40, 40, 40, 40, 40, 40, 40, 40, 41, 41, 41, 40, 40, 41, 40, 40, 40, 40, 41, 40, 41, 40, 40, 40, 41, 40, 40, 40, 41, 40, 40, 41, 40, 40, 40, 40, 41, 40, 41, 42, 42, 41, 41, 41, 41, 42, 42, 41, 41, 41, 41, 41, 40, 40, 40, 41, 40, 40, 40, 40, 40, 40, 41, 40, 40, 40, 40, 40, 40, 40, 40, 40, 40, 40, 40, 41, 40, 39, 40, 40, 40, 40, 40, 40, 40, 40, 40, 40, 40, 40, 40, 41, 41, 39, 40, 41, 40, 39, 40, 40, 40, 40, 40, 41, 40, 41, 42, 41, 41, 41, 41, 41, 41, 41, 40, 40, 41, 40, 40, 40, 40, 40, 40, 40, 40, 40, 40, 40, 40, 40, 41, 40, 40, 41, 41, 40, 40, 40, 40, 40, 41, 40, 40, 40, 40, 40, 40, 41, 40, 40, 40, 40, 40, 40, 40, 40, 40, 39, 39, 39, 39, 39, 39, 39, 39, 40, 40, 40, 41, 41, 40, 40, 41, 40, 41, 41, 41, 41, 40, 40, 40, 40, 41, 40, 40, 40, 40, 40, 40, 41, 40, 41, 41, 40, 40, 40, 41, 40, 40, 40, 40, 40, 40, 40, 40, 40, 40, 41, 40, 41, 40, 40, 40, 40, 40, 40, 41, 40, 40, 40, 40, 40, 40, 40, 40, 40, 40, 40, 40, 40, 41, 40, 40, 40, 40, 40, 40, 40, 40, 40, 40, 40, 39, 41, 39, 39, 39, 39, 40, 40, 39, 39, 39, 39, 41, 40, 39, 39, 39, 39, 39, 40, 39, 39, 39, 39, 39, 39, 40, 39, 39, 39, 38, 39, 39, 39, 39, 39, 39, 39, 39, 39, 39, 39, 40, 39, 40, 39, 39, 39, 39, 39, 39, 39, 39, 39, 39, 40, 39, 39, 39, 38, 39, 39, 38, 39, 39, 39, 39, 39, 39, 39, 38, 39, 40, 40, 40, 40, 40, 40, 40, 40, 40, 40, 41, 39, 39, 40, 40, 39, 39, 40, 40, 40, 40, 40, 40, 40, 40, 41, 41, 41, 40, 41, 40, 41, 41, 41, 40, 41, 41, 41, 41, 41, 41, 41, 42, 41, 42, 42, 42, 42, 42, 42, 42, 42, 42, 42, 42, 42, 42, 42, 42, 42, 42, 42, 43, 44, 43, 43, 43, 43, 43, 43, 43, 43, 43, 43, 43, 43, 43, 43, 43, 43, 43, 43, 44, 43, 43, 43, 43, 43, 42, 42, 42, 42, 42, 42, 42, 42, 42, 42, 43, 43, 44, 42, 42, 43, 41, 42, 42, 42, 43, 42, 42, 42, 42, 42, 42, 42, 42, 42, 42, 42, 42, 41, 42, 42, 41, 42, 42, 42, 42, 42, 42, 42, 42, 41, 42, 43, 42, 43, 42, 42, 42, 42, 42, 42, 42, 42, 42, 42, 43, 42, 42, 42, 42, 42, 42, 42, 42, 42, 42, 42, 42, 42, 42, 42, 42, 42, 42, 42, 42, 42, 42, 43, 42, 42, 42, 42, 42, 43, 42, 42, 42, 42, 42, 42, 42, 43, 42, 42, 42, 41, 42, 43, 42, 42, 42, 42, 42, 42, 42, 42, 42, 42, 42, 42, 42, 42, 42, 42, 42, 43, 42, 42, 42, 43, 42, 42, 42, 42, 42, 42, 42, 42, 42, 42, 42, 42, 43, 42, 43, 42, 43, 41, 42, 43, 42, 42, 42, 42, 42, 42, 42, 44, 43, 42, 42, 42, 42, 42, 41, 42, 42, 42, 42, 42, 42, 42, 42, 42, 43, 42, 42, 42, 42, 43, 42, 42, 42, 42, 42, 42, 42, 42, 42, 42, 42, 42, 42, 42, 42, 42, 43, 42, 42, 42, 42, 42, 43, 42, 41, 42, 42, 42, 42, 42, 42, 42, 41, 42, 42, 42, 42, 42, 42, 42, 42, 42, 42, 43, 42, 42, 42, 42, 42, 42, 42, 42, 42, 43, 42, 42, 42, 42, 42, 41, 42, 42, 42, 42, 42, 42, 43, 42, 42, 42, 42, 43, 42, 42, 42, 42, 42, 43, 42, 42, 42, 42, 42, 41, 42, 42, 42, 42, 42, 42, 43, 42, 43, 43, 42, 42, 42, 42, 42, 42, 42, 41, 42, 42, 43, 42, 42, 43, 43, 43, 43, 43, 43, 43, 42, 43, 43, 43, 42, 43, 43, 43, 42, 43, 43, 42, 42, 43, 43, 43, 42, 42, 43, 42, 42, 42, 42, 43, 43, 42, 42, 42, 42, 42, 42, 42, 42, 42, 43, 42, 42, 42, 42, 42, 42, 42, 42, 42, 42, 42, 42, 42, 42, 42, 42, 42, 42, 43, 42, 42, 42, 42, 42, 42, 42, 42, 42, 42, 42, 42, 42, 42, 42, 42, 42, 42, 42, 42, 42, 42, 42, 42, 43, 42, 42, 42, 42, 42, 41, 42, 42, 42, 44, 42, 42, 42, 42, 42, 42, 42, 42, 42, 42, 42, 42, 42, 42, 42, 42, 42, 42, 41, 42, 42, 42, 42, 42, 42, 42, 42, 42, 42, 42, 42, 41, 42, 42, 42, 42, 42, 42, 42, 42, 41, 42, 42, 42, 43, 42, 42, 42, 42, 42, 42, 42, 42, 42, 42, 42, 42, 42, 42, 42, 42, 42, 43, 42, 42, 42, 42, 42, 42, 42, 42, 42, 42, 42, 42, 43, 42, 43, 42, 42, 42, 42, 42, 43, 43, 42, 43, 42, 43, 42, 42, 42, 42, 42, 43, 42, 42, 42, 42, 42, 42, 42, 42, 42, 42, 42, 42, 42, 43, 42, 42, 42, 42, 42, 42, 42, 43, 42, 42, 42, 42, 42, 42, 42, 42, 42, 42, 42, 42, 42, 42, 42, 43, 43, 43, 43, 43, 43, 43, 43, 43, 43, 43, 43, 43, 44, 43, 43, 43, 43, 43, 43, 43, 43, 43, 43, 43, 43, 43, 43, 43, 43, 43, 43, 43, 44, 43, 43, 43, 43, 43, 43, 43, 43, 43, 43, 43, 43, 43, 43, 43, 43, 43, 43, 43, 43, 43, 42, 43, 43, 42, 43, 43, 43, 43, 43, 43, 44, 43, 43, 44, 44, 43, 43, 43, 43, 43, 43, 43, 42, 43, 43, 43, 43, 44, 43, 43, 42, 43, 44, 43, 43, 43, 43, 43, 43, 43, 43, 44, 43, 44, 43, 43, 42, 42, 42, 42, 42, 42, 42, 42, 42, 42, 42, 42, 42, 42, 42, 42, 42, 42, 42, 42, 42, 42, 42, 42, 42, 42, 42, 42, 41, 42, 42, 42, 42, 42, 43, 42, 43, 42, 42, 42, 42, 42, 42, 43, 43, 41, 42, 42, 42, 42, 42, 42, 43, 42, 42, 42, 42, 42, 42, 42, 42, 42, 43, 42, 42, 42, 42, 43, 42, 42, 42, 42, 42, 42, 42, 42, 42, 42, 42, 42, 43, 41, 43, 42, 42, 42, 42, 43, 42, 42, 42, 42, 42, 42, 42, 42, 42, 42, 41, 42, 42, 42, 43, 41, 43, 42, 42, 42, 42, 42, 42, 42, 42, 42, 42, 42, 42, 41, 42, 42, 42, 42, 42, 42, 42, 41, 41, 41, 41, 43, 41, 41, 41, 41, 40, 41, 41, 41, 41, 41, 41, 41, 40, 41, 41, 41, 41, 41, 41, 42, 40, 41, 41, 41, 41, 41, 42, 41, 42, 42, 41, 41, 41, 41, 41, 41, 41, 41, 41, 41, 42, 41, 42, 41, 41, 41, 41, 41, 41, 41, 41, 41, 41, 42, 41, 41, 41, 42, 41, 41, 41, 41, 41, 41, 40, 40, 41, 41, 41, 41, 42, 41, 41, 40, 41, 41, 41, 41, 42, 41, 41, 41, 42, 41, 41, 41, 41, 41, 41, 42, 41, 41, 41, 41, 41, 41, 41, 42, 41, 40, 42, 41, 41, 41, 41, 40, 41, 41, 41, 41, 41, 41, 41, 41, 41, 41, 41, 41, 41, 41, 41, 41, 43, 41, 42, 42, 42, 42, 41, 41, 41, 41, 41, 41, 41, 41, 41, 41, 41, 41, 42, 41, 41, 41, 41, 41, 41, 41, 42, 41, 41, 41, 41, 41, 42, 41, 41, 41, 41, 41, 41, 42, 41, 41, 40, 41, 41, 41, 42, 41, 41, 41, 41, 41, 42, 43, 40, 41, 41, 41, 41, 41, 41, 43, 42, 41, 41, 42, 41, 41, 41, 42, 42, 42, 42, 41, 42, 41, 41, 41, 41, 41, 41, 41, 41, 41, 41, 42, 41, 40, 41, 41, 41, 41, 41, 41, 41, 41, 41, 41, 41, 42, 42, 42, 41, 41, 41, 42, 41, 41, 41, 42, 41, 41, 41, 42, 42, 42, 41, 41, 41, 40, 41, 41, 41, 42, 41, 41, 41, 41, 41, 41, 41, 41, 41, 44, 41, 41, 42, 41, 41, 41, 40, 41, 42, 41, 41, 42, 41, 41, 41, 41, 40, 41, 42, 41, 41, 41, 41, 42, 41, 41, 41, 41, 41, 41, 41, 41, 41, 41, 41, 41, 41, 41, 42, 41, 41, 42, 41, 41, 41, 41, 41, 41, 41, 41, 41, 41, 42, 41, 41, 41, 41, 41, 41, 42, 41, 41, 41, 41, 41, 41, 40, 41, 41, 41, 41, 41, 41, 41, 42, 41, 40, 41, 43, 42, 41, 42, 41, 42, 42, 41, 41, 41, 42, 41, 42, 42, 42, 42, 42, 42, 42, 42, 42, 43, 43, 42, 42, 42, 42, 42, 41, 42, 42, 42, 42, 42, 42, 42, 42, 42, 41, 42, 41, 41, 41, 41, 41, 41, 41, 41, 41, 41, 41, 41, 41, 41, 41, 41, 40, 41, 41, 41, 41, 41, 41, 41, 41, 41, 41, 40, 42, 41, 41, 41, 41, 41, 41, 41, 41, 41, 43, 41, 41, 41, 41, 41, 41, 41, 41, 42, 41, 41, 41, 41, 43, 43, 41, 41, 41, 41, 41, 41, 41, 41, 41, 41, 41, 41, 41, 41, 41, 41, 41, 41, 41, 42, 41, 41, 41, 41, 41, 41, 41, 41, 41, 41, 41, 41, 41, 41, 41, 41, 41, 41, 41, 40, 41, 41, 41, 40, 42, 42, 42, 42, 42, 42, 41, 41, 42, 42, 43, 42, 43, 43, 43, 42, 42, 43, 43, 42, 42, 42, 42, 42, 42, 42, 43, 41, 41, 41, 41, 41, 41, 41, 41, 42, 41, 42, 42, 41, 42, 41, 41, 42, 42, 41, 41, 41, 41, 41, 41, 41, 41, 41, 40, 41, 41, 41, 41, 42, 42, 42, 41, 42, 41, 42, 41, 42, 41, 41, 41, 41, 41, 41, 41, 41, 41, 41, 41, 40, 41, 42, 41, 41, 41, 41, 41, 41, 41, 41, 41, 41, 41, 42, 41, 41, 41, 41, 41, 41, 41, 41, 41, 41, 42, 41, 42, 43, 41, 41, 41, 41, 41, 41, 41, 41, 41, 41, 40, 42, 42, 41, 41, 41, 41, 40, 41, 41, 41, 41, 41, 41, 41, 42, 41, 42, 40, 41, 40, 41, 41, 41, 41, 41, 41, 41, 41, 41, 41, 41, 42, 42, 43, 42, 42, 42, 42, 42, 42, 42, 42, 42, 41, 42, 42, 42, 42, 43, 42, 42, 42, 42, 42, 42, 42, 42, 42, 42, 42, 42, 42, 42, 42, 42, 42, 43, 42, 42, 42, 42, 42, 42, 44, 43, 42, 42, 42, 42, 42, 42, 42, 42, 42, 42, 43, 42, 42, 42, 42, 42, 42, 42, 43, 42, 42, 42, 42, 42, 42, 42, 42, 42, 42, 43, 42, 42, 42, 42, 42, 42, 42, 42, 42, 42, 42, 42, 43, 43, 42, 42, 42, 41, 41, 41, 41, 44, 41, 41, 41, 41, 41, 42, 42, 41, 41, 41, 41, 41, 41, 41, 41, 41, 41, 41, 41, 41, 41, 42, 42, 41, 41, 41, 42, 41, 41, 41, 41, 42, 42, 41, 41, 41, 41, 42, 42, 43, 43, 44, 42, 42, 42, 41, 42, 41, 41, 42, 41, 41, 41, 41, 41, 43, 42, 42, 41, 42, 42, 42, 42, 41, 41, 40, 41, 41, 41, 41, 41, 41, 41, 41, 41, 40, 41, 42, 41, 41, 42, 42, 43, 42, 41, 42, 41, 41, 42, 43, 41, 40, 42, 41, 42, 43, 41, 41, 41, 40, 41, 41, 42, 41, 42, 42, 41, 41, 41, 41, 41, 41, 41, 42, 42, 42, 41, 41, 41, 41, 41, 41, 41, 41, 41, 41, 41, 41, 41, 41, 41, 42, 41, 42, 41, 41, 41, 41, 42, 41, 41, 41, 41, 41, 41, 41, 41, 41, 41, 41, 41, 40, 41, 41, 42, 41, 41, 41, 41, 42, 41, 41, 41, 41, 41, 41, 42, 41, 41, 42, 41, 41, 42, 41, 41, 41, 41, 43, 42, 41, 41, 42, 42, 41, 41, 41, 41, 42, 42, 42, 41, 41, 42, 41, 41, 41, 41, 41, 42, 42, 42, 41, 42, 41, 41, 41, 41, 41, 41, 43, 42, 42, 42, 41, 41, 41, 41, 41, 43, 41, 41, 41, 41, 42, 41, 41, 41, 41, 41, 42, 41, 42, 42, 41, 41, 41, 41, 43, 41, 41, 41, 41, 41, 42, 43, 41, 43, 41, 41, 42, 41, 41, 41, 41, 42, 41, 41, 41, 41, 41, 41, 41, 41, 41, 41, 41, 42, 41, 41, 41, 41, 41, 41, 41, 41, 41, 41, 41, 42, 42, 41, 41, 41, 41, 42, 41, 41, 41, 41, 42, 42, 41, 41, 41, 41, 42, 41, 41, 41, 41, 41, 41, 42, 42, 41, 41, 41, 42, 43, 41, 41, 41, 41, 42, 41, 41, 42, 41, 41, 41, 41, 41, 42, 42, 42, 43, 43, 42, 43, 44, 42, 42, 42, 43, 42, 42, 42, 43, 43, 42, 42, 42, 42, 42, 42, 42, 43, 42, 42, 43, 43, 42, 42, 43, 42, 42, 41, 43, 43, 43, 42, 43, 43, 43, 44, 43, 42, 42, 43, 42, 42, 42, 42, 42, 42, 42, 41, 43, 42, 42, 41, 42, 42, 42, 44, 42, 42, 42, 42, 42, 42, 43, 41, 42, 43, 42, 42, 43, 42, 42, 44, 43, 42, 42, 41, 43, 42, 42, 42, 41, 42, 42, 42, 42, 41, 41, 42, 41, 41, 41, 41, 41, 42, 41, 42, 42, 42, 41, 41, 41, 42, 41, 41, 41, 41, 41, 41, 41, 41, 41, 41, 41, 43, 41, 41, 42, 42, 41, 41, 42, 43, 42, 42, 42, 42, 42, 42, 44, 42, 41, 41, 42, 42, 42, 43, 42, 42, 42, 43, 42, 42, 42, 43, 42, 42, 41, 42, 43, 42, 42, 42, 43, 44, 43, 42, 42, 42, 42, 42, 42, 42, 42, 42, 42, 42, 42, 42, 42, 42, 42, 42, 42, 42, 42, 42, 42, 42, 42, 42, 42, 42, 42, 43, 42, 42, 42, 42, 42, 42, 42, 43, 44, 44, 42, 42, 42, 43, 43, 42, 42, 42, 42, 42, 42, 42, 43, 42, 43, 42, 42, 42, 43, 42, 42, 42, 42, 42, 42, 43, 43, 42, 41, 42, 42, 42, 42, 42, 42, 42, 42, 42, 42, 42, 42, 42, 42, 42, 43, 42, 42, 42, 42, 42, 42, 42, 41, 42, 42, 42, 43, 43, 42, 42, 42, 42, 42, 41, 42, 42, 42, 42, 42, 42, 42, 42, 42, 42, 42, 42, 42, 42, 41, 41, 42, 42, 42, 43, 43, 42, 42, 42, 42, 42, 42, 42, 42, 41, 42, 42, 41, 41, 44, 42, 42, 42, 42, 43, 42, 42, 42, 42, 42, 43, 42, 42, 42, 42, 42, 42, 43, 42, 41, 43, 42, 42, 42, 42, 42, 42, 42, 42, 42, 42, 42, 42, 42, 42, 42, 42, 42, 42, 42, 42, 42, 42, 42, 42, 42, 42, 42, 42, 43, 42, 42, 42, 42, 42, 42, 42, 42, 42, 42, 42, 42, 42, 43, 42, 42, 44, 42, 42, 42, 42, 42, 42, 42, 42, 42, 42, 42, 42, 42, 42, 42, 42, 42, 42, 42, 42, 42, 43, 42, 42, 42, 42, 42, 42, 42, 42, 42, 42, 43, 43, 42, 42, 41, 41, 41, 41, 41, 41, 41, 41, 41, 42, 41, 43, 41, 41, 42, 42, 41, 41, 42, 42, 42, 42, 41, 41, 42, 41, 40, 42, 41, 41, 41, 41, 41, 41, 41, 40, 41, 42, 41, 41, 41, 41, 42, 42, 42, 41, 41, 41, 43, 42, 42, 42, 42, 42, 41, 43, 41, 42, 41, 42, 42, 44, 42, 42, 42, 43, 43, 42, 42, 42, 42, 42, 42, 42, 41, 42, 42, 42, 42, 42, 42, 42, 42, 42, 42, 42, 42, 41, 42, 42, 42, 42, 42, 42, 42, 42, 43, 42, 43, 42, 42, 42, 42, 43, 43, 43, 43, 43, 43, 43, 43, 42, 43, 43, 43, 43, 43, 43, 43, 43, 43, 43, 44, 43, 43, 43, 43, 44, 43, 42, 43, 43, 43, 43, 43, 43, 44, 43, 43, 43, 43, 43, 43, 43, 43, 43, 44, 43, 43, 43, 43, 43, 43, 44, 43, 43, 43, 43, 43, 43, 43, 43, 43, 43, 43, 43, 44, 43, 43, 43, 43, 43, 43, 43, 43, 43, 43, 43, 43, 43, 43, 44, 43, 43, 43, 43, 43, 43, 43, 43, 43, 43, 44, 43, 43, 43, 43, 43, 43, 43, 43, 43, 43, 43, 43, 43, 43, 43, 43, 44, 43, 43, 43, 44, 43, 43, 43, 43, 43, 44, 43, 43, 43, 43, 43, 43, 43, 43, 43, 43, 43, 43, 43, 43, 43, 43, 43, 43, 43, 43, 43, 42, 43, 43, 43, 43, 43, 43, 43, 43, 44, 43, 43, 43, 43, 43, 43, 43, 44, 43, 43, 43, 42, 43, 43, 43, 43, 43, 44, 44, 43, 43, 44, 43, 43, 43, 43, 44, 44, 44, 44, 44, 44, 44, 45, 44, 44, 44, 44, 44, 44, 44, 44, 45, 44, 44, 44, 44, 44, 44, 44, 44, 43, 44, 44, 44, 44, 44, 44, 45, 43, 44, 44, 43, 44, 44, 44, 45, 44, 44, 44, 44, 44, 44, 44, 44, 45, 44, 45, 44, 45, 44, 44, 46, 45, 44, 44, 44, 44, 44, 45, 44, 44, 44, 45, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 45, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 45, 44, 44, 44, 44, 44, 44, 44, 44, 44, 43, 44, 44, 44, 44, 44, 45, 44, 43, 44, 44, 44, 44, 44, 44, 44, 44, 44, 43, 44, 45, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 45, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 45, 44, 44, 45, 46, 44, 44, 44, 44, 44, 44, 43, 44, 44, 44, 44, 43, 44, 44, 44, 44, 44, 44, 44, 44, 45, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 45, 45, 45, 45, 45, 45, 45, 45, 45, 46, 44, 45, 46, 46, 47, 46, 46, 46, 46, 46, 45, 45, 45, 45, 45, 46, 45, 46, 46, 46, 45, 44, 45, 44, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 46, 45, 45, 46, 46, 45, 45, 44, 45, 45, 45, 45, 45, 45, 45, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 45, 45, 45, 45, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 45, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 43, 44, 44, 44, 44, 44, 44, 44, 45, 45, 44, 45, 45, 46, 45, 45, 45, 45, 45, 45, 45, 45, 44, 45, 45, 45, 45, 45, 45, 45, 45, 46, 45, 45, 45, 45, 45, 45, 45, 46, 45, 45, 46, 44, 44, 44, 44, 44, 43, 44, 44, 44, 44, 44, 45, 46, 45, 45, 45, 44, 44, 44, 44, 44, 44, 44, 44, 44, 45, 44, 44, 44, 44, 44, 45, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 43, 44, 44, 44, 45, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 45, 45, 45, 46, 44, 44, 44, 45, 44, 44, 44, 44, 45, 44, 44, 44, 44, 45, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 45, 44, 44, 44, 44, 44, 44, 45, 44, 45, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 45, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 45, 45, 45, 45, 45, 44, 45, 44, 45, 44, 44, 44, 44, 44, 44, 45, 44, 44, 44, 44, 44, 44, 43, 44, 44, 44, 44, 44, 44, 45, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 45, 45, 45, 45, 46, 45, 45, 45, 46, 46, 46, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 43, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 45, 44, 44, 44, 44, 44, 44, 44, 44, 45, 44, 44, 44, 44, 44, 44, 44, 44, 44, 43, 44, 44, 44, 44, 46, 45, 44, 44, 44, 44, 44, 44, 44, 44, 45, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 43, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 43, 44, 44, 44, 44, 44, 44, 46, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 43, 44, 44, 44, 43, 44, 44, 44, 44, 43, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 43, 44, 44, 44, 44, 45, 44, 44, 45, 44, 44, 45, 44, 45, 45, 44, 44, 44, 44, 44, 44, 44, 44, 43, 44, 44, 44, 44, 44, 44, 44, 44, 45, 44, 44, 45, 45, 45, 46, 46, 46, 46, 46, 46, 46, 46, 46, 46, 46, 45, 45, 45, 45, 46, 45, 45, 44, 44, 44, 43, 44, 45, 44, 44, 44, 44, 44, 45, 44, 44, 44, 44, 44, 44, 44, 44, 45, 44, 44, 44, 44, 44, 45, 44, 44, 45, 44, 44, 44, 44, 44, 44, 44, 45, 44, 44, 44, 44, 44, 44, 44, 43, 44, 44, 45, 44, 44, 44, 44, 44, 43, 44, 44, 44, 45, 43, 44, 44, 44, 44, 44, 44, 44, 44, 44, 46, 45, 44, 45, 44, 44, 44, 44, 43, 44, 44, 44, 45, 44, 44, 44, 44, 45, 44, 44, 43, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 45, 44, 45, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 45, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 45, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 45, 45, 44, 44, 43, 44, 45, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 45, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 45, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 45, 43, 44, 44, 45, 44, 44, 44, 44, 44, 44, 45, 44, 44, 45, 44, 44, 44, 45, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 43, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 45, 45, 45, 44, 44, 45, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 45, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 45, 44, 44, 44, 44, 45, 44, 44, 44, 44, 44, 44, 44, 44, 44, 45, 45, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 46, 44, 43, 44, 44, 43, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 45, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 45, 44, 44, 44, 44, 45, 46, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 45, 44, 44, 44, 45, 44, 44, 45, 44, 44, 45, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 45, 44, 44, 45, 44, 44, 44, 43, 44, 43, 44, 44, 44, 44, 45, 43, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 45, 44, 44, 43, 44, 45, 45, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 45, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 43, 44, 44, 44, 44, 44, 45, 45, 46, 44, 44, 44, 44, 45, 45, 44, 44, 44, 44, 44, 44, 45, 45, 44, 45, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 45, 45, 45, 45, 45, 46, 45, 45, 45, 44, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 44, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 46, 45, 45, 45, 45, 45, 47, 45, 44, 45, 45, 45, 45, 45, 45, 45, 45, 46, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 44, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 46, 45, 45, 45, 45, 45, 44, 45, 45, 45, 45, 45, 45, 45, 45, 45, 46, 46, 46, 46, 46, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 47, 45, 45, 46, 45, 45, 45, 44, 45, 46, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 46, 45, 45, 46, 45, 45, 46, 46, 47, 46, 45, 45, 46, 45, 45, 44, 45, 45, 45, 46, 46, 45, 46, 46, 46, 46, 46, 46, 46, 46, 46, 46, 45, 45, 45, 45, 46, 46, 46, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 47, 45, 45, 45, 45, 45, 45, 45, 45, 46, 45, 45, 45, 45, 45, 45, 46, 45, 45, 45, 45, 46, 46, 45, 45, 45, 45, 45, 45, 44, 45, 45, 45, 45, 45, 45, 45, 45, 45, 44, 45, 45, 45, 46, 46, 45, 45, 45, 44, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 46, 44, 45, 45, 45, 45, 45, 45, 45, 46, 45, 45, 45, 45, 45, 45, 45, 45, 44, 44, 45, 45, 46, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 46, 45, 45, 46, 45, 45, 45, 45, 46, 45, 45, 45, 45, 45, 45, 46, 45, 45, 47, 45, 45, 45, 45, 45, 45, 45, 44, 45, 45, 45, 45, 45, 45, 46, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 46, 45, 45, 45, 45, 45, 45, 44, 45, 45, 45, 45, 45, 45, 45, 44, 45, 46, 47, 46, 46, 46, 46, 46, 46, 45, 46, 45, 45, 45, 45, 45, 45, 45, 45, 44, 45, 45, 45, 45, 45, 44, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 46, 45, 46, 46, 46, 46, 46, 45, 45, 45, 45, 45, 45, 45, 45, 45, 46, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 44, 45, 45, 46, 46, 46, 45, 46, 45, 45, 45, 45, 45, 46, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 46, 45, 46, 46, 46, 46, 46, 45, 45, 45, 45, 45, 45, 46, 46, 46, 46, 46, 46, 47, 46, 46, 45, 45, 45, 44, 45, 45, 46, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 46, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 46, 45, 46, 45, 45, 45, 45, 45, 45, 46, 45, 45, 45, 45, 45, 45, 45, 46, 45, 46, 45, 45, 46, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 46, 45, 45, 45, 45, 45, 45, 45, 45, 46, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 44, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 44, 45, 45, 46, 45, 45, 45, 45, 47, 46, 45, 46, 46, 45, 45, 45, 45, 45, 45, 45, 46, 46, 45, 45, 44, 45, 44, 45, 45, 45, 45, 45, 45, 46, 45, 45, 46, 45, 45, 45, 45, 44, 45, 45, 45, 46, 47, 46, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 44, 45, 45, 45, 45, 45, 46, 46, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 46, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 46, 45, 45, 45, 45, 45, 45, 45, 44, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 44, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 44, 45, 45, 46, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 44, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 46, 45, 45, 45, 45, 45, 45, 45, 45, 46, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 44, 45, 45, 46, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 46, 46, 46, 47, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 46, 45, 45, 46, 45, 45, 45, 45, 46, 45, 46, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 44, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 46, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 46, 45, 45, 45, 45, 45, 44, 45, 45, 45, 45, 45, 45, 45, 45, 45, 46, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 44, 45, 45, 46, 44, 45, 45, 45, 45, 45, 45, 45, 46, 45, 45, 45, 45, 45, 45, 45, 45, 46, 46, 46, 45, 45, 45, 45, 45, 45, 45, 46, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 44, 44, 44, 44, 44, 44, 45, 44, 44, 44, 43, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 45, 45, 44, 44, 44, 44, 44, 44, 44, 44, 43, 44, 44, 44, 44, 44, 44, 44, 44, 45, 45, 45, 45, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 45, 44, 45, 44, 44, 44, 44, 44, 43, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 45, 44, 44, 44, 44, 44, 46, 44, 45, 44, 45, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 45, 44, 44, 44, 44, 45, 44, 43, 44, 44, 44, 44, 44, 44, 44, 44, 44, 45, 44, 44, 44, 44, 45, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 45, 45, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 45, 44, 44, 44, 44, 43, 44, 44, 45, 45, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 45, 44, 44, 45, 44, 45, 44, 44, 45, 46, 44, 44, 45, 44, 44, 44, 44, 45, 44, 44, 44, 44, 44, 44, 44, 44, 43, 44, 45, 47, 45, 44, 44, 43, 44, 44, 44, 44, 44, 44, 45, 46, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 45, 45, 44, 43, 44, 44, 44, 44, 45, 44, 44, 44, 44, 45, 44, 45, 44, 44, 44, 44, 44, 46, 44, 44, 44, 45, 44, 45, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 45, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 45, 44, 44, 44, 45, 45, 44, 44, 44, 43, 44, 44, 44, 45, 45, 44, 44, 44, 44, 44, 44, 44, 45, 44, 44, 45, 45, 45, 45, 44, 45, 45, 45, 45, 46, 45, 45, 46, 45, 45, 46, 45, 45, 45, 46, 46, 45, 45, 45, 45, 44, 44, 44, 44, 44, 44, 45, 45, 46, 45, 45, 46, 45, 44, 45, 45, 45, 45, 45, 45, 46, 45, 45, 45, 45, 45, 45, 45, 46, 45, 44, 45, 45, 45, 45, 46, 45, 44, 44, 45, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 45, 45, 44, 44, 44, 44, 45, 45, 45, 45, 45, 45, 44, 44, 44, 44, 45, 45, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 45, 45, 44, 44, 44, 44, 44, 44, 44, 44, 43, 44, 45, 44, 45, 44, 44, 44, 44, 44, 44, 44, 44, 43, 44, 44, 44, 44, 45, 43, 43, 44, 44, 44, 44, 45, 46, 44, 44, 44, 44, 45, 44, 44, 44, 44, 44, 44, 44, 44, 45, 45, 44, 44, 44, 46, 44, 44, 44, 44, 44, 44, 44, 44, 43, 44, 44, 43, 43, 44, 44, 44, 44, 44, 43, 44, 44, 44, 44, 44, 44, 44, 44, 44, 45, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 45, 45, 45, 45, 44, 44, 44, 44, 44, 44, 45, 44, 43, 44, 44, 44, 44, 44, 44, 45, 44, 45, 44, 44, 44, 44, 44, 44, 44, 44, 44, 43, 44, 44, 44, 43, 43, 44, 44, 45, 45, 44, 44, 44, 44, 44, 45, 44, 45, 44, 43, 44, 44, 44, 44, 45, 44, 44, 44, 45, 44, 44, 44, 45, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 45, 44, 44, 44, 44, 44, 45, 44, 45, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 45, 44, 44, 44, 44, 44, 45, 44, 44, 45, 45, 45, 45, 45, 45, 44, 44, 44, 44, 44, 44, 45, 44, 44, 44, 44, 44, 45, 44, 45, 44, 44, 44, 44, 44, 44, 44, 45, 44, 44, 44, 44, 44, 44, 44, 44, 45, 45, 44, 44, 44, 44, 44, 44, 45, 43, 44, 44, 44, 44, 45, 44, 44, 45, 44, 44, 44, 46, 44, 44, 43, 44, 44, 44, 44, 45, 44, 44, 44, 44, 44, 44, 44, 45, 44, 44, 45, 44, 44, 45, 44, 44, 44, 44, 44, 44, 45, 44, 44, 44, 45, 44, 45, 44, 44, 44, 45, 43, 44, 44, 44, 44, 44, 44, 44, 44, 45, 44, 44, 44, 44, 44, 44, 44, 43, 45, 44, 44, 44, 44, 44, 44, 44, 44, 44, 45, 46, 45, 46, 44, 45, 44, 44, 44, 44, 44, 44, 45, 44, 44, 44, 44, 44, 44, 44, 44, 44, 45, 44, 44, 44, 44, 44, 44, 45, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 45, 45, 45, 45, 45, 44, 44, 44, 44, 44, 45, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 46, 44, 43, 44, 45, 44, 44, 45, 44, 44, 45, 45, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 45, 44, 44, 44, 44, 45, 45, 45, 44, 44, 44, 45, 44, 44, 45, 44, 44, 44, 45, 44, 44, 44, 44, 44, 44, 45, 45, 44, 45, 44, 44, 45, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 45, 43, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 45, 43, 44, 44, 44, 44, 45, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 45, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 43, 44, 44, 44, 44, 44, 44, 44, 46, 46, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 43, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 45, 44, 44, 44, 44, 44, 45, 45, 45, 44, 44, 43, 44, 44, 45, 44, 44, 44, 44, 44, 45, 44, 44, 44, 44, 44, 45, 45, 44, 45, 44, 45, 44, 44, 43, 44, 44, 44, 44, 44, 44, 44, 43, 44, 45, 45, 45, 44, 45, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 43, 44, 44, 44, 44, 45, 44, 44, 45, 44, 45, 45, 44, 44, 44, 43, 44, 44, 44, 45, 44, 44, 44, 44, 45, 45, 44, 44, 43, 44, 44, 45, 44, 45, 44, 44, 44, 45, 44, 44, 44, 45, 44, 45, 44, 44, 44, 43, 44, 44, 44, 44, 44, 45, 44, 45, 44, 44, 45, 45, 45, 46, 45, 44, 44, 45, 45, 44, 44, 44, 44, 44, 44, 46, 44, 44, 44, 45, 44, 44, 44, 45, 44, 44, 43, 44, 44, 44, 43, 44, 44, 43, 44, 44, 44, 44, 43, 46, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 45, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 45, 45, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 43, 45, 44, 44, 45, 44, 44, 44, 45, 45, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 45, 44, 44, 44, 44, 44, 44, 45, 44, 44, 44, 43, 44, 44, 44, 44, 44, 44, 44, 44, 43, 44, 44, 45, 45, 44, 44, 44, 44, 44, 44, 44, 44, 45, 44, 44, 44, 44, 44, 44, 45, 45, 44, 44, 44, 44, 44, 45, 44, 44, 44, 44, 45, 44, 43, 44, 44, 45, 44, 44, 45, 44, 45, 44, 44, 44, 46, 45, 45, 44, 44, 44, 43, 44, 44, 45, 44, 44, 44, 45, 44, 44, 44, 45, 44, 44, 44, 44, 44, 44, 44, 44, 45, 44, 44, 43, 44, 46, 44, 44, 44, 44, 44, 44, 44, 45, 45, 45, 45, 45, 46, 46, 45, 45, 44, 45, 45, 45, 45, 45, 45, 45, 45, 44, 44, 44, 45, 44, 44, 45, 45, 44, 44, 46, 44, 46, 44, 44, 44, 44, 44, 44, 44, 44, 45, 44, 45, 46, 44, 44, 45, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 45, 44, 45, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 47, 45, 44, 44, 45, 44, 44, 43, 44, 44, 44, 44, 44, 44, 45, 44, 44, 44, 44, 44, 44, 44, 44, 44, 45, 44, 44, 44, 44, 44, 44, 44, 43, 44, 44, 44, 45, 44, 45, 44, 44, 44, 43, 44, 44, 44, 44, 44, 44, 44, 44, 44, 45, 44, 45, 45, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 45, 45, 44, 44, 44, 45, 44, 44, 44, 44, 44, 44, 45, 44, 44, 44, 44, 44, 45, 44, 44, 44, 44, 43, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 45, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 45, 43, 45, 44, 44, 44, 45, 45, 45, 45, 44, 44, 44, 45, 45, 44, 44, 44, 44, 44, 44, 44, 45, 43, 44, 44, 44, 44, 44, 45, 44, 45, 44, 45, 44, 44, 43, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 43, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 45, 44, 44, 44, 44, 44, 43, 44, 44, 45, 45, 44, 44, 44, 44, 44, 45, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 45, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 45, 45, 46, 44, 44, 44, 43, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 45, 44, 44, 44, 44, 44, 45, 44, 44, 45, 44, 44, 44, 44, 43, 44, 44, 45, 45, 45, 45, 44, 44, 44, 43, 44, 44, 45, 44, 44, 44, 44, 44, 45, 44, 45, 44, 44, 44, 44, 44, 45, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 45, 44, 44, 44, 45, 45, 44, 44, 44, 44, 44, 45, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 45, 46, 45, 44, 44, 44, 44, 44, 45, 45, 43, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 45, 44, 44, 44, 44, 45, 45, 43, 44, 45, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 43, 45, 44, 44, 44, 44, 44, 44, 44, 44, 44, 45, 45, 45, 45, 45, 45, 46, 44, 45, 46, 45, 45, 45, 46, 47, 45, 45, 45, 46, 45, 45, 46, 46, 45, 45, 45, 46, 45, 45, 45, 45, 45, 45, 45, 45, 44, 46, 45, 45, 46, 45, 45, 44, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 47, 45, 45, 45, 47, 46, 46, 46, 46, 45, 45, 45, 45, 45, 46, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 44, 45, 45, 45, 45, 44, 46, 45, 45, 45, 45, 45, 46, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 44, 44, 44, 46, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 45, 44, 43, 44, 44, 43, 44, 45, 44, 45, 44, 44, 45, 44, 44, 44, 44, 44, 44, 44, 44, 45, 46, 44, 44, 44, 44, 44, 45, 45, 44, 44, 44, 44, 45, 45, 45, 44, 44, 44, 44, 45, 45, 44, 45, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 45, 44, 44, 43, 44, 44, 44, 45, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 43, 43, 44, 44, 44, 46, 44, 44, 44, 45, 46, 46, 45, 45, 46, 45, 45, 45, 45, 45, 45, 45, 44, 44, 45, 45, 45, 45, 45, 45, 45, 46, 46, 45, 46, 45, 45, 45, 45, 45, 45, 46, 46, 45, 45, 45, 45, 45, 45, 45, 44, 45, 45, 45, 45, 45, 45, 46, 45, 45, 45, 46, 45, 45, 45, 46, 45, 45, 46, 46, 46, 46, 47, 45, 45, 45, 45, 45, 45, 44, 45, 45, 45, 45, 45, 45, 45, 46, 45, 45, 46, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 46, 46, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 46, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 47, 44, 45, 45, 45, 45, 45, 45, 45, 45, 46, 45, 46, 46, 46, 46, 45, 45, 45, 45, 45, 46, 46, 45, 45, 45, 45, 45, 45, 45, 46, 45, 45, 46, 45, 44, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 46, 45, 45, 45, 45, 46, 45, 45, 45, 46, 45, 45, 45, 46, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 46, 45, 45, 45, 45, 46, 45, 45, 45, 45, 45, 45, 45, 45, 45, 46, 46, 45, 44, 45, 46, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 46, 45, 45, 46, 45, 45, 46, 45, 45, 45, 45, 45, 45, 45, 45, 45, 46, 46, 46, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 46, 44, 45, 45, 45, 45, 45, 45, 45, 44, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 44, 45, 45, 45, 46, 45, 45, 46, 45, 45, 45, 45, 45, 46, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 47, 45, 45, 45, 45, 45, 46, 45, 45, 46, 45, 45, 45, 44, 45, 45, 45, 45, 44, 45, 45, 45, 45, 45, 45, 45, 45, 46, 46, 47, 46, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 44, 45, 45, 46, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 44, 45, 45, 46, 46, 45, 45, 45, 45, 45, 45, 45, 44, 44, 44, 44, 44, 44, 44, 45, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 45, 45, 45, 44, 44, 44, 44, 44, 44, 44, 46, 46, 44, 44, 44, 44, 44, 44, 44, 44, 45, 44, 44, 43, 44, 44, 44, 44, 44, 44, 46, 45, 45, 45, 45, 44, 44, 44, 44, 44, 45, 44, 44, 44, 44, 44, 44, 44, 45, 44, 44, 44, 44, 44, 44, 45, 44, 44, 44, 44, 44, 44, 45, 44, 44, 44, 45, 45, 44, 44, 44, 44, 44, 44, 44, 44, 43, 44, 45, 44, 45, 45, 45, 44, 44, 44, 44, 44, 44, 44, 44, 45, 44, 43, 44, 45, 44, 44, 44, 44, 44, 44, 43, 44, 44, 45, 44, 44, 44, 43, 43, 44, 45, 44, 44, 44, 44, 44, 45, 44, 44, 44, 43, 44, 43, 44, 44, 44, 44, 45, 44, 44, 44, 44, 44, 44, 44, 44, 45, 44, 44, 44, 44, 44, 44, 45, 44, 44, 44, 44, 45, 44, 44, 44, 44, 44, 45, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 45, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 43, 44, 43, 44, 45, 44, 44, 46, 44, 44, 44, 44, 45, 44, 44, 44, 43, 44, 44, 44, 44, 45, 44, 44, 44, 44, 44, 44, 44, 45, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 45, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 45, 44, 44, 44, 44, 44, 45, 44, 44, 44, 45, 44, 44, 45, 44, 44, 45, 45, 46, 44, 44, 45, 44, 44, 44, 44, 44, 44, 44, 45, 44, 44, 44, 44, 44, 44, 45, 44, 44, 44, 44, 43, 44, 45, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 43, 43, 44, 44, 44, 44, 44, 44, 44, 44, 44, 45, 45, 43, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 45, 44, 44, 44, 45, 44, 45, 44, 44, 44, 45, 44, 44, 44, 44, 45, 44, 44, 44, 44, 44, 44, 44, 44, 45, 45, 44, 44, 44, 44, 43, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 45, 44, 44, 44, 44, 44, 44, 44, 44, 44, 45, 45, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 45, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 45, 44, 45, 45, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 45, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 45, 44, 45, 44, 45, 44, 44, 44, 44, 44, 44, 44, 43, 44, 44, 44, 46, 46, 45, 45, 45, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 45, 45, 45, 45, 45, 44, 44, 44, 44, 45, 44, 44, 44, 45, 44, 44, 45, 45, 44, 45, 44, 44, 45, 44, 44, 44, 46, 44, 45, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 45, 44, 44, 44, 44, 43, 44, 44, 44, 44, 44, 44, 45, 44, 44, 44, 44, 44, 44, 44, 44, 44, 46, 45, 45, 44, 44, 44, 44, 46, 46, 45, 45, 44, 44, 46, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 45, 44, 44, 44, 44, 43, 44, 44, 44, 44, 44, 45, 44, 44, 44, 45, 44, 44, 44, 44, 43, 44, 44, 43, 45, 44, 44, 44, 45, 45, 44, 44, 44, 44, 44, 44, 45, 45, 44, 44, 44, 45, 44, 44, 44, 45, 44, 44, 44, 44, 44, 44, 44, 43, 44, 44, 45, 45, 43, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 45, 44, 44, 45, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 45, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 45, 45, 44, 44, 44, 44, 46, 44, 43, 44, 44, 44, 44, 46, 44, 45, 44, 44, 45, 44, 44, 44, 44, 43, 44, 44, 44, 44, 44, 45, 44, 44, 44, 44, 44, 46, 44, 44, 45, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 45, 44, 45, 44, 45, 44, 44, 44, 44, 45, 44, 45, 44, 44, 45, 45, 44, 45, 44, 45, 44, 44, 45, 45, 44, 44, 44, 44, 44, 44, 44, 44, 44, 45, 45, 45, 45, 46, 45, 46, 45, 45, 44, 44, 44, 44, 44, 44, 44, 45, 44, 43, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 45, 44, 44, 44, 44, 44, 44, 44, 45, 45, 43, 44, 44, 44, 44, 44, 44, 44, 44, 44, 43, 44, 45, 44, 45, 44, 44, 44, 44, 44, 44, 44, 45, 44, 44, 44, 45, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 45, 44, 44, 45, 45, 45, 44, 44, 45, 44, 44, 44, 44, 44, 45, 45, 45, 45, 44, 44, 44, 44, 44, 44, 45, 44, 44, 44, 44, 44, 44, 43, 44, 44, 44, 45, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 45, 44, 44, 44, 44, 44, 44, 44, 44, 44, 45, 44, 45, 45, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 45, 44, 44, 44, 44, 44, 44, 44, 44, 45, 44, 44, 44, 44, 44, 44, 45, 44, 44, 45, 45, 45, 45, 44, 45, 45, 45, 45, 46, 46, 46, 47, 45, 45, 45, 45, 45, 45, 45, 45, 45, 46, 45, 47, 46, 46, 46, 45, 45, 45, 45, 46, 45, 45, 44, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 46, 45, 45, 44, 45, 45, 45, 45, 45, 45, 45, 45, 47, 45, 45, 45, 45, 45, 46, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 44, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 46, 46, 45, 46, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 46, 45, 45, 45, 45, 45, 46, 45, 45, 45, 45, 45, 45, 46, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 46, 45, 46, 45, 45, 45, 45, 45, 45, 44, 45, 45, 45, 45, 46, 45, 45, 45, 46, 46, 46, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 46, 45, 45, 45, 45, 44, 45, 45, 45, 45, 45, 45, 45, 46, 46, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 46, 45, 45, 45, 45, 45, 45, 45, 45, 46, 45, 45, 45, 44, 45, 45, 45, 45, 47, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 44, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 46, 45, 45, 45, 45, 44, 44, 45, 45, 45, 44, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 46, 46, 46, 46, 46, 45, 45, 45, 45, 45, 45, 45, 45, 45, 44, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 46, 46, 46, 45, 45, 45, 45, 45, 45, 45, 45, 46, 46, 46, 45, 45, 45, 45, 45, 45, 45, 46, 45, 45, 45, 45, 45, 45, 45, 45, 45, 46, 45, 45, 44, 45, 46, 45, 45, 45, 46, 45, 45, 45, 45, 45, 45, 45, 46, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 44, 45, 45, 46, 46, 45, 45, 44, 45, 45, 45, 45, 46, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 46, 45, 45, 45, 45, 45, 46, 47, 45, 45, 46, 45, 44, 45, 46, 46, 46, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 46, 45, 44, 44, 44, 44, 44, 45, 44, 44, 45, 44, 44, 44, 44, 44, 44, 45, 44, 44, 44, 44, 44, 44, 44, 45, 44, 44, 44, 44, 44, 43, 44, 44, 44, 44, 45, 45, 44, 44, 44, 44, 44, 44, 44, 43, 44, 44, 44, 43, 44, 44, 44, 44, 44, 44, 44, 44, 44, 45, 44, 45, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 45, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 43, 45, 44, 44, 44, 44, 44, 44, 44, 45, 44, 44, 44, 44, 44, 44, 44, 44, 44, 46, 44, 44, 44, 44, 44, 44, 44, 44, 44, 43, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 45, 46, 46, 45, 44, 44, 44, 44, 43, 44, 44, 44, 44, 44, 44, 44, 44, 44, 43, 44, 44, 44, 44, 44, 44, 44, 44, 45, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 43, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 45, 44, 45, 44, 44, 44, 45, 45, 45, 45, 46, 45, 45, 46, 46, 45, 45, 46, 44, 44, 44, 44, 44, 44, 44, 44, 45, 44, 43, 44, 44, 43, 44, 44, 44, 44, 43, 44, 44, 44, 44, 44, 44, 45, 44, 44, 44, 44, 44, 44, 44, 45, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 45, 44, 44, 44, 44, 44, 44, 44, 44, 44, 45, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 45, 44, 44, 44, 44, 44, 44, 44, 44, 45, 43, 44, 45, 44, 44, 46, 45, 44, 44, 44, 44, 44, 44, 44, 45, 44, 44, 44, 45, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 45, 44, 45, 44, 44, 44, 44, 44, 44, 45, 46, 44, 44, 44, 44, 44, 45, 44, 44, 45, 44, 45, 44, 44, 44, 44, 45, 44, 44, 44, 44, 44, 43, 44, 43, 45, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 45, 44, 44, 44, 44, 44, 44, 44, 45, 45, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 45, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 43, 45, 45, 44, 45, 44, 44, 45, 45, 45, 45, 45, 46, 44, 44, 44, 44, 45, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 43, 43, 44, 44, 44, 44, 44, 44, 46, 44, 43, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 45, 44, 44, 45, 44, 44, 43, 43, 44, 45, 45, 44, 44, 44, 44, 45, 44, 44, 44, 44, 44, 44, 45, 44, 45, 44, 44, 45, 44, 44, 44, 44, 44, 43, 44, 44, 44, 44, 44, 45, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 43, 44, 44, 44, 44, 44, 44, 45, 44, 45, 44, 44, 44, 44, 44, 44, 44, 43, 44, 44, 44, 44, 45, 45, 44, 44, 44, 44, 44, 44, 44, 44, 45, 44, 44, 44, 45, 45, 44, 44, 44, 43, 44, 44, 44, 44, 44, 44, 45, 44, 44, 44, 45, 44, 44, 44, 44, 44, 43, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 46, 44, 45, 44, 44, 44, 45, 46, 44, 44, 44, 45, 45, 44, 45, 44, 44, 44, 45, 46, 44, 44, 44, 44, 44, 44, 44, 44, 44, 45, 45, 44, 44, 44, 44, 45, 45, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 45, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 45, 44, 45, 44, 44, 44, 44, 45, 44, 45, 44, 44, 44, 44, 44, 44, 45, 44, 43, 44, 44, 44, 44, 44, 44, 44, 44, 43, 44, 45, 45, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 45, 45, 44, 45, 45, 44, 44, 45, 44, 44, 44, 44, 44, 44, 44, 44, 44, 43, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 45, 44, 44, 44, 45, 44, 44, 44, 44, 44, 45, 44, 44, 44, 44, 44, 44, 44, 44, 45, 44, 44, 43, 44, 44, 44, 44, 44, 44, 44, 44, 44, 45, 44, 44, 45, 44, 44, 44, 45, 45, 44, 45, 46, 45, 44, 44, 44, 44, 44, 44, 45, 45, 44, 44, 44, 45, 44, 45, 44, 44, 43, 44, 45, 44, 44, 44, 44, 44, 44, 44, 45, 45, 44, 44, 44, 44, 44, 44, 45, 44, 44, 43, 45, 44, 44, 44, 44, 44, 44, 46, 44, 44, 43, 44, 44, 44, 44, 44, 45, 44, 43, 45, 44, 44, 44, 44, 44, 44, 44, 44, 43, 43, 44, 45, 45, 44, 44, 44, 44, 44, 44, 44, 44, 44, 43, 44, 46, 44, 44, 44, 44, 44, 44, 44, 44, 44, 45, 44, 44, 44, 44, 44, 45, 44, 44, 44, 46, 45, 45, 44, 44, 44, 44, 44, 44, 44, 44, 45, 44, 44, 44, 44, 44, 44, 45, 44, 44, 44, 44, 44, 44, 44, 45, 44, 44, 45, 44, 45, 45, 44, 44, 44, 43, 44, 44, 45, 44, 45, 44, 44, 44, 43, 44, 44, 44, 45, 45, 45, 45, 45, 45, 44, 44, 44, 44, 45, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 43, 44, 44, 44, 44, 43, 44, 44, 44, 44, 45, 44, 44, 44, 45, 45, 44, 44, 43, 44, 44, 44, 44, 44, 46, 44, 45, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 45, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 45, 44, 45, 44, 44, 46, 47, 45, 45, 45, 45, 45, 45, 44, 44, 44, 45, 46, 44, 44, 44, 44, 43, 44, 44, 45, 44, 44, 44, 44, 45, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 45, 46, 44, 45, 44, 45, 44, 44, 44, 45, 44, 44, 44, 44, 44, 44, 44, 44, 44, 43, 44, 44, 44, 44, 45, 45, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 46, 43, 44, 44, 44, 44, 44, 44, 44, 45, 44, 43, 44, 44, 44, 44, 44, 45, 44, 44, 44, 44, 44, 44, 44, 45, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 45, 44, 44, 44, 44, 44, 43, 44, 45, 43, 44, 44, 44, 44, 44, 45, 44, 44, 45, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 45, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 45, 44, 44, 44, 44, 45, 45, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 45, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 45, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 45, 44, 44, 44, 44, 45, 44, 44, 44, 44, 44, 44, 45, 46, 45, 45, 44, 44, 44, 44, 44, 44, 45, 43, 44, 44, 44, 44, 45, 45, 45, 45, 44, 45, 44, 44, 44, 45, 44, 45, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 43, 44, 44, 44, 45, 45, 47, 45, 45, 45, 44, 44, 44, 43, 44, 44, 44, 44, 44, 44, 44, 44, 44, 45, 45, 45, 45, 44, 44, 44, 44, 44, 44, 45, 44, 44, 44, 44, 44, 44, 44, 44, 45, 44, 44, 44, 44, 44, 45, 44, 44, 44, 44, 45, 45, 44, 44, 45, 45, 44, 44, 44, 44, 44, 44, 44, 45, 45, 43, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 45, 46, 46, 45, 45, 45, 45, 45, 46, 45, 44, 44, 44, 44, 44, 44, 45, 44, 45, 44, 44, 44, 44, 44, 44, 45, 45, 44, 44, 44, 45, 44, 44, 45, 44, 44, 44, 45, 44, 44, 44, 44, 44, 44, 45, 44, 44, 44, 45, 44, 44, 45, 45, 44, 44, 44, 44, 45, 44, 44, 44, 44, 44, 45, 44, 45, 44, 45, 43, 44, 44, 44, 44, 44, 44, 47, 44, 44, 44, 44, 44, 44, 43, 44, 44, 44, 44, 44, 45, 45, 44, 44, 44, 44, 44, 44, 44, 43, 43, 44, 44, 47, 45, 45, 45, 44, 45, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 43, 44, 45, 45, 44, 45, 45, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 45, 45, 45, 45, 45, 44, 45, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 45, 45, 45, 45, 43, 44, 43, 44, 44, 44, 44, 44, 45, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 45, 44, 46, 44, 44, 44, 45, 46, 47, 46, 45, 44, 44, 45, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 45, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 43, 44, 44, 45, 45, 44, 44, 45, 44, 44, 44, 45, 46, 45, 44, 44, 44, 44, 45, 44, 44, 45, 44, 44, 44, 44, 44, 44, 44, 46, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 45, 45, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 45, 44, 44, 44, 44, 45, 44, 44, 44, 46, 44, 44, 44, 45, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 43, 44, 44, 44, 44, 44, 44, 44, 44, 44, 46, 46, 45, 45, 45, 45, 44, 44, 45, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 43, 44, 45, 44, 44, 44, 44, 44, 44, 44, 44, 45, 44, 45, 45, 44, 45, 44, 44, 44, 44, 44, 45, 46, 45, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 45, 44, 45, 44, 44, 44, 44, 44, 44, 44, 45, 44, 44, 44, 44, 44, 45, 44, 45, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 45, 44, 44, 44, 44, 44, 44, 45, 44, 44, 44, 44, 44, 44, 44, 44, 43, 44, 44, 44, 44, 44, 44, 45, 44, 44, 45, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 46, 44, 44, 44, 45, 44, 44, 44, 44, 44, 44, 45, 44, 44, 45, 45, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 45, 44, 44, 44, 43, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 45, 45, 45, 44, 45, 45, 44, 44, 44, 44, 44, 44, 44, 44, 44, 45, 45, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 43, 44, 45, 43, 45, 45, 44, 44, 44, 44, 44, 44, 44, 44, 44, 45, 44, 44, 44, 44, 44, 44, 45, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 45, 45, 44, 44, 44, 45, 44, 46, 44, 45, 44, 44, 44, 45, 44, 44, 44, 44, 44, 44, 45, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 45, 45, 44, 44, 44, 44, 44, 44, 44, 44, 44, 45, 45, 44, 44, 45, 44, 45, 44, 44, 44, 44, 44, 44, 44, 44, 45, 45, 45, 45, 44, 44, 45, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 43, 44, 45, 44, 44, 44, 45, 44, 44, 45, 44, 44, 44, 44, 44, 45, 45, 44, 44, 46, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 43, 44, 45, 45, 44, 44, 44, 46, 46, 44, 44, 43, 44, 44, 44, 44, 44, 44, 44, 44, 43, 44, 44, 44, 44, 44, 44, 44, 44, 45, 45, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 45, 43, 43, 44, 44, 44, 44, 44, 45, 45, 45, 44, 44, 46, 44, 46, 44, 44, 44, 45, 45, 45, 45, 45, 45, 45, 45, 45, 46, 45, 45, 45, 44, 44, 44, 45, 46, 45, 44, 44, 44, 44, 44, 46, 45, 44, 44, 44, 44, 44, 45, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 45, 45, 45, 46, 46, 45, 45, 45, 45, 46, 44, 46, 45, 45, 45, 45, 45, 45, 45, 44, 45, 44, 45, 45, 45, 45, 44, 44, 44, 45, 45, 45, 44, 44, 44, 44, 44, 44, 44, 44, 45, 44, 44, 45, 44, 44, 45, 44, 44, 44, 45, 44, 44, 44, 44, 44, 44, 45, 44, 44, 44, 45, 44, 44, 43, 45, 44, 45, 44, 45, 44, 44, 45, 44, 44, 43, 45, 44, 43, 44, 45, 45, 46, 44, 43, 44, 44, 44, 44, 44, 44, 44, 45, 45, 44, 45, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 45, 44, 44, 44, 45, 44, 44, 44, 44, 44, 44, 45, 45, 44, 44, 44, 45, 44, 44, 45, 44, 44, 44, 44, 45, 44, 44, 43, 43, 44, 44, 44, 44, 44, 44, 45, 44, 44, 44, 44, 44, 45, 45, 44, 44, 44, 44, 45, 44, 44, 44, 45, 44, 44, 44, 44, 44, 44, 44, 44, 45, 45, 44, 44, 44, 44, 44, 44, 44, 44, 43, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 45, 44, 44, 45, 44, 46, 45, 44, 44, 44, 44, 45, 44, 44, 44, 44, 45, 46, 44, 44, 44, 44, 44, 44, 46, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 43, 44, 44, 43, 44, 44, 44, 44, 44, 46, 44, 44, 44, 44, 45, 44, 44, 44, 44, 44, 44, 44, 45, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 45, 44, 45, 44, 44, 43, 44, 44, 45, 44, 44, 44, 44, 44, 44, 45, 44, 44, 44, 44, 44, 44, 45, 44, 44, 44, 45, 44, 44, 44, 44, 44, 44, 44, 44, 43, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 45, 44, 45, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 45, 43, 44, 43, 44, 44, 44, 44, 44, 44, 44, 44, 44, 45, 44, 44, 44, 44, 44, 45, 44, 44, 44, 44, 44, 44, 45, 44, 44, 44, 44, 44, 43, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 45, 46, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 46, 45, 45, 45, 46, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 44, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 46, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 46, 45, 45, 45, 45, 45, 45, 45, 45, 45, 46, 45, 45, 44, 45, 45, 45, 45, 45, 46, 45, 45, 45, 45, 45, 45, 45, 45, 46, 46, 45, 44, 45, 45, 45, 45, 45, 45, 45, 46, 45, 44, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 46, 46, 45, 45, 45, 45, 45, 45, 46, 46, 47, 45, 46, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 46, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 46, 45, 45, 45, 45, 46, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 46, 44, 45, 45, 45, 45, 46, 45, 45, 45, 45, 46, 46, 46, 47, 45, 46, 45, 44, 45, 45, 45, 45, 45, 45, 45, 45, 45, 46, 45, 45, 46, 45, 45, 45, 46, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 46, 45, 46, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 46, 45, 45, 45, 45, 46, 45, 45, 45, 45, 45, 45, 45, 45, 45, 46, 45, 44, 44, 45, 45, 45, 45, 45, 47, 45, 45, 45, 45, 46, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 44, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 46, 45, 45, 47, 45, 45, 45, 45, 46, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 46, 46, 45, 45, 45, 45, 46, 45, 45, 45, 45, 44, 45, 45, 45, 45, 45, 45, 45, 45, 45, 46, 46, 47, 46, 46, 46, 46, 46, 46, 46, 46, 46, 46, 46, 46, 47, 46, 46, 46, 46, 46, 47, 46, 46, 46, 46, 46, 46, 46, 47, 47, 46, 46, 46, 46, 46, 46, 46, 46, 46, 46, 48, 46, 46, 46, 46, 47, 46, 46, 46, 46, 46, 46, 46, 46, 45, 46, 46, 47, 46, 46, 47, 46, 46, 47, 46, 46, 46, 46, 47, 45, 46, 47, 46, 46, 47, 46, 46, 46, 46, 46, 46, 46, 45, 46, 46, 47, 45, 46, 46, 46, 46, 46, 46, 48, 46, 46, 46, 46, 46, 46, 46, 46, 46, 46, 46, 46, 47, 46, 46, 46, 47, 46, 46, 46, 45, 46, 46, 46, 46, 46, 46, 46, 46, 46, 47, 45, 46, 46, 46, 46, 47, 46, 46, 46, 46, 46, 46, 46, 47, 46, 46, 46, 46, 46, 46, 47, 46, 47, 46, 46, 46, 46, 46, 46, 47, 47, 47, 47, 47, 46, 47, 47, 46, 46, 47, 46, 46, 46, 45, 46, 46, 46, 46, 46, 46, 46, 46, 46, 47, 47, 46, 47, 46, 46, 46, 46, 46, 46, 46, 46, 46, 46, 46, 46, 49, 47, 46, 47, 47, 45, 46, 46, 47, 46, 46, 46, 46, 46, 47, 46, 46, 46, 46, 45, 46, 46, 46, 46, 47, 45, 47, 47, 46, 46, 45, 46, 46, 45, 45, 46, 47, 46, 46, 46, 46, 46, 47, 50, 48, 47, 47, 46, 47, 46, 46, 46, 46, 46, 46, 46, 46, 46, 46, 46, 46, 47, 47, 47, 47, 46, 46, 46, 46, 46, 47, 46, 46, 46, 46, 46, 46, 46, 46, 46, 46, 46, 46, 46, 47, 46, 46, 46, 46, 47, 46, 46, 46, 46, 46, 44, 45, 45, 45, 45, 46, 45, 45, 45, 44, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 46, 45, 46, 44, 45, 46, 45, 45, 45, 45, 45, 45, 45, 46, 45, 45, 45, 45, 45, 45, 45, 45, 46, 45, 45, 45, 45, 45, 45, 45, 46, 45, 45, 45, 44, 45, 45, 46, 46, 46, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 46, 45, 45, 45, 45, 45, 45, 45, 45, 45, 46, 46, 46, 46, 46, 46, 46, 46, 47, 46, 46, 46, 46, 46, 46, 47, 47, 48, 47, 47, 47, 47, 47, 47, 47, 48, 46, 47, 47, 48, 47, 47, 47, 47, 47, 47, 48, 48, 46, 48, 46, 46, 47, 46, 46, 46, 46, 46, 46, 46, 47, 46, 46, 46, 46, 46, 46, 47, 46, 46, 46, 46, 47, 45, 46, 48, 46, 47, 46, 47, 46, 46, 46, 46, 46, 46, 46, 47, 46, 46, 46, 46, 47, 47, 46, 46, 46, 46, 46, 48, 48, 46, 46, 46, 46, 46, 46, 46, 46, 46, 46, 46, 47, 46, 46, 47, 47, 47, 47, 47, 47, 46, 46, 46, 46, 47, 46, 46, 46, 46, 46, 47, 47, 48, 47, 46, 47, 46, 48, 47, 46, 46, 46, 46, 46, 46, 46, 47, 47, 46, 46, 47, 46, 46, 46, 46, 47, 46, 47, 46, 46, 47, 45, 46, 46, 46, 47, 46, 46, 47, 46, 46, 45, 46, 46, 46, 46, 46, 46, 46, 46, 46, 47, 46, 46, 46, 46, 46, 46, 46, 46, 46, 46, 46, 47, 46, 47, 46, 46, 46, 46, 46, 47, 47, 46, 45, 46, 46, 46, 46, 46, 46, 46, 46, 47, 46, 46, 46, 47, 48, 46, 45, 47, 47, 47, 46, 46, 47, 46, 46, 46, 46, 46, 47, 46, 46, 46, 46, 47, 46, 46, 46, 45, 46, 46, 46, 46, 46, 46, 46, 46, 47, 46, 46, 46, 46, 46, 46, 47, 47, 47, 47, 47, 47, 47, 48, 46, 46, 47, 46, 46, 46, 46, 46, 46, 46, 47, 47, 46, 46, 46, 46, 46, 46, 46, 46, 46, 45, 45, 46, 46, 46, 46, 46, 46, 46, 46, 46, 45, 47, 46, 46, 46, 46, 46, 46, 47, 46, 46, 46, 46, 46, 47, 46, 46, 47, 46, 47, 47, 47, 47, 47, 47, 47, 47, 47, 48, 48, 46, 46, 46, 46, 45, 46, 46, 46, 46, 46, 47, 46, 46, 47, 47, 47, 46, 46, 46, 46, 46, 46, 46, 46, 46, 46, 46, 45, 46, 47, 46, 46, 46, 46, 46, 46, 47, 46, 46, 46, 46, 46, 46, 46, 46, 45, 46, 46, 46, 46, 47, 46, 46, 46, 46, 46, 46, 46, 46, 47, 46, 46, 46, 46, 46, 46, 46, 46, 47, 46, 46, 46, 46, 46, 46, 46, 47, 45, 46, 46, 46, 46, 46, 46, 46, 46, 46, 46, 47, 46, 46, 46, 46, 46, 46, 47, 46, 46, 46, 46, 47, 46, 46, 46, 46, 47, 47, 47, 47, 47, 48, 48, 48, 48, 48, 48, 49, 48, 48, 48, 49, 47, 48, 48, 48, 47, 47, 47, 47, 47, 48, 47, 47, 47, 47, 47, 47, 47, 47, 47, 47, 47, 47, 46, 46, 46, 46, 46, 46, 46, 47, 46, 45, 47, 46, 46, 47, 46, 46, 46, 46, 46, 46, 46, 46, 46, 46, 46, 46, 46, 46, 46, 46, 47, 46, 47, 45, 46, 46, 46, 46, 46, 46, 46, 46, 46, 47, 46, 46, 46, 46, 46, 46, 45, 46, 46, 46, 46, 46, 47, 46, 47, 46, 46, 46, 46, 46, 45, 47, 46, 46, 46, 48, 46, 46, 46, 46, 46, 46, 46, 46, 46, 46, 46, 46, 46, 46, 46, 46, 46, 46, 46, 46, 46, 46, 46, 47, 47, 47, 47, 46, 47, 46, 46, 46, 46, 46, 46, 46, 47, 46, 45, 46, 46, 46, 46, 46, 46, 48, 45, 46, 46, 46, 46, 46, 47, 46, 46, 46, 47, 46, 46, 46, 46, 46, 46, 47, 46, 46, 46, 46, 46, 46, 46, 46, 46, 46, 46, 46, 46, 46, 46, 47, 47, 47, 48, 46, 47, 46, 46, 46, 46, 46, 47, 46, 46, 46, 46, 45, 46, 47, 46, 46, 46, 46, 46, 46, 46, 46, 46, 46, 47, 46, 46, 46, 46, 47, 46, 46, 46, 46, 46, 47, 46, 46, 46, 46, 46, 46, 45, 46, 46, 46, 46, 46, 47, 46, 46, 46, 46, 46, 47, 46, 46, 46, 46, 46, 46, 46, 46, 46, 46, 46, 46, 46, 46, 46, 46, 47, 46, 46, 46, 46, 46, 45, 46, 46, 46, 46, 46, 46, 45, 45, 46, 46, 46, 46, 46, 46, 46, 47, 46, 46, 46, 46, 47, 47, 46, 46, 46, 46, 46, 46, 46, 46, 46, 46, 45, 46, 46, 46, 46, 46, 46, 46, 46, 46, 47, 47, 47, 47, 47, 47, 47, 47, 48, 47, 47, 47, 46, 48, 47, 47, 47, 47, 47, 47, 47, 48, 47, 47, 47, 47, 47, 48, 47, 47, 47, 47, 47, 46, 47, 47, 46, 47, 47, 47, 47, 47, 47, 47, 48, 47, 47, 47, 48, 46, 46, 47, 47, 48, 48, 47, 47, 47, 47, 47, 47, 48, 47, 47, 47, 47, 47, 47, 47, 47, 47, 47, 47, 47, 47, 47, 47, 48, 46, 47, 47, 48, 47, 47, 48, 47, 47, 47, 47, 47, 47, 47, 47, 47, 47, 47, 47, 47, 46, 47, 47, 46, 47, 47, 47, 47, 47, 47, 47, 47, 47, 47, 47, 47, 47, 47, 47, 47, 47, 47, 47, 47, 47, 47, 47, 47, 47, 47, 47, 47, 47, 48, 47, 47, 47, 47, 47, 48, 47, 48, 47, 48, 47, 47, 47, 46, 47, 47, 49, 47, 47, 47, 47, 47, 47, 47, 47, 47, 47, 47, 47, 47, 47, 47, 47, 47, 46, 47, 47, 47, 47, 47, 47, 47, 47, 47, 47, 48, 47, 47, 47, 48, 48, 48, 47, 48, 47, 47, 47, 46, 48, 48, 47, 47, 47, 47, 47, 47, 48, 48, 47, 48, 47, 47, 47, 48, 48, 47, 47, 47, 47, 47, 47, 47, 47, 48, 48, 47, 47, 47, 47, 47, 47, 47, 47, 47, 47, 46, 47, 47, 47, 47, 47, 47, 47, 47, 47, 47, 47, 47, 47, 48, 48, 47, 47, 47, 47, 47, 47, 47, 47, 47, 47, 47, 47, 47, 48, 47, 47, 47, 47, 47, 47, 48, 47, 47, 47, 47, 47, 48, 48, 47, 47, 48, 47, 48, 47, 46, 47, 48, 49, 48, 47, 47, 47, 48, 47, 47, 47, 47, 48, 47, 47, 47, 47, 47, 47, 47, 47, 47, 47, 47, 47, 47, 47, 47, 47, 48, 48, 48, 48, 48, 48, 48, 48, 48, 48, 47, 48, 48, 48, 48, 48, 49, 48, 48, 48, 48, 49, 48, 49, 48, 48, 49, 48, 48, 48, 47, 48, 48, 48, 48, 48, 48, 48, 48, 48, 47, 48, 48, 49, 48, 49, 48, 48, 48, 48, 48, 48, 48, 49, 49, 47, 48, 48, 48, 48, 48, 48, 48, 48, 48, 48, 48, 48, 48, 48, 48, 48, 48, 48, 48, 48, 48, 48, 48, 48, 47, 48, 49, 48, 48, 47, 48, 49, 48, 48, 48, 48, 48, 48, 48, 48, 48, 48, 48, 48, 48, 48, 48, 48, 48, 48, 48, 48, 48, 48, 48, 48, 48, 48, 48, 48, 48, 48, 48, 48, 48, 48, 48, 48, 48, 48, 48, 48, 48, 49, 48, 48, 49, 48, 48, 49, 48, 48, 48, 48, 48, 48, 48, 48, 48, 48, 48, 48, 48, 48, 47, 49, 48, 48, 49, 48, 48, 49, 47, 47, 47, 47, 47, 48, 48, 47, 47, 48, 47, 47, 48, 47, 46, 48, 47, 47, 47, 47, 47, 47, 47, 47, 47, 47, 47, 47, 47, 46, 47, 47, 47, 47, 48, 47, 47, 47, 47, 47, 47, 47, 47, 47, 47, 47, 47, 47, 47, 47, 46, 47, 46, 47, 47, 47, 47, 47, 47, 48, 48, 47, 47, 47, 47, 47, 47, 47, 47, 46, 47, 48, 47, 47, 47, 47, 47, 47, 47, 47, 47, 48, 47, 46, 47, 47, 47, 47, 47, 47, 47, 48, 47, 48, 47, 47, 47, 47, 47, 47, 47, 47, 47, 47, 47, 47, 47, 47, 48, 48, 46, 47, 47, 47, 47, 47, 47, 47, 47, 47, 47, 47, 47, 48, 49, 48, 48, 48, 48, 49, 48, 48, 48, 48, 48, 48, 48, 48, 49, 48, 48, 47, 48, 48, 48, 48, 48, 48, 48, 48, 48, 48, 49, 48, 48, 48, 48, 47, 48, 48, 49, 49, 48, 48, 49, 47, 48, 48, 47, 47, 47, 47, 47, 47, 47, 47, 47, 47, 46, 47, 47, 47, 47, 47, 47, 46, 47, 47, 47, 47, 47, 47, 47, 47, 47, 47, 48, 47, 48, 47, 47, 47, 47, 48, 48, 47, 47, 47, 47, 49, 48, 47, 47, 47, 47, 48, 48, 47, 47, 47, 47, 47, 47, 47, 48, 47, 47, 47, 47, 47, 47, 48, 47, 46, 47, 47, 47, 47, 47, 47, 47, 47, 47, 47, 47, 47, 47, 47, 47, 47, 47, 47, 46, 47, 47, 47, 47, 46, 48, 47, 47, 48, 47, 47, 47, 47, 47, 47, 47, 47, 47, 47, 48, 47, 47, 47, 48, 48, 47, 47, 47, 47, 47, 47, 47, 47, 47, 47, 47, 47, 47, 47, 47, 47, 47, 47, 47, 47, 47, 47, 47, 47, 47, 47, 47, 47, 46, 47, 47, 47, 47, 47, 47, 47, 47, 46, 47, 46, 47, 47, 47, 47, 47, 47, 47, 47, 47, 47, 47, 47, 47, 47, 47, 47, 46, 47, 47, 47, 47, 47, 47, 47, 48, 47, 47, 48, 47, 47, 47, 47, 47, 47, 47, 47, 48, 47, 47, 47, 47, 48, 47, 48, 48, 47, 47, 47, 48, 48, 47, 48, 47, 47, 47, 47, 47, 47, 47, 47, 47, 47, 47, 47, 47, 47, 47, 47, 47, 48, 47, 47, 47, 47, 48, 47, 47, 47, 47, 47, 47, 47, 47, 47, 47, 47, 47, 47, 47, 47, 47, 47, 47, 47, 47, 47, 47, 47, 47, 46, 47, 47, 47, 47, 47, 47, 47, 48, 47, 47, 47, 47, 47, 47, 47, 47, 47, 49, 47, 47, 47, 47, 47, 48, 47, 47, 48, 47, 47, 47, 47, 47, 47, 47, 47, 47, 48, 47, 47, 47, 47, 47, 47, 47, 47, 47, 47, 47, 47, 47, 48, 47, 47, 47, 47, 48, 47, 47, 47, 47, 47, 47, 47, 47, 49, 48, 47, 47, 47, 48, 47, 47, 47, 47, 47, 47, 47, 47, 47, 47, 47, 47, 48, 47, 47, 47, 47, 47, 47, 47, 49, 48, 47, 47, 48, 47, 47, 47, 47, 47, 47, 47, 47, 47, 47, 47, 46, 47, 48, 48, 47, 48, 47, 47, 47, 48, 48, 48, 48, 47, 47, 47, 47, 48, 48, 48, 48, 48, 48, 48, 49, 48, 47, 48, 48, 48, 49, 48, 48, 48, 49, 48, 48, 48, 48, 48, 48, 48, 48, 48, 48, 48, 48, 48, 48, 48, 48, 49, 48, 48, 48, 48, 48, 48, 47, 48, 48, 48, 48, 48, 48, 48, 48, 48, 48, 48, 48, 48, 48, 48, 48, 49, 48, 49, 48, 48, 48, 48, 48, 48, 48, 48, 48, 49, 49, 49, 49, 48, 49, 49, 48, 48, 48, 48, 48, 48, 48, 48, 48, 48, 48, 48, 48, 48, 48, 48, 47, 48, 49, 48, 48, 48, 47, 48, 48, 48, 48, 48, 50, 47, 48, 48, 49, 48, 49, 49, 49, 47, 48, 48, 48, 48, 48, 48, 48, 48, 48, 48, 48, 48, 48, 48, 48, 48, 48, 48, 48, 48, 47, 48, 48, 48, 49, 48, 48, 47, 48, 48, 48, 48, 48, 47, 48, 48, 48, 48, 49, 48, 49, 48, 48, 48, 48, 48, 48, 47, 48, 49, 48, 48, 48, 48, 48, 48, 48, 48, 48, 48, 48, 48, 49, 49, 47, 48, 48, 48, 48, 48, 48, 48, 48, 48, 48, 48, 48, 48, 48, 48, 48, 48, 49, 48, 48, 48, 48, 48, 48, 48, 49, 48, 49, 48, 48, 48, 48, 48, 49, 47, 48, 49, 49, 49, 48, 48, 48, 49, 48, 48, 48, 49, 48, 49, 48, 48, 49, 48, 48, 49, 49, 48, 49, 48, 49, 48, 48, 48, 49, 48, 48, 48, 48, 48, 48, 48, 48, 49, 48, 47, 48, 48, 49, 48, 48, 48, 48, 48, 49, 50, 48, 48, 49, 48, 47, 48, 48, 48, 48, 48, 48, 49, 49, 49, 49, 48, 48, 48, 48, 48, 48, 48, 48, 48, 48, 48, 48, 50, 48, 48, 48, 48, 48, 48, 48, 48, 48, 48, 48, 48, 48, 48, 48, 48, 48, 48, 48, 48, 48, 48, 48, 48, 48, 48, 48, 48, 48, 48, 48, 48, 48, 48, 48, 48, 48, 48, 49, 48, 48, 48, 48, 48, 48, 48, 47, 47, 48, 48, 49, 48, 48, 48, 49, 48, 49, 48, 48, 48, 48, 48, 48, 48, 48, 47, 48, 48, 48, 48, 48, 49, 48, 49, 50, 48, 48, 48, 48, 48, 48, 48, 48, 48, 48, 48, 48, 48, 48, 48, 48, 48, 48, 48, 48, 48, 48, 48, 48, 48, 48, 49, 49, 48, 48, 48, 48, 48, 48, 47, 48, 49, 48, 49, 48, 48, 48, 48, 48, 48, 48, 48, 48, 48, 49, 48, 48, 48, 48, 48, 48, 50, 50, 49, 48, 48, 48, 48, 48, 48, 48, 48, 48, 48, 48, 48, 49, 48, 48, 48, 48, 48, 48, 48, 48, 48, 48, 48, 48, 48, 48, 48, 48, 48, 48, 48, 50, 48, 49, 48, 49, 48, 48, 48, 48, 48, 48, 48, 48, 48, 48, 49, 48, 48, 48, 48, 47, 48, 48, 48, 48, 48, 48, 48, 48, 48, 48, 47, 48, 48, 48, 47, 48, 48, 48, 48, 48, 50, 48, 48, 48, 48, 49, 48, 48, 48, 48, 48, 49, 48, 48, 48, 49, 48, 48, 48, 48, 48, 48, 48, 48, 48, 48, 48, 48, 48, 48, 48, 48, 48, 48, 48, 48, 48, 48, 48, 48, 48, 48, 49, 48, 48, 47, 47, 47, 47, 47, 47, 47, 47, 48, 46, 47, 47, 47, 47, 46, 47, 47, 47, 47, 47, 47, 48, 47, 48, 47, 48, 47, 47, 47, 47, 47, 47, 48, 47, 49, 49, 46, 47, 47, 47, 46, 47, 47, 47, 47, 47, 47, 47, 47, 48, 48, 47, 48, 47, 48, 47, 47, 47, 46, 47, 47, 47, 47, 47, 47, 47, 47, 47, 47, 48, 48, 47, 47, 47, 47, 47, 47, 47, 47, 47, 47, 47, 47, 48, 48, 48, 47, 47, 47, 46, 47, 47, 47, 47, 47, 47, 48, 47, 48, 47, 48, 49, 47, 48, 48, 47, 48, 47, 47, 47, 47, 47, 47, 47, 47, 47, 48, 47, 47, 47, 48, 47, 47, 47, 47, 46, 47, 47, 47, 47, 47, 47, 46, 47, 47, 48, 47, 47, 47, 47, 47, 47, 47, 47, 46, 47, 47, 47, 47, 47, 47, 47, 48, 47, 48, 47, 47, 46, 47, 47, 47, 47, 48, 48, 48, 48, 47, 47, 47, 47, 47, 47, 47, 47, 48, 47, 47, 47, 47, 46, 47, 47, 47, 47, 47, 47, 47, 47, 47, 48, 47, 47, 47, 46, 47, 47, 47, 47, 48, 47, 47, 48, 48, 47, 48, 47, 47, 47, 47, 47, 47, 47, 47, 47, 48, 47, 46, 47, 48, 46, 47, 47, 47, 47, 47, 47, 47, 47, 47, 48, 47, 47, 47, 47, 47, 47, 47, 47, 47, 48, 47, 47, 47, 47, 48, 47, 47, 47, 48, 47, 47, 47, 48, 47, 47, 47, 47, 47, 47, 49, 48, 47, 47, 47, 47, 47, 47, 48, 47, 47, 48, 47, 47, 46, 47, 49, 47, 47, 47, 47, 48, 47, 47, 46, 47, 47, 47, 47, 48, 47, 47, 47, 47, 47, 47, 47, 47, 48, 47, 47, 47, 47, 47, 47, 48, 47, 48, 47, 47, 47, 47, 47, 48, 47, 47, 47, 47, 47, 47, 47, 46, 47, 47, 47, 47, 48, 47, 49, 47, 48, 47, 47, 47, 47, 48, 47, 47, 47, 46, 47, 48, 47, 47, 48, 46, 47, 48, 46, 47, 47, 47, 47, 47, 47, 47, 47, 48, 47, 48, 47, 48, 47, 47, 47, 47, 47, 47, 47, 47, 47, 48, 47, 47, 47, 47, 47, 48, 47, 47, 47, 47, 47, 47, 47, 47, 47, 48, 47, 47, 47, 47, 47, 47, 47, 47, 47, 48, 47, 48, 48, 47, 47, 47, 47, 47, 48, 47, 47, 47, 48, 47, 49, 47, 47, 47, 47, 47, 48, 47, 47, 48, 47, 47, 48, 47, 47, 48, 47, 47, 47, 47, 47, 48, 47, 48, 47, 47, 47, 47, 47, 47, 47, 47, 47, 48, 47, 48, 47, 47, 47, 47, 47, 49, 48, 47, 47, 47, 47, 48, 47, 47, 47, 47, 46, 48, 48, 47, 47, 47, 47, 47, 47, 48, 48, 47, 47, 48, 47, 48, 47, 47, 47, 48, 47, 48, 47, 47, 47, 47, 47, 47, 48, 47, 47, 47, 47, 48, 49, 49, 47, 47, 47, 47, 47, 47, 47, 47, 47, 47, 48, 48, 48, 47, 47, 48, 47, 47, 47, 48, 48, 48, 47, 47, 47, 47, 47, 47, 47, 47, 48, 48, 47, 47, 47, 47, 47, 47, 47, 48, 47, 48, 47, 47, 47, 47, 47, 47, 47, 47, 47, 47, 47, 47, 47, 47, 47, 47, 47, 47, 47, 47, 48, 48, 47, 47, 48, 47, 47, 47, 47, 47, 47, 47, 47, 47, 47, 47, 47, 47, 47, 48, 47, 47, 47, 47, 47, 47, 47, 47, 47, 47, 47, 47, 47, 47, 47, 47, 47, 47, 48, 48, 49, 48, 47, 47, 47, 47, 49, 47, 47, 47, 47, 47, 47, 46, 47, 47, 47, 47, 47, 46, 47, 48, 47, 47, 47, 48, 48, 49, 47, 47, 48, 48, 47, 47, 47, 48, 48, 48, 48, 47, 47, 47, 47, 48, 47, 46, 47, 47, 48, 48, 47, 47, 48, 47, 48, 47, 47, 48, 47, 48, 48, 47, 47, 47, 47, 47, 47, 47, 47, 47, 47, 48, 47, 48, 47, 47, 48, 47, 47, 47, 47, 47, 47, 47, 47, 47, 47, 47, 47, 47, 47, 48, 47, 47, 48, 47, 47, 47, 47, 47, 47, 47, 48, 47, 47, 47, 48, 48, 47, 47, 47, 48, 47, 49, 47, 47, 47, 47, 47, 48, 47, 48, 47, 47, 47, 47, 48, 48, 47, 47, 47, 47, 47, 47, 47, 47, 46, 48, 48, 47, 47, 46, 47, 48, 47, 47, 47, 47, 47, 48, 47, 48, 47, 47, 47, 46, 47, 47, 47, 47, 47, 47, 46, 47, 47, 47, 47, 48, 47, 48, 47, 47, 47, 47, 47, 47, 47, 47, 47, 49, 47, 48, 48, 47, 47, 48, 48, 47, 47, 47, 46, 47, 47, 47, 47, 47, 48, 47, 47, 47, 47, 47, 47, 47, 48, 48, 47, 47, 47, 48, 47, 47, 47, 47, 47, 47, 47, 47, 47, 47, 47, 48, 47, 48, 47, 47, 47, 47, 48, 47, 47, 47, 47, 47, 47, 46, 47, 47, 48, 47, 48, 47, 47, 47, 47, 47, 47, 47, 47, 47, 48, 47, 47, 47, 47, 47, 49, 47, 47, 47, 47, 47, 47, 47, 47, 47, 47, 47, 47, 47, 47, 48, 47, 47, 47, 48, 47, 46, 47, 47, 47, 47, 47, 47, 48, 47, 48, 47, 47, 50, 47, 47, 47, 47, 48, 47, 47, 47, 48, 48, 47, 47, 46, 47, 47, 47, 47, 47, 47, 48, 47, 47, 46, 47, 47, 47, 48, 48, 47, 47, 47, 47, 47, 47, 47, 47, 47, 47, 47, 47, 48, 48, 47, 47]
Topic Token Allocation Count (sum=7.68434972E8):
[42395289, 28354748, 26437256, 25069138, 23907517, 23409569, 22807626, 22196797, 22167377, 21589591, 21183834, 21079393, 20925933, 20602243, 20356925, 19050504, 18924590, 18615630, 18284060, 18188165, 18033777, 17735741, 17407078, 16897525, 16308024, 16127302, 15652453, 15424751, 15128822, 14063217, 13801793, 13754638, 13562338, 13198564, 12893584, 12308227, 10819160, 10580068, 10432985, 10354201, 10306885, 9090977, 9006485, 116, 62, 13, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0]
Topic Token Allocation Count (%):
[0.0552, 0.0369, 0.0344, 0.0326, 0.0311, 0.0305, 0.0297, 0.0289, 0.0288, 0.0281, 0.0276, 0.0274, 0.0272, 0.0268, 0.0265, 0.0248, 0.0246, 0.0242, 0.0238, 0.0237, 0.0235, 0.0231, 0.0227, 0.0220, 0.0212, 0.0210, 0.0204, 0.0201, 0.0197, 0.0183, 0.0180, 0.0179, 0.0176, 0.0172, 0.0168, 0.0160, 0.0141, 0.0138, 0.0136, 0.0135, 0.0134, 0.0118, 0.0117, 0.000000151, 0.0000000807, 0.0000000169, 0.00000000130, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000]
Topic Token Allocation CDF (%):
[0.0552, 0.0921, 0.1265, 0.1591, 0.1902, 0.2207, 0.2504, 0.2792, 0.3081, 0.3362, 0.3638, 0.3912, 0.4184, 0.4452, 0.4717, 0.4965, 0.5211, 0.5454, 0.5692, 0.5928, 0.6163, 0.6394, 0.6620, 0.6840, 0.7052, 0.7262, 0.7466, 0.7667, 0.7864, 0.8047, 0.8226, 0.8405, 0.8582, 0.8753, 0.8921, 0.9081, 0.9222, 0.9360, 0.9496, 0.9630, 0.9764, 0.9883, 1.0000, 0.999999901, 0.9999999818, 0.9999999987, 1.00000000000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000]
Fri May 24 10:14:35 EEST 2019: I am done!
Build info:Implementation-Build = 21f3fa031204320aa15d4613c5a67a1c833b26e8, Implementation-Version = 8.0.6
